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In this work, a delayed release osmotically triggered delivery device was developed that 
was able to release a payload after a delay of approximately 21 days in a consistent and 
reproducible manner.  The device was constructed out of a flexible polycaprolactone 
photo-cured network, which expelled up to 21.5 % of its total payload after burst, enabling 
close to bolus-like release profile.  Characterisation of the factors that control the delay 
of release was also performed, with evidence demonstrating that it was advantageous to 
adjust material permeability and device wall thickness over manipulation of the osmogent 
concentration, in order to maintain burst reproducibility.  The photo-cured 
polycaprolactone network was shown to be degradable under simulated physiological 
conditions, and there was no evidence of cytotoxicity after 11 days of direct contact with 
primary dermal fibroblasts.  This study provides strong evidence to support further 
development of flexible biomaterials with the aim of continuing improvement of the 
device burst characteristics in order to provide the greatest chance of the devices 
succeeding with in-vivo vaccine booster delivery.  Additionally, a polycaprolactone-
based stereolithography resin was developed that retains a degree of semi-crystallinity, 
thus providing significantly improved toughness while retaining biocompatibility.  
Benzyl alcohol was shown to be a more suitable diluent than dioxane for the formulation 
of PCL macromer photo-curable resins. An improved automated dip-coat-curing machine 
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 – General introduction 
1.1 Immunisation and vaccine delivery 
Immunisation through the utilisation of vaccines is a pivotal component of modern 
healthcare systems, with availability of immunisation classed as a core component of the 
human right to health [1].  Licenced vaccines to prevent or control 25 different infections 
are available, and cover previously widespread diseases with high mortality rates, such 
as neonatal tetanus and tuberculosis [2].  The current standard for vaccine administration 
is injection via syringe and needle, with vaccines being administered via intramuscular, 
subcutaneous, or intradermal routes.  For vaccines that require ‘boosters’, the bolus 
injectable approach requires the patient to receive further injections often weeks later in 
order to achieve reliable immunity.  This need for multiple single bolus injections can 
have a negative effect on patient compliance, and creates logistical issues which are 
greatly exacerbated in developing countries [3].  Veterinary vaccination programmes can 
be very expensive, and in some cases unprofitable.  The wage bill resulting from multiple 
visits by a veterinary team to deliver the initial and booster doses can be significantly 
more expensive than the combined total cost of all the doses [4].  Therefore, there is great 
interest in development of single administration vaccine (SAV) delivery devices or 
methods, not only to reduce costs but also to improve the efficacy of both human and 
animal vaccination programmes.  
Development of new vaccine delivery technologies are recognised as an important part 
of the World Health Organisation’s Global Vaccine Action Plan [2].  Development of 
non-injectable delivery routes such as oral and intranasal delivery have been attempted in 
order to address patient compliance [5].  Unfortunately, each new delivery route presents 
different problems to be overcome, such as mucosal membrane permeability or stability 
of antigenic material within gastrointestinal(GI) fluids when delivered using the oral route 
[6].  As such, only polio and rotavirus vaccines have licenced oral administration options 
[7], [8], and currently there is only a single intranasal vaccine on the market for influenza 
[9].  While these methods provide the advantage of not requiring injectables, progress on 
overcoming the harsh environment of the GI tract has not been swift, and they generally 
still require multiple administrations to achieve immunity. 
Birrenbach and Speiser (1976) were the first to demonstrate evidence that novel 
controlled release forms of antigen delivery were effective at not only delivery of the 
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antigen to the immune system, but also the potential to increase the immune response 
against the associated antigen [10].  Shortly after, Preis and Langer (1979) proposed use 
of such controlled release technologies to simplify vaccination schedules, and went on to 
demonstrate the first sustained release vaccine delivery device in the form of an 
implantable degradable polymer/antigen pellet that was able to illicit prolonged antibody 
formation [11].  While these early delivery systems did not make it to the clinic due to 
their toxicity, they demonstrated a strong proof of concept which has driven the 
development of modern SAV systems [12].  The sustained interest in SAV approaches is 
due to their potential to eliminate the need for booster doses, and therefore could reduce 
the logistical costs and impact on point-of-care staff/facilities associated with repeat 
administrations.  Furthermore, SAV systems have the ability to ensure the optimal time-
delay between initial and future doses, resulting in better development of immunity 
against the desired pathogen.  Similarly, use of a SAV system to deliver the doses of 
vaccine required in one appointment also eliminates the issue of patient non-compliance 
part of the way through a vaccination programme.  The significance of the ability to 
immunise completely at first point of healthcare contact is highlighted by drop-out rates 
from vaccination programmes in developing countries.  Such rates of individuals 
receiving the initial dose, but not returning for subsequent boosters, can reach 70 %.  
There are numerous potential reasons for these drop-out rates, with geographical and 
geopolitical issues such as difficulty in traveling to the clinic from isolated areas, areas 
experiencing war or political turmoil, or more personal reasons such as needle phobia, 
fear of side effects, or a general lack of faith in vaccination [13], [14].  Numerous SAV 
approach delivery platforms are currently being researched.  Potential platforms include 
liposome vesicles, polymeric particles, inorganic nanoparticles, and self-exploding 
microcapsules [15]–[20].  While most of the systems listed above involve micro or 
nanoscale dispersions, an approach where the vaccine dose is stored within an osmotically 
active macroscale polymer implant was first published by Melchels et al [21]. 
Exploiting osmosis as the driving force for drug delivery is not a new concept, with initial 
designs such as the Rose-Nelson [22], where constant release was achieved through 
osmotic-induced swelling pushing drug through an orifice via a distended membrane, 
dating back to 1955.  One of the main advantages of drug release from osmotic systems 
is that they are generally unaffected by the body’s pH, presence of food or other 
physiological factors, resulting in excellent in vitro to in vivo bioequivalence [23].  
However, osmotic systems are typically utilised in advanced oral delivery formats, rather 
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than implants.  The elementary osmotic pump (EOP) developed by ALZA in 1974 as the 
OROS™ system was the first practical example of an osmotic pump-based drug release 
system for oral use.  The original tablet consisted of an osmotic core containing the drug, 
surrounded by a semi-permeable membrane with a laser drilled orifice.  Following 
ingestion, water is absorbed into the tablet, which dissolves the drug and swells the 
osmogent, resulting in the resulting solution being created and dispensed at the same rate 
as the water entering the tablet.  The format has continued to be modernised with new 
generation devices based on the OROS™ concept being clinically approved for oral 
sustained-release of drug treatments across a wide range of therapeutic areas, including 
cardiology, endocrinology, urology, and neurology [23], [24].  Osmotic devices for 
delayed pulsatile release have been described where no orifice is made.  Osmotic uptake 
generates a gradual increase in hydrostatic pressure within the device that operates the 
release trigger, which can be in the form of ejection of a plug, expansion of an orifice, or 
rupturing of a membrane allowing bolus release of drug [25].  Use of such devices for 
vaccine delivery has been suggested [26], and appropriate delay times have been shown 
for an injectable osmotic-implant system [27].   
1.2 Device concept overview 
The proposed device resembles a hollow tubular structure that is sealed at both open ends 
of the tube.  The dimensions of the devices are proposed to be similar to the Implanon™ 
contraceptive device, approximately 30 mm long with an outer diameter of ~ 2 mm [28].  
The internal space will contain the vaccine payload and an osmotically active solution 
(osmogent).  The device will be implanted subdermally during the same appointment as 
the initial priming dose of vaccine.  The capsule trigger method is depicted in the cartoon 




Figure 1.1:- a) schematic of a device implanted under the skin. b) osmosis-driven water uptake leads to an internal 
volume increase that swells the device. c) the internal hydrostatic pressure overcomes the burst strength of the device 
causing it to rupture, releasing the vaccine into the surrounding space. Images reproduced from Melchels et al [21]. 
The device walls function like a semi-permeable membrane; impermeable to the vaccine 
and osmogent, but permeable to water.  The osmogent drives water uptake into the central 
compartment of the device at a rate dictated by primarily the material permeability, the 
osmogent concentration, and the device wall thickness.  As the internal volume increases, 
and hydrostatic pressure rises, an increasing force is exerted on the walls of the devices.  
Ultimately, the increasing pressure will overcome the burst pressure of the devices and 
will burst, releasing the vaccine payload.  Thus, the aforementioned characteristics also 
directly affect the delay to burst.  The devices are constructed from a material capable of 
being biodegraded or bioresorbed after burst, eliminating the need for surgical removal.  
Similarly to orifice-based osmotic systems, it is expected that the osmotically driven 
devices will function independently of external factors [23], therefore presenting a 
reliable platform for vaccine delivery.  Melchels et al demonstrated delayed burst release 
of a model dye from such devices, with an average delay of approximately 9 days.  The 
authors also demonstrated that the delay time could be tailored through parameters 
relating to the capsule material, capsule geometry, and osmogent concentration [21].        
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1.3 Research motivation 
The main motivation to this work was to develop and demonstrate a polymeric 
biomaterial device capable of storing and releasing a chosen payload in bulk after a 
reproducible and tunable delay period.  The main shortcoming from Melchels et al’s 1st 
generation devices was that at burst only a small pinhole was formed for payload to 
diffuse though, and so did not demonstrate the large bolus immediate-release desired.  
This work aimed to improve upon the 1st generation devices, by using a more flexible 
material which would burst in a manner more capable of immediate bolus dose release.  
This research would also deliver in-vitro evidence to support future in-vivo testing of such 
a device and its ability to deliver a vaccine to a live animal.  Furthermore, this study would 
contribute to the material science field new photo-curable biomaterials suitable for the 
production of implantable biomedical devices that offer unique mechanical 
characteristics. 
1.4 Aims and outline of the thesis 
The aims of this thesis are: 
• to develop new photo-crosslinkable resins (specifically based on 
polycaprolactone) that result in biocompatible, biodegradable materials, and can 
be processed by stereolithography. 
• to characterise the resulting photo-crosslinked networks in an appropriate manner 
regarding general biomedical use, and also specifically regarding their suitability 
for developing novel vaccine delivery devices.    
• to design, and manufacture prototype vaccine delivery devices produced from the 
developed resins and perform mechanical characterisation of the constructed 
devices.  
• to perform in vitro osmotic burst testing of the crosslinked devices to demonstrate 
the capability of the devices to mimic the delayed bolus delivery of a booster 
injection, and compare them to 1st generation devices. 
 
Chapter 2 contains a literature review covering the main themes and techniques that 
feature within this thesis. In particular, vaccine delivery systems, delivery systems for 
SAV, the fundamentals of osmotic-based drug release, structure-property relations for 
polymer networks, and how the devices could be manufactured, are reviewed. 
Chapter 3 describes the preparation of functionalised poly(caprolactone)(PCL) 
macromonomers, the development of a method for the purification and recovery of low 
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(<1,500 g/mol) molecular weight PCL macromers, and the identification of a suitable 
non-reactive diluent for photo-curable resin formulations. 
Chapter 4 describes the development of a series of PCL macromer-based photocurable 
resins and in particular a tough, degradable bimodal PCL network suitable for 
stereolithography 3D printing.  The effect of molecular weight and distribution of chain 
length in polymer networks on mechanical properties and resin reactivity and ‘green’ part 
network development were investigated.  
Chapter 5 presents the findings of in-vitro cytotoxicity assessments of our photo-
crosslinked networks.  Direct contact experiments were performed to evaluate any effect 
on the metabolic activity, and proliferation of human primary dermal fibroblasts cultured 
on the surfaces of the materials. 
Chapter 6 describes the manufacture of the delivery devices through dip coating and 
stereolithography techniques.  Characterisation of the wall thicknesses of the produced 
tubular parts is conducted by micro computerised tomography.  Mechanical burst 
assessments are investigated as a method predicting osmotic burst behaviour, which is 
performed using universal testing apparatus. 
Chapter 7 details the motivation behind the design and construction of a bespoke dip 
coating machine for the production of the tubular part of the delivery devices and details 
its construction and use.  Evidence of tubes successfully produced using this machine is 
also shown. 
Chapter 8 describes the in-vitro osmotic dye release study of prototype photo-cured 
vaccine delivery devices.  Devices are compared with thermoplastic devices similar to 
those used in the initial concept paper [21] to investigate the effect of chemical/permanent 
crosslinking on the device’s osmotic and burst behaviours.  The rate of water uptake, 
delay to burst, release at the moment of burst, and total release are assessed and discussed. 
Chapter 9 summarises the main findings of the work presented within this thesis, 
discusses and lays out recommendations for future work. 
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 – State of the art 
2.1 Vaccine delivery systems 
The hypodermic needle is the current gold standard of vaccine delivery technology due 
to offering a direct, low cost method, with instant verification of dose delivery. Bolus-
dose injections have demonstrated an excellent efficacy profile over decades of use, 
despite limitations such as pain and needle phobia which can be detrimental to patient 
compliance. In some developing or 3rd world countries, vaccine coverage can be low due 
to failure in booster follow-up, or a lack of trained personnel or facilities [29]. 
Additionally, such follow-ups can be highly expensive in a veterinary setting. Thus, 
methods of delivering antigenic material in a controlled manner from a system that can 
be injected/implanted in a single appointment would be advantageous. Examples of the 
SAV methods in the literature are discussed below, as well as other novel vaccine delivery 
methods being proposed. 
2.1.1 Polymer particles 
Polymeric particles form the main focus for development of SAV systems [15], [30]. The 
concept typically involves encapsulation of antigen in a biodegradable polymer matrix. 
Release from such particles typically show either a continuous or pulsatile profile due to 
degradation erosion of the polymer. For continuous release particles, the profile is 
typically biphasic, while the pulsatile release particles show triphasic profiles [31]. The 
initial release stage of both variants is typically due to release of loosely bound antigenic 
material near the surfaces of the particles. For continuous release particles, this transitions 
into a period of zero-order release, while for pulsatile particles there is typically a lag-
phase where minimal release occurs, followed by a significant burst release [30], [31]. A 
wide range of natural and synthetic polymers have been used to make vaccine delivery 
particles, such as poly (D,L-lactic-coglycolic acid)(PGLA), poly(lactic acid) (PLA), 
alginate, starch, and dextran [15], [32]–[34]. Most particle formulations developed feature 
the continuous release profile [35], [36]. However, there is currently no evidence from 
human clinical trials that demonstrate whether continuous release of antigenic material 
can achieve an equal level of immune system stimulation to typical pulsatile methods 
[30]. Some particle design considerations for pulsatile antigen release can contrast with 
those for continuous release methods. One such consideration is that the delayed release 
pulsatile particles must persist within the body for the desired time with minimal antigen 
release or loss. This is typically achieved through very low concentrations of antigen 
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payload, so that large barriers of polymer slow or prevent diffusion [37]. Additionally, 
the carrier particle should be immunologically inert to prevent recognition and premature 
clearance by the immune system prior to payload release [30].  One of the more recent 
examples of pulsatile microparticle antigen delivery was able to replicate 3 antigen pluses 
in vitro mimicking the kinetics of 3 bolus doses in a clinical setting. The PLGA particles 
from the same study were also able to approximately match antibody titre development 
over time, and peak antibody titres produced by 3 bolus vaccine injections [38].   While 
the feasibility of vaccine encapsulation within degradable polymers for SAVE purposes 
have been shown in many studies, particle systems are yet to show convincing utility in 
clinical trials [30]. A disadvantage of this approach is that mixing of the polymer with the 
antigenic material to produce the loaded particles typically involves harsh conditions, 
including high temperatures, organic solvents (methylene chloride), and freeze drying, all 
of which have been shown to affect antigen conformation [39]. Additionally, particle 
antigen-loading efficiencies are typically low, and the more desirable pulsatile-profile 
particles often fail to release the complete dose upon burst. This low efficiency also has 
a negative impact on projected cost of such an approach. 
2.1.2 Liposome vesicles 
Since the ability of antigen-laden liposomes to induce immune responses was first 
demonstrated by Gregoriadis and Allison [40], the field of liposomes and liposome-based 
vaccines has become one of the most widely researched vaccine development systems 
[16]. The field includes liposome-derived nanovesicles such as archaeosomes and 
virosomes. The liposome construct encapsulates the antigenic material payload within a 
bilayer phospholipid bilayer sphere, or can be incorporated into the membrane itself, or 
by surface attachment on the membrane [33]. Stability enhancing polymers (such as 
poly(ethylene glycol)(PEG), and charged membrane-associated adjuvants that affect how 
liposomes behave in vivo are also typical components. A key advantage of liposomes and 
their associated derivatives is their versatility through the adjustability of their 
physicochemical attributes, which enables them to be tailored for individual applications 
[15]. Typically changes in surface charge, membrane fluidity, overall size, and location 
of loaded antigen can significantly alter the vaccine delivery functionality of the liposome 
system. Subsequently, this customisability also introduces a significant degree of 
complexity. Liposome-based vaccines for hepatitis A (Epaxal®) [41] and influenza 
(Inflexal®) [42] have been approved for use in humans, however liposomal delivery 
systems still have some outstanding concerns. Many novel liposome systems feature 
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synthetic materials which may generate cytotoxic effects in vivo. Furthermore, most 
liposomal systems do not have long-term safety profiles in animal models, let alone 
human use [43]. Long term storage stability is also a concern, due to often being 
customised with functional materials that are environment sensitive. Manufacturing scale 
up of the multi-level liposomal modifications required is of practical difficulty, due to the 
number of complex steps required, and severe batch variation. Use of expensive materials 
to modify the liposomes may price any clinically successful liposome system out of the 
market. Additionally, like many areas of the drug development field [44], liposome 
vaccine delivery research suffers from prevalence of low reproducibility of published 
outcomes.   
2.1.3 Self-exploding microcapsules 
De Geest et al’s microcapsule concept involves a degradable hydrogel core surrounded 
by a semi-permeable polyelectrolyte membrane [3], [45], [46]. Microcapsule have been 
explored previously for drug release, but typically involve an external trigger mechanism 
such as an electric field [47], IR light [48], or pH [49]. The payload-laden core was 
constructed from a crosslinked dextran-hydroxyethyl methacrylate (dex-HEMA) 
network. Degradability was incorporated by activating HEMA with 1,1’-
carbonyldiimidazole (CDI), which following conjugation to dextran, results in formation 
of carbonate esters that are able to be hydrolysed under physiological conditions [20]. 
The outer semi-permeable membrane enables influx of water to the core, while retaining 
the core materials and payload within the microcapsule. The microcapsule releases the 
antigenic material through osmotic swelling and degradation of the hydrogel core so that 
it bursts through the membrane outer layer. The rate upon which the swelling occurs is 
regulated by crosslinking density of the dex-HEMA core. A release profile with separate 
pulsed waves of antigen release was theoretically possible by injecting populations of 
microcapsules with sets of dex-HEMA hydrogels with varied crosslinking densities. 
Unfortunately, the polyelectrolyte shell of the capsules was prone to infiltration and 
degradation by recruited inflammatory cells, which caused early rupture of the capsules 
and led to disruption of the desired controlled release profile of the payload [50]. The 
osmotically active microcapsules also possessed other limitations such as the burst times 
being highly sensitive to variations in size of the capsules, and potential redistribution 
throughout, or clearance from the body. Additionally, in the case of an adverse event, due 
to their size and distribution it would be impossible to remove the particles.  
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By removing the dex-HEMA osmotic core, an alternative approach of antigen 
presentation directly to dendritic cells was tested. An in vitro antigen presentation assay 
demonstrated that dendritic cells actively uptake the polyelectrolyte microcapsules, which 
then rupture within endolysomal vesicles where the antigen is released and processed. It 
was shown that the capsules could efficiently stimulate CD4 and CD8 T-cell proliferation 
by this method [51], [52].  
2.1.4 Inorganic particles 
Despite their low degradability, many inorganic micro- and nanoparticle-based vaccine 
systems have been researched due to the excellent level of control over their synthesis 
[53], [54]. Gold particles are highly stable and extensively modifiable enabling relatively 
straightforward antigen conjugation [55], [56]. Carbon particles are rapidly taken up by 
antigen-presenting cells and are capable of carrying multiple antigens simultaneously 
[57]. Mesoporous carbon spheres are being investigated as potential oral vaccination 
systems [58]. Calcium phosphate particles are a promising candidate for vaccine delivery 
systems as they are bioresorbable, non-toxic, and easily loaded with antigenic material 
[59]. Calcium phosphate was used as an adjuvant in a series of commercialised vaccines 
in France, but was replaced by aluminium salts in the 1980s, and later disregarded due to 
the success of the aluminium adjuvants [60]. It has been suggested in recent years that 
calcium phosphate may return to replace the aluminium adjuvants in current vaccines due 
to toxicity and side-effect concerns. Aluminium particles have been researched for use as 
antigen-carrying particles themselves. Studies shown that the aluminium particles are 
able to simultaneously act as the delivery system and adjuvant. However, it was also been 
shown that the antigenic material adsorbed by the aluminium can be bound so tightly that 
the protein structure of the antigen is altered, ultimately reducing vaccine efficacy.  
2.1.5 Osmotic spherical capsules 
Early work on spherical osmotic capsules were recently demonstrated as a potential 
delayed-release drug delivery system [61]. Biodegradable poly(lactic acid-co-glycolic 
acid)(PLGA) was used to construct the outer spherical shell with a radius of between 1.5 
and 2.2 mm. The internal space contained a saturated salt solution of sodium chloride or 
lithium chloride, which were used as osmogents to drive water uptake into the capsule at 
a controlled rate, alongside a payload. The capsule function through an increase in 
hydrostatic pressure generated by the water influx, which eventually overcomes the 
tensile strength of the outer PLGA shell resulting in release of the payload. Therefore, 
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these spherical capsules operate in a highly similar manner to the tubular monolithic 
capsules described by Melchels et al [21] and those proposed within this thesis. Multiple 
spherical capsules would be employed to provide pulsatile release profiles over a series 
of time points. In vitro testing indicated that the delay time could be adjusted between 
approximately 1.5 – 17 days by changing the osmogent solution, capsule radius, and shell 
thickness.  However, the current manufacturing process is laborious and uses organic 
solvents during encapsulation of the osmogent and payload, which may destroy the 
antigenic compound. Additionally, beyond the 10 day mark it was found that the capsule 
burst point deviated from predictions and was attributed to significant degradation of the 
PLGA shell.  
2.1.6 Outer membrane vesicles 
Outer membrane vesicles (OMVs) are naturally occurring, non-replicating vesicles 
derived from Gram-negative bacteria [62]. OMVs generally consist of bacterial 
phospholipids, lipopolysaccharides, outer membrane proteins and entrapped periplasmic 
components, depending on the host bacteria species, which give OMVs inherent 
immunostimulatory properties [63]. Desired antigenic material can be present either on 
the surface, inside the lumen of the vesicle or unbound in the contained solution. 
However, strong immune responses against the platform backbone have been reported, 
while other issues are due to the heterogeneity of the vesicle product populations, which 
introduces complications in processing during manufacture [62]. At present, two outer 
membrane vesicle vaccines (Bexsero [64] and Trumenba [65]) for meningitis B are 
licensed for human use and are delivered via intramuscular injection. 
2.1.7 Other novel approaches to vaccine delivery 
Plant and algae cells have been researched as oral vaccine delivery platforms due to the 
potential ease and low cost to vaccinate large populations [15], [66]. The tough cell walls 
are able to protect intracellular material from the harsh GI tract environments that often 
pose as a major complication for other oral delivery systems. The cell wall is able to be 
digested by microbes that colonise the intestines, releasing the antigenic payload [67].  
Both plant-, and algae-based systems are subject to variance in the reliability of the 
immunogenic response generated due to the complexity and diversity of the gut 
microbiome [15]. Additionally, poor expression yields of antigenic material within 
transgenic cells is also a concern [66]. Separately, pollen grains have been investigated 
as an oral vaccine delivery platform due to the outer shell of the grain being shown to be 
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able to survive the harsh conditions of the stomach [68]. While systemic and mucosal 
responses could be generated from antigenic material within pollen grains [69], [70], a 
greater knowledge of the molecular mechanisms behind the internalisation and 
interactions of the pollen particle and immune cells is required. Microarray patches 
(MAP) consists of a cluster of tens to thousands of projections less than one millimetre 
in length attached to a backing that can be applied to the skin typically with finger pressure 
or an applicator. While a series of MAPs are in preclinical, and one in clinical stage trials, 
to date no microarray technology has been FDA-approved for the delivery of a vaccine 
[71]. Barriers to approval currently include skin irritation, confirmation of doses 
delivered, and compatibility of the antigenic material with the microneedle manufacturing 
process [15]. Another, drawback is that even if it is proven to be an effective approach it 
is difficult to identify a market due to the MAP approach likely to cost more than any 
existing product [71]. 
2.1.8 The monolithic capsule  
The initial concept of the monolithic osmosis-driven delayed vaccine delivery device was 
first described by Melchels et al [21]. An overview of the device was shown in Section 
1.2. The device uses water uptake as the delay mechanism and trigger to release a bolus 
booster dose of vaccine. Such a method offers a series of advantages when compared with 









Tailoring delay time + - ++ 
Exposure of antigen to harsh conditions - + + 
Pulse-like delivery - + ++ 
Dependence on physiological factors - - + 
Sterilisation - - + 
Ease of administration + + - 
Removal if adverse reaction - - + 
Cost - - ++ 
Table 2.1:- Comparison of advantages and disadvantages of monolithic osmosis driven delayed burst release capsules 





One of the main advantages of the monolithic capsule is that the device itself is developed 
and prepared independently from the payload, and so the devices could potentially be 
loaded with a variety of different payloads to suit different purposes without extensive 
redesigns or adjustments to loading. Due to the capsule being largely manufactured prior 
to filling with payload and osmogent, the antigenic payload will be exposed to minimal 
processing in comparison to those required (heat/organic solvents) for polymer 
microparticles. The main disadvantage of the monolithic capsule approach is the method 
of administration due to the size of the device. The capsule requires use of a large diameter 
needle to be implanted under the skin. However, a device with similar geometry marketed 
as Implanon™ contraceptive is currently being used successfully in women, where the 
application via a needle and plunger is performed by nurses and general practitioners 
without the need for specific training. Implanon is termed a “single rod subdermal 
implant”, where the rod is 40 mm long with a diameter of 2 mm. Progestin etonogestrel 
is continuously released from the device through rate controlling membrane of ethylene 
vinyl acetate for up to 3 years. The Implanon device is not biodegradable, and therefore 
must be removed through an incision through which the device can be extracted using 
forceps. From large scale post marketing surveillance studies, Implanon has been found 
to be a highly effective drug delivery system with low complication incidence rates and 
severities [28], [72]–[75]. The device geometry, positioning, and implantation procedure 
have been demonstrated to be acceptable to patients, with the main insertion complication 
being local skin irritation which occurred in less than 5 % of women [28], [72], [75]. A 
disadvantage relating specifically to the osmotic capsules is the possibility of cell necrosis 
resulting from local hypertonicity after burst, due to release of the osmogent into the local 
tissue. This is expected to be transient however, as local isotonicity would be re-
established. The osmotic delivery devices will be constructed from a 
biodegradable/bioresorbable material, thus eliminating the need for surgical removal as 
is required with Implanon.  
A previous attempt at a monolithic delayed-burst delivery device was proposed by Barr 
and Thiel in 1992 [27]. The payload was integrated into a core of solidum starch glycolate, 
coated with a pH-sensitive Eudragit S 100 film. An outer coating of insoluble Eudragit 
NE30D mixed with hydroxypropyl-methylcellulose (HPMC) as pore former was applied. 
When introduced to an aqueous environment, the HPMC in the outer coat dissolved, 
allowing water to access the S 100 coating underneath, which dissolves at tissue pH. This 
allows water to penetrate and swell the inner core, completely rupturing the outer NE30D 
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membrane and releasing antigen payload. This device concept was last referred to within 
a review by Stubbe et al in 2004 [26], however no further literature on the device has 
been found.  
This thesis aims to build upon the work by Melchels et al through the development of the 
next (2nd) generation of osmosis-driven burst-release capsules. 
2.2 Osmotic uptake and burst mechanics 
2.2.1 Osmotic water uptake 
A simplified one-dimensional process of osmotic water uptake into the internal 
compartment of the device can be described in terms of Fick’s laws. The driving force 
behind the transport process which involves sorption, diffusion, and permeation is the 
concentration difference between the external and internal phases. An example of osmotic 
flux through a water-permeable polymer membrane (wall) is shown in Figure 2.1. 
 
Figure 2.1:- Flux of water across a polymer wall of thickness t driven by the concentration gradient ΔC. 
Fick’s first law describes this process, where the rate of mass transfer or flux (J) is 
proportional to the concentration gradient (δC/δx), and the proportionality constant is the 




 Equation 2-1 
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Fick’s first law is only applicable to diffusion in the steady state.   
By integrating Fick’s first law we attain a formula that can be used to approximate 
diffusivity through a membrane [76], shown in Equation 2-2, where, t is the thickness of 
the wall and C2 and C1 are respectively the concentration of water at the downstream and 




 Equation 2-2 
We can introduce the sorption equilibrium parameter (S) into Equation 2-2, to form 
Equation 2-4, through the relationship in Equation 2-3. S is the constant of proportionality 
between pressure (p) and concentration (C). 




 Equation 2-4 
The diffusion coefficient (D) can be combined with the sorption equilibrium parameter 
(s) to get the final form of the equation: 
𝑃𝑤 = 𝐷𝑆 Equation 2-5 
𝐽 =  −
𝑃𝑤(𝑝2 − 𝑝1)
𝑡
 Equation 2-6 
Where J is the diffusion flux, Pw is the permeability of the polymer wall, and p represents 
the pressure on each side of the wall. Use of a polymer with different water uptake 
equilibria is a method of adjusting the burst delay time. 
 
The osmotic pressure generated by the concentrated osmogent within the capsule can be 
calculated. The Van’t Hoff equation (Equation 2-7) is only suitable for dilute mixtures, 
therefore the Granik et al theory and associated equation (Equation 2-8) [77] can be used: 











Where, R is the gas constant, T is the temperature in kelvin, C2 is the solute molar 
concentration, V is the volume of a solution of m2 moles of solute dissolved in 1 L of 
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solvent, and m’1 and m’2 are the solute molal concentrations of solute and solvent 
respectively. Through modulation of the loaded osmogent concentration, the osmotic 
pressure can be varied as a possible method of controlling the delay to burst, however it 
has been previously shown that lower osmotic pressures can introduce burst variance 
[21]. 
2.2.2 Burst mechanics 
As translocated water driven by osmotic uptake fills the space within the device, an 
internal pressure is produced and exerts stress on the material comprising the cylinder 
walls in all directions. The device is considered a perfect, straight cylinder with 
homogenous wall thickness throughout, and the plugs/caps that seal the open ends are 
assumed to stay flat under load. Only the deformation of the tubular part is considered 
due to the capsule length being substantially larger than the diameter (L >> D). For 
simplicity, the device is considered a thin walled pressure vessel and therefore radial 
stress is assumed to be substantially smaller than circumferential stress and can be 
ignored. 
The stress in the axial (σz) and circumferential (σθ) direction can be described by Barlow’s 
formulae [78], where P is the internal hydrostatic pressure, t is the wall thickness, and r 








 Equation 2-10 
As indicated by the denominator, the stress in the circumferential direction is twice as 
large as the stress in the axial direction, and therefore burst can be expected along the 
tubular part rather than the end caps.  
By rearranging Equation 2-10 the pressure at which the tubular part will burst (Pburst) can 




 Equation 2-11 
Where, Su is the ultimate strength of the material, and D is the outer diameter of the device. 
From Equation 2-11, it can be shown that burst pressure decreases as diameter increases, 
making this another possible parameter to control the burst delay time with. Additionally, 
Melchels et al experimentally confirmed the linear correlation of burst pressure with wall 
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thickness for PCL tubes [21]. While the equations above are not utilised to model the 
device burst within this thesis, they provide a basis to what we expect and observe from 
device burst testing. 
2.3 Polycaprolactone 
2.3.1 Physiochemical properties and biomedical use 
Polycaprolactone (PCL) is a semi-crystalline, biodegradable polymer with low glass 
transition (- 60 oC) and melting temperatures (~ 60 oC). The degree of crystallinity tends 
to increase with increasing molecular weight. PCL offers superior rheological and 
viscoelastic properties over other resorbable polymers, which make the material highly 
processable. The attractiveness of PCL for medical device development is aided by the 
presence of PCL-containing medical devices already FDA approved and CE Mark 
registered, which enables a faster route to market [79]. One such example is the slow 
degrading monofilament suture marketed under the name MONOCRYL® [80]. Other 
biomedical applications of PCL devices include degradable cardiovascular stents[81], 
[82], tissue scaffolds [83], nerve guidance conduits [84], contraceptive devices [85], and 
as a root canal filler in dentistry [86], [87]. 
2.3.2 PCL networks and stereolithography 3D printing 
To enable network formation, PCL oligomers have been modified with functionalised 
end groups containing an unsaturated moiety such as an acrylate [88]–[90], methacrylate 
[91] or fumarate [92], [93] group to form macromers. To be photo-cured the macromers 
must be in the liquid state, which is achieved via heat or use of a diluent, and be mixed 
with a photo-initiator. To date, only photo-curing of low Mw PCL-macromers (300-6,000 
g/mol) have been reported. The resulting networks have been amorphous, and 
demonstrate tougher mechanical properties as Mw increases [88], [91]. Elomaa et al was 
first to print a network with low Mw trifunctional PCL-macromers in the melt [91]. Green 
et al, more recently demonstrated printing of low Mw bi- and trifunctional PCL-
macromers formulated into a resin using dioxane as a diluent [88]. Both studies performed 
in vitro cytotoxicity studies that indicate the photo-cured PCL networks are non-toxic and 
allow cells to proliferate. Furthermore, Green et al implanted thin film networks to the 
subretinal area of one eye in five pigs. One month after the surgery, none of the eyes 
showed evidence of intraocular inflammation, and all the retinas had reattached, with 
preservation of the retinal layers adjacent to the implant [88].  
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2.3.3 PCL degradation 
Degradation of PCL in vivo proceeds through a two-stage degradation process. The first 
stage involves predominantly non-enzymatic hydrolytic cleavage of ester groups, while 
the second stage involves intracellular degradation of sub 3,000 Mw chains after uptake 
by macrophages, giant cells, and fibroblasts [94].  Due to the hydrophobicity of PCL, 
degradation both in vivo and in vitro can take between 2-4 years, depending on the initial 
molecular weight and crystallinity [79]. To study PCL degradation within more 
acceptable time frames, use of acidic or alkaline pH environments and/or temperature to 
accelerate the rate of degradation can be performed. Different variants of these 
accelerated methods are evaluated within a recent review by Bartnikowski et al [95]. 
Studies most commonly utilise alkaline solutions and elevated temperatures, which can 
bring degradation times of high molecular weight oligomer structures, or crosslinked 
networks, down to hours instead of years [96]–[98]. 
2.4 Biological evaluation of biomedical devices and their materials 
2.4.1 Overview 
Medical devices and the materials they are composed of need to be evaluated for their 
safety within the context of a biological risk management process. The guidance for the 
biological safety evaluation of medical devices is presented within the ISO 10993 
standard framework [99]. By aiming for inherent safety by design (sometimes referred to 
as quality by design [QbD]), the risks should be controlled by eliminating or minimising 
them to the greatest extent possible. This applies not only to the finished product, but to 
the manufacturing process as well. In vitro cytotoxicity studies are the preferred primary 
evaluation method as they are fast, simple, and highly sensitive tests can that identify 
toxic components during early stage pilot studies which can then feedback into the 
manufacturing process [100]. Use of such tests at an early stage also minimises the use 
of animal models for preliminary testing [101]. The cytotoxic evaluation specific 
guidelines are presented within ISO 10993-5 [102]. 
2.4.2 Commonly used cytotoxicity assays 
Cytotoxicity and cell viability assays typically fall into the following classifications based 
on their measurement types of end points, colourimetric, fluorometric, or luminometric.  
Perhaps the most commonly used assay is the colourimetric MTT assay, which 
determines cell viability through reduction of the dye to a purple formazan product by the 
intracellular mitochondrial enzymes of viable cells. The degree of formazan production 
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is used to indicate the extent of cell viability. The main disadvantage of the MTT assay is 
the formazan product is water-insoluble and requires a 2nd step to solubilise the formazan 
into a solution so that the absorbance can be taken [103]. This disadvantage can be 
overcome through use of similar colourimetric assays such as XTT, MTS and the WSTs, 
where the converted dye product is water soluble, and therefore no solubilisation step is 
required. These assays are very similar and feature negatively charged dyes that prevent 
penetration into the cell and are therefore used in conjunction with an intermediate 
electron acceptor which reduces the dye extracellularly or at the cell membrane. These 
assays are generally regarded as being less toxic than other assays that require 
intracellular dye reduction; however, the potentially toxic nature of the co-administered 
intermediate electron acceptor likely makes this advantage small [104]. Another 
colourimetric assay is the lactate dehydrogenase (LDH) assay. LDH enzyme is released 
from cells with damaged membranes, therefore as cell viability reduces, LDH 
concentration in the media will increase.  Addition of a tetrazolium salt to the media 
initiates a coupled enzymatic reaction that ultimately results in production of a red 
formazan product. The absorbance of the solution can be quantified and used as an 
indicator of cell death. The major limitation of this assay is that serum and some other 
compounds have inherent LDH activity, and therefore can generate substantial 
background absorbance [103]. The resazurin reduction assays are a common example of 
fluorometric assays and are often synonymously referred to using the commercial 
trademark name Alamar Blue (AB). The AB assay functions through reduction of a cell 
permeable indicator resazurin to resorufin by viable cells [105]. AB is generally regarded 
as being more sensitive than the tetrazolium assays, providing there is no fluorescent 
interference from test compounds or sample materials [103]. The ATP assay is an 
example of a luminometric assay. The ATP assay is based on the oxidisation of luciferin 
to oxyluciferin, which is catalysed through the enzyme luciferase in the presence of Mg2+ 
ions and ATP. The catalysed reaction produces light (bioluminescence) that can be 
quantified using a plate reader. Due to the high sensitivity of the assay, the main limitation 
is the reproducibility of pipetting replicates rather than through the assay chemistry itself 
[103]. The above assays cover the more commonly used assays for cell viability and 
cytotoxicity estimation. It is important to note that each assay has its own set of 
advantages and disadvantages. However regardless of the assay method chosen, major 
factors such as a consistent cell population, determination and use of the optimal reagent 
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incubation times and concentrations, and ensuring interfering components are eliminated 
or kept to a minimum, are essential.    
2.4.3 Requirements for the implantable medical device 
The monolithic delivery capsule is classified as a long-term implantable device as the 
contact time of the device with surrounding issues will exceed 30 days, considering the 
estimated degradation time of the device. Devices within this category generally require 
a total of 11 endpoints of biological evaluation to be assessed, such as cytotoxicity, 
carcinogenicity, genotoxicity, irritation or intracutaneous reactivity, and implantation site 
effects. Information regarding the physical and chemical nature of the materials used in 
the device and its manufacture are also required. Assessment can be satisfied through the 
use of existing data, or presentation of a rationale for why a specific endpoint does not 
apply. In the case of novel materials that have not been previously used in similar medical 
device applications and where no toxicological data exists in the literature, specific 
endpoint testing is required. While the ISO guidelines do not stipulate that the device 
implanted must be biodegradable/bioresorbable, such a property is typically viewed as 
positive due to the elimination of the necessity to surgically remove a non-degradable 
device after it has performed the desired function. In the case of a degrading 
material/device, the degradation products require characterisation and biological 
evaluation with regards to the same endpoints are the bulk material or device. 
2.5 Dip coating 
Dip coating is a common bulk manufacturing process often used to produce coated fabrics 
and for adding friction materials or corrosion protection to metal tooling. In its most basic 
form, dip coating involves submerging a substrate in a solution and then lifting the 
substrate out from the solution, which causes a wet film to be deposited on the substrate 
surface. In industry, dip coating typically involves immersion of the desired part in 
thermoset polymer materials, which are baked on to the object. In biomedical research, 
dip coating can be used to deposit thin film coatings to fabricate biosensors, and tissue 
engineering implants [106], [107]. While appearing simplistic, the dip-coating process 
involves a complex combination of often counteracting factors, such as the immersion 
time, number of dipping cycles, solution composition, the speed of substrate removal 
from the vat, viscous drag from the liquid during removal, among many others [108].  
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2.6 Stereolithography 3D printing 
2.6.1 Introduction to stereolithography 
Stereolithography (STL) was the first additive manufacturing (AM) technology 
developed [109], [110]. STL technology falls under what is typically referred to as 3D 
printing, which is a blanket term encompassing all AM technologies. 3D printing 
technologies produce the final 3D object typically through the layer-by-layer creation and 
subsequent joining of cross-sectional slices in a repeated manner. The process of printing 
a part or model by 3D printing, including STL, can be summarised in a few steps. Firstly, 
a computer aided design (CAD) of the desired part created or obtained. The CAD file is 
then converted into a format that can be understood by the printer software/firmware. 
This file format is typically a “stl” file. The print settings such as the layer thickness or 
speed of the printer mechanical movements are then chosen. Finally, the print is initiated, 
and the printer autonomously manufactures the part. Modern 3D printers are generally 
pre-optimised for a specific brand or set of materials, which when used together require 
little user input or supervision. 
While sharing the generic manner of operation with other 3D printing techniques, in most 
other ways STL is quite different from other technologies. STL utilises spatially 
controlled light irradiation to cure a liquid photo-polymerisable resin into a solid. The 
resins are typically composed of highly reactive, low molecular weight monomers and/or 
polymers, reactive diluents, photo-initiators, and photo-absorbers. The curing process 
occurs through photo-initiated radial polymerisation to produce a crosslinked thin layer, 
generally between 10 – 100 µm thick. The light source and build platform that the printed 
structure is built upon are computer controlled. The first layer pattern solidifies the resin 
and adheres to a build platform which is then moved by the desired layer thickness to 
make space for the next layer. Fresh resin flows into the space or recoats the build head 
ready for the next layer to be photo-cured. Each new layer crosslinks into the previous 
layer and is repeated many times, which ultimately generates one 3D highly crosslinked 
polymeric network. After completion of the print, excess resin is washed off the printed 
part to obtain the ‘as-fabricated’ (or green) part. The green structure is usually only partly 
cured, and so post-curing is often performed to improve the mechanical properties of the 
parts.  
STL printers come in two main orientations. The ‘bottom-up’ orientation was the original 
format when the apparatus was first designed. A cartoon diagram of this arrangement is 




Figure 2.2:- A cartoon schematic of ‘bottom-up’ stereolithography printing. 
 The ‘bottom-up’ arrangement involves a build platform submerged within the vat of 
resin, where the surface of the build platform rests just below the resin surface. The light 
source above illuminates the remaining thin layer of resin between the resin surface and 
the build head surface. The build head is then retracted further into the resin vat, ready 
for the next thin layer to be illuminated and cured. This process is then repeated until the 





Figure 2.3:- Cartoon schematic of a ‘top-down’ stereolithography system.  
The ‘top-down’ method involves light being illuminated through a transparent window 
on the bottom of the resin vat, while the build head rests within the liquid resin so that 
only a thin layer of resin is trapped between the platform surface and the inner window 
surface. This orientation is becoming more common on modern STL printers. While 
structures printed on ‘top-down’ STL printers are subjected to larger mechanical forces 
during the layer peeling stage between layers, the ‘top-down’ layout offers a series of 
advantages. In ‘top-down’ printing, smaller volumes of resin are required, the illuminated 
layer is not exposed to the atmosphere – so oxygen inhibition is limited, recoating of the 
structure is not required, and the surface being illuminated is always smooth. 
The light source for STL printers was typically a laser system that sweeps the desired 
pattern for each layer. While still in common use in modern commercial STL printers, an 
alternative illumination method is becoming more prevalent in the form of digital light 
processing (DLP). With DLP technology, light is reflected off a digital mirror device 
(DMD), which is composed of an array of up to several millions of mirrors that can be 
toggled on or off. Use of such a device enables projection of a complete layer at once. 
Build times are reduced in comparison to the laser-based systems, particularly if printing 
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large or multiple objects due to the elimination of the need for the laser to trace out and 
fill in each area desired. DLP layer completion times only depend on the layer thickness 
desired, and the associated exposure time required for that depth.   
STL printers of all typical forms are considered as the most accurate form of 3D printing, 
due to their ability to form complex geometries with features detail sizes within the 100 
µm range. One form of STL apparatus offers an even greater level of resolution by 
utilisation of two-photon polymerisation (2PP) technology, resulting in two-photon 
stereolithography (2PSL). 2PSL offers nanoscale accuracy (100 nm or better) but at a 
considerable increase in cost and large build times for macroscale objects.  
2.6.2 Stereolithography layer thickness control 
In STL, control of the layer thickness is one of the most critical parameters. Each resin 
formulation will possess different curing kinetics and will require different doses of 
light(energy) to generate a layer of a specific thickness. In DLP systems the dose of light 
is controlled by adjusting the power of the light source, or through adjusting the exposure 
time. For laser-based systems, the light source power and the scanning speed are the main 
variables for control of dose. To obtain successful prints with the desired level of detail, 
it is fundamental to have knowledge of the photo-curing behaviour relating to the 
combination of the resin and printer system in use. Characterisation of such behaviour is 
generally performed through use of a semi-empirical equation, which relates the thickness 
of a solidified layer (the cure depth, Cd in µm) to the light irradiation dose E (mJ/cm
2), 
and is shown in Equation 2-12. 
𝐶𝑑 = 𝐷𝑝 𝑙𝑛 (
𝐸
𝐸𝑐
) Equation 2-12 
The equation is used in combination with a semi-logarithmic plot of the determined cure 
depth versus the applied irradiation dose results in a linear relationship and is known as 
the Jacob’s working curve [111]. The slope of the working curve is the penetration depth 
(Dp) of the resin for that light source wavelength. Since ln(1) = 0, the intercept of the 
working curve (i.e the value of E where Cd = 0) is the critical exposure (Ec) or gel point 
of the resin for that light source wavelength. Equation 2-12 is an adaptation of the Beer-
Lambert equation, which describes the exponential decay of the intensity of light as it 
passes through a medium in which it is absorbed, therefore we can write: 
𝐼(𝑧) =  𝐼0𝑒𝑥𝑝 (
−𝑧
𝐷𝑝
) Equation 2-13 
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Where I(z) is the irradiance at a depth z in reference to the position in which the light 
enters the resin, where it takes the value I0. An assumption is made that the degree of 
curing is directly proportional to the absorbed energy at that depth, meaning that initiation 
is deemed the limiting step of the polymerisation, and not propagation and termination. 
Therefore, Dp is the inverse of the absorption coefficient and works as the characteristic 
depth at which the light irradiance has decreased to 37 % of its initial value. Subsequently, 
this means that it can be considered that 4 Dp is a practical upper limit of printable layer 
thickness [112], as due to the exponential decay any further curing becomes extremely 
slow. Additionally, the value of Dp can be considered to be the lower printable thickness 
limit, because at this thickness the green part is strong enough to withstand the printing 
process. The most effective manner of adjusting Dp is through the resin formulation, 
specifically the photo-initiator and photo-absorber as they absorb the most light [113], 
[114]. While the kinetics of the different stages of the addition-type polymerisation 
(initiation, propagation-termination) of multi-vinyl monomers can be expressed 
mathematically [115], in practise the simpler equations described above more commonly 
used to good effect. 
2.6.3 STL of biomaterials 
The poor selection of degradable and biocompatible materials with varied mechanical 
properties to suit specific biomedical tasks is one of the biggest disadvantages of STL. 
However, considerable research into utilisation of polymeric materials already used for 
biomedical purposes in their bulk forms has been conducted, and largely driven by the 
tissue engineering community [116], [117]. As such, novel macromers from PCL [88], 
[91], poly(D, L-lactide)(PDLLA) [118]–[120], poly(trimethylene carbonate) (PTMC) 
[121]–[123], poly(ethylene glycol) (PEG) [124], poly(propylene fumarate) (PPF) [125] 
have been processed via STL. Essentially all of the above work produced tissue 
engineering scaffolds, although were of varied geometries and purpose.  While STL has 
undoubtedly great potential for patient-specific biomedical applications, the clinical use 
of devices/implants produced from STL-compatible biomaterials is rare.   Research tends 
to focus on temporary degradable polymer networks for biomedical purposes, but 
occasionally circumstances require a more permanent solution and use of non-degradable 
biomaterials can offer great benefits to the patient in specific circumstances. One such 
circumstance was a patient suffering from Van Buchem Disease, where hyperostosis of 
the skull can lead to increased pressure on the brain, had her entire cranium replaced with 
a poly(methylmethacrylate) STL printed patient specific implant in a world first 
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procedure. The part was produced by Anatomics Australia, with the surgical procedure 
performed at the University Medical Center Utrecht by Dr. Bon Verweij [126]. More 
common and less invasive uses of non-degradable STL printed materials are as patient 
specific dental surgical guides, and retainers [127].   
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 – Development of photocurable PCL-based resins 
3.1 Introduction 
In this chapter, we discuss the synthesis of the PCL macromonomers (macromers) used, 
and the assessment of solvents for formulating liquid resins.  
Photo-crosslinkable polymer resins have been used in the preparation of biomaterials for 
various biomedical applications such as dentistry, tissue engineering, and development 
of drug delivery systems. To produce such resins, biomaterial oligomers are typically 
end-functionalised with reactive moieties, such as acrylate or methacrylate groups, 
capable of undergoing photo-initiated radical polymerisation to produce highly 
crosslinked polymeric networks. Due to the semi-crystalline nature of the PCL 
macromers use of a diluent or heat is required to generate a liquid resin suitable for photo-
curing applications, including stereolithography. Previous work with PCL methacrylate 
macromers demonstrated that macromers of smaller than 1,500 g/mol were not able to be 
recovered from the reaction mixture precipitation in isopropanol method employed with 
macromers of higher molecular weight [91].  
In this work, a method for the purification and recovery of <1,500 g/mol methacrylated 
PCL macromers was developed. Methacrylate end-functionalised PCL macromonomers 
(macromers) were produced with the intention of being used to formulate photo-curable 
resins that can generate bioresorbable networks suitable for implantation. Aiming for 
networks with stronger and more elastic mechanical behaviour than previously 
demonstrated in the literature, use of relatively high molecular weight linear PCL 
macromer was desired. The detailed rationale for use of the selection of macromers 
produced is presented in Chapter 4. Due to the macromers existing in a crystalline or 
waxy state at room temperature, a solvent was desired to formulate low viscosity liquid 
resins suitable for UV curing methods, including stereolithography printing. 
The first objective is the synthesis and characterisation of PCL methacrylate macromers 
of various molecular weights with high degrees of functionalisation. As part of this 
objective, development of a reliable method for the purification and recovery of <1,500 
g/mol PCL macromers will be performed. Secondly, an evaluation of solvents to 
determine the most suitable diluent for preparation of PCL macromer-laden liquid resins 
will be undertaken, where suitability will be determined by the ability of a solvent to 
dissolve the largest (10,000 g/mol) PCL macromer, possess low vapour pressure, and be 
of low toxicity. 
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3.2 Materials and methods 
3.2.1 Materials 
Polycaprolactone (PCL) diol [Mn = 10,000 g/mol and Mn = 2, 000 g/mol], PCL triol [Mn 
= 900 g/mol], methacrylic anhydride (MAAh), sodium hydroxide pellets (NaOH) 
magnesium sulphate (MgSO4), and trifluroacetic anhydride (TFAA) were acquired from 
Sigma Aldrich (UK); potassium carbonate (K2CO3), toluene, dichloromethane (DCM), 
and hexane were obtained from Fisher Scientific (UK). All chemicals were used as 
received.  
3.2.2 Macromonomer synthesis 
The PCL oligomers were reacted with MAAh to synthesise reactive macromers with 
methacrylate end groups. An excess of 50-100 mol% of MAAh per hydroxyl group was 
used. K2CO3 was used as a proton scavenger in the same molar quantity as the added 
MAAh. Methacrylation of both PCL oligomers was performed within a round bottom 
flask (RBF) with a PTFE stirring bar, at 130 oC under a nitrogen (N2) atmosphere. 
Methacrylation of the 900 g/mol PCL was performed in the melt with no further solvents 
required. Due to the increased viscosity of the 10,000 g/mol PCL oligomer, small 
quantities of anhydrous toluene were added until smooth stirring at circa 150 rpm was 
achieved and maintained. Upon development of a well-mixed solution, MAAh was added 
in full with the K2CO3 added slowly to avoid foaming, and the N2 atmosphere re-
established.  The degree of functionalisation (DF) was monitored over the course (4-8 
hours) of the reaction using proton-nuclear magnetic resonance spectroscopy (1H-NMR, 
CDCL3, Bruker AVIII 300 MHz). Prior to addition of MAAh, a 
1H-NMR sample was 
taken of the reaction mixture to determine the initial integral of the peak at ~3.65 ppm 
attributed to the penultimate methylene group adjacent to the hydroxyl termini of the 
oligomers. Subsequent spectral peak integrals for that reaction were normalised to one 
another by keeping the integral of the peak associated with methylene groups at ~2.3 ppm 
constant. To confirm the nature of the protons, the oligomers were reacted with 
trifluroacetic anhydride (TFAA). The progression of the methacrylation reaction was 
observed by monitoring the disappearance of the peak at ~3.65 ppm, with the reaction 
continued until the peak was completely abolished, indicating 100 % DF.  
3.2.3 Precipitation and purification of macromers 
The 10,000 g/mol and 2,000 g/mol PCL macromer reaction mixtures were precipitated in 
cold (-80 oC) hexane under stirring. The precipitated mass (fine powder) was filtered off, 
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and the filtrate discarded. The filtered mass was left to dry within the conical filters 
overnight, before being transferred to a large surface area glass dish to encourage further 
evaporation of any remaining solvent. After a steady mass was obtained, the final product 
was vacuum-sealed into bags and stored in a freezer (-20 oC). 
The 900 g/mol PCL macromer reaction mixture was poured into hexane under stirring. 
The macromer forms a low viscosity wax at the bottom of the beaker. The beaker contents 
were mixed vigorously, and allowed to settle before decanting off the upper phase. This 
was repeated several times until a clear upper phase was achieved. After the final 
decanting step is performed, the remaining wax was transferred to a separation funnel. 
Further hexane washes are then performed, recycling the waxy phase, while discarding 
the hexane phase. The wax was then transferred to suitable centrifugation containers and 
mixed with DCM and a 2 M NaOH solution in a 1:1:6 volume ratio. Containers were 
briefly shaken prior to loading into the centrifuge (Beckman Coulter, Allegra X-12R). 
Samples were then subjected to 2,000 G for 5 minutes at 25 oC.   The upper aqueous phase 
was decanted/pipetted off and discarded, and the containers topped up with water, shaken 
and returned to the centrifuge. This was repeated until a clear aqueous phase was 
achieved. The final aqueous phase was discarded and the DCM/macromer phases from 
each container were poured into a beaker and mixed with MgSO4 to scavenge any 
remaining water. After successful removal of water, the MgSO4 was filtered off, leaving 
a clear DCM/macromer solution, which was transferred to an RBF. The RBF was moved 
to a rotary evaporator, where the DCM was boiled off leaving behind the waxy macromer. 
The macromer was melted and poured into falcon tubes and stored away from heat and 
light. 
3.2.4 Solvent evaluation for formulation of photo-curable resins 
A selection of solvents known in the literature to dissolve HMW PCL were evaluated as 
suitable candidates. Potential solvents were assessed in terms of vapour pressure, reported 
toxicity, and the ability to dissolve quantities of 10 kg/mol macromer.  Vapour pressures 
of the solvents were taken from the U.S National Library of Medicine database PubChem, 
or from appropriate literature if no value was listed. The International Council for 
Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) 
guidelines were referred to for data regarding reported toxicity and residual solvent limits. 
If no data was recorded on the ICH databases, the European Chemicals Agency (ECHA) 
database and the literature were searched for toxicological data. Following acceptable 
vapour pressure and toxicity levels, solvents were purchased for macromer solubility 
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testing. Increments of 0.25g were added to 1 mL of each solvent. Each time macromer 
was added, the solution was heated to 50 oC for 30 mins, before being maintained at 25 
oC overnight. If the solution was a single phase, flowable, and showed no signs of 
precipitation, it was deemed a soluble concentration of macromer. This was repeated until 
precipitation of the macromer occurred, showing that the solubility limit had been 
breached. The largest mass of macromer able to be added without precipitation occurring 
was regarded as the maximum soluble concentration of macromer. 
3.3 Results 
3.3.1 PCL macromers 
The 1H-NMR spectrum and associated proton identification for the PCL oligomers are 























Figure 3.1:- The nomenclature and 1H-NMR spectra of the 10 kg/mol oligomer. b represents the initiator residue, while 
R is the symmetry axis. The g’peak associated with the penultimate CH2 methylene group adjacent to the terminal OH 
hydroxyl group was used to monitor the methacrylation reaction and determine DF. 
 
Spectra of the 10 kg/mol oligomer, TFAA reacted oligomer, and methacrylated 
macromer, are shown in Figure 3.2. Nomenclature for the vinylic protons on the 




Figure 3.2:- 1H-NMR spectra of the 10 kg/mol oligomer (blue), TFAA reacted oligomer (green), and macromer (red). 
The g’ peak at 3.65 ppm in the oligomer trace, is not present in the TFAA or macromer spectra. The macromer spectra 
shows the methacrylate end-group vinyl carbons at 5.57 and 6.11 ppm. Here, R represents the rest of the molecule.   
 
Reacting the oligomer with TFAA results in a shift of approximately +0.8 ppm of the g’ 
peak associated with the penultimate methylene groups adjacent to the hydroxyl termini. 
The completed methacrylation reaction results in a similar shift of g’ to the left (4.18 
ppm) of the g peak at ~4.00 ppm. The macromer spectra also features the development of 
new peaks at 5.57, and 6.11 ppm (i and j) corresponding to the vinylic protons of the 
methacrylate end groups as well as peak k at ~ 2.00 ppm attributed to the methyl group. 
The summation of the integrals of these peaks closely matches the initial g’ integral from 
the original oligomer 1H-NMR indicating the absence of side reactions on the hydroxyl 
termini.  By comparing the oligomer and macromer spectra, it can be seen that the g’ peak 
in the macromer data is completely abolished at 3.65 ppm, indicating essentially 100 % 
DF.  
 
Addition of each methacrylate unit adds 68 g/mol to the theoretical Mn of the oligomer. 
The oligomer starting molecular weight and final fully functionalised macromer 
molecular weights are shown in Table 3.1, alongside the nomenclature to which the 
















900  1,104 0.9k-3MA triol/trimethacrylate 
2,000  2,136 2k-2MA diol/dimethacrylate 
10,000 10,136 10k-2MA diol/dimethacrylate 
Table 3.1:- Oligomer molecular weights as described by manufacturer, with associated theoretical macromer 
molecular weights after methacrylation. The assigned macromer shorthand label and functionality is also shown.   
The macromer labels take a condensed form of the original oligomer Mn, combined with 
their functionality, where MA is shorthand for methacrylate and the number indicates the 
number of end termini. 
 
Over the course of the project, various batches of macromers were produced. Prepared 
macromer batches and their DF and recovery yields are shown in Table 3.2. 
 





EXP045v2 97 30+ 
EXP048 98 31+ 
KS840.9k 100* n.d 
Aus/Jongryul 100* 71 
KS 18/4/19 100* n.d 
EXP008 - 2k 
2,000 
95 85 
EXP024 100* n.d 




EXP024 100* n.d 
EXP037 100* 91 
EXP052 100* 82 
KS8410k 100* n.d 
Aus/xin 100* n.d 
Table 3.2:- Degree of functionalisation and yield of macromer products from batches produced from oligomers of 
various molecular weights. Experiments are grouped per oligomer. * indicates g’ peak was completely undetectable, 
n.d = not determined, +indicates that purification method was still under development. 
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With 10,000 g/mol oligomer, methacrylation was typically complete within 4 hours, with 
the g’ peak completely abolished. Recovery of the 10,000 g/mol oligomer derived 
macromer resulted in reliable yields of >80 %. Methacrylation of the 2,000 g/mol 
oligomer generally took approximately 5 hours to reach completion. The recovery yield 
of the 2,000 g/mol macromer was only calculated for one reaction batch, but in that 
instance was 85 %.  The 900 g/mol triol oligomer needed the longest time to reach 100 
% DF, typically taking up to 6 hours to abolish g’. Recovery yields for the 900 g/mol 
macromer were poor for the early batches that were recovered through primarily 
liquid/liquid extraction (indicated by +). Later batches that were precipitated into cold 
hexane resulted in higher yields closer to 70 %. The 10k-2MA product was a white fine 
powder, while the 2k-2MA product was coarser and waxier, often forming clumps. The 
0.9k-3MA product exists as a moderate viscosity wax and is pourable (although slow 
moving) and able to be handled with positive displacement pipettes.  
3.3.2 Solvent selection for the preparation of photo-sensitive resins 
The search for suitable solvents for our PCL macromers was primarily directed by the 
extensive list of chemicals assessed by their ability to solubilise 14 kg/mol PCL oligomers 
by Bordes et al [128]. From this database, 27 potential solvents were found, however 21 
of them were immediately disregarded due to severe toxicity or high volatility. 
Acceptable solvent toxicity status was defined through the solvent being ICH class 3, 
evidence of current use in products for biomedical purposes, and/or other evidence of 















Solvent/Chemical name Exclusion reason 
Morpholine Banned (UK and EU) fruit waxing component. Exceptional 
fire hazard. Capable of severe eye damage. Corrosive. 
Chloroform ICH Class 2 - 60ppm limit. CNS depressant 
Benzene ICH Class 1 - 2ppm limit. Carcinogenic 
Methylene chloride ICH Class 2 - 600ppm limit. Carcinogenic (ECHA) 
Dimethyl sulfide Highly irritant to skin, Bp = 37 
oC, Vp = ~500 mmHg at 25 
oC. “Disagreeable odor”. 
Acetyl chloride Corrosive to metals and tissue.  Vp = ~287 mmHg; flash 
point 4-5 oC. 
Tetrahydrofuran ICH Class 2 - 720ppm limit. Carcinogenic. 
Furan Carcinogen. Bp = 31 
oC. Vp = ~600 mmHg. 
Pyridine ICH Class 2 - 200ppm limit. 
2,2,2-Trifluoroethanol Highly toxic to multiple organ systems 
Trifluroacetic acid Strong acid, highly exothermic. 
1,2-Dichlorobenzene Irritant. 50ppm per 8 h limit 
1,2-Dichloroethane Toxic. ICH Class 1 - 5ppm limit. 
2-Chloroethanol Highly toxic via inhalation and skin absorption 
Methyl formate Bp = 32 
oC. Vp = ~585 mmHg. Respiratory irritation. 
1,4-dioxane ICH Class 2 – 380 ppm limit. Group 2B carcinogen 
Aniline Toxic, carcinogenic, mutagenic 
Toluene ICH Class 2 - 890ppm limit 
o-Xylene ICH Class 2 - 2170ppm limit. Suspected teratogen. 
3-Pentanone nervous and organ system damage 
Nitrobenzene highly toxic, CNS damage, easily absorbed through skin 
Table 3.3:- Eliminated solvents with a description of the reason.  
The vapour pressure (Vp), and maximum soluble concentration of the 10 kg/mol 
macromer of the remaining solvents, are shown in Table 3.4. Vapour pressure was 
evaluated on the basis that the lowest pressure at 25 oC was most desirable, with the 
vapour pressure of water (~23 mmHg at 25 oC) being the upper maximum acceptable 
limit. An additional 5 solvents that were already in use by the group for photo-curable 
resin formulation of other macromers are also shown. These were propylene carbonate, 
diethylene glycol, ethyl benzoate, diethylene glycol diethyl ether and butyl lactate, 
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Solvent Vp (mm Hg) 
Max conc. 
(g/mL) 
Acetophenone 0.40 1.00 
Benzaldehyde 1.27 0.75 
Benzyl alcohol 0.09 1.50 
Methyl salicylate 0.03 0.75 
Propylene carbonate 0.05 n.s 
Diethylene glycol <0.01 n.s 
Ethyl benzoate 0.27 0.5 
Diethylene glycol diethyl ether 0.52 n.s 
Butyl lactate 0.4 n.s 
Table 3.4:- Lists the vapour pressures, maximum soluble 10 kg/mol PCL- macromer concentrations of the tested 
solvents.  
Benzyl alcohol achieved the greatest concentration of dissolved macromer, and also 
possesses one of the lowest vapour pressures of all the tested solvents. Acetophenone, 
benzaldehyde, methyl salicylate, and ethyl benzoate were able to dissolve the PCL 
macromer but at a lower concentration than that of benzyl alcohol. Propylene carbonate, 
diethylene glycol, diethylene glycol diethyl ether and butyl lactate were not able to 
solubilise the lowest concentration (0.25 g/mL) of macromer. None of the solvents listed 
in Table 3.4 are currently listed in the latest ICH residual solvent guidelines (ICH Q3C 
R6), and only 5 were listed in the ECHA Council on classification, labelling, and 
packaging of substances and mixtures (CLP) legislation databases. Essentially all the 
solvents listed demonstrate acute/minor skin irritation and/or eye irritation.   
3.4 Discussion 
3.4.1 Summary 
PCL oligomers of 10,000, 2,000, and 900 g/mol Mn were successfully functionalised with 
methacrylate end groups. Macromers of all molecular weights were shown to be of 
essentially 100 % DF, by the absence of the g’ peak at 3.65 ppm and the establishment of 
peaks typical of methacrylate-functionalised oligomers. A new method for the 
purification of low (sub 1500 g/mol) molecular weight PCL macromers was 
demonstrated.  During the evaluation of potential solvents benzyl alcohol was found to 
be most effective at solubilising the 10 kg/mol PCL macromer, while also possessing a 
low vapour pressure of 0.09 mmHg at 25 oC, and acceptable toxicological profile with 
multiple current examples of use in/with medicinal products and procedures.  
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3.4.2 Recovery of PCL macromers 
PCL macromers of <1,500 g/mol have been shown to be difficult to recover from the 
reaction mixture using methods that work well for higher molecular weight macromers, 
such as precipitation in isopropanol [91]. Initial attempts to develop a method for the 
recovery of such macromers involved repeated liquid/liquid extractions steps between the 
macromer dissolved in DCM and distilled water to remove excess anhydride and 
methacrylic acid side product. Such methods resulted in yields of between 17-31 % 
(shown in Table 3.2), which was deemed unacceptable. Further literature searches found 
that it had been shown that acrylated PCL macromers down to 900 g/mol could be 
successfully recovered from precipitation in hexane [129]. The method detailed in 3.2.3 
incorporates recovery of the 1,104 g/mol waxy macromer from hexane precipitation and 
removal of non-hexane soluble methacrylic acid using liquid/liquid extraction. The yield 
from this improved method was calculated to be 71 %. However, this method is also 
labour intensive in comparison to relatively simple precipitate and filtration methods. 
The 2,000, and 10,000 g/mol macromers were easily recovered though precipitation into 
cold hexane, followed by filtration to obtain the solid product. Recovery yields were 
typically >80 %, and did not present a particular efficiency issue, leading to exact 
determination of the yield not being performed.  
3.4.3 Benzyl alcohol for resin formulation 
From Bordes’ list, acetophenone, anisole, benzaldehyde, benzyl alcohol, and methyl 
salicylate were determined to possess acceptable vapour pressures, and toxicology. 
However, anisole was found to be prohibitively expensive and was not pursued further. 
Of the solvents currently in use with other macromers in the lab, only ethyl benzoate 
demonstrated any ability to solubilise the 10 kg/mol PCL macromer. Benzyl alcohol was 
found to be able to solubilise the greatest concentration of macromer, with a maximum 
soluble concentration of 1.5 g/mL. This value was 0.5 g/mL greater than the joint second 
highest maximum soluble concentration demonstrated by acetic acid and acetophenone. 
Benzyl alcohol also offers a very low vapour pressure of 0.09 mmHg at 25 oC, which 
makes it attractive for open vat stereolithography. Benzyl alcohol is not currently 
classified under ICH residual solvent guidelines, however it is often used as an excipient 
in medicinal products that are administered intramuscularly, or intravenously, as well as 
being used in topical preparations [130]. Outside of medicine, benzyl alcohol sees use as 
a flavouring substance in the food industry (up to 400 mg/kg) and in the cosmetics 
industry as a fragrance component, preservative, solvent and viscosity-reducing agent. It 
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is also a natural constituent in some edible fruits (~ 5 mg/kg) and teas (up to 30 mg/kg).  
In vivo toxicology assessments in rodents did not show compound-related adverse effects 
at dose levels up to 200 mg/kg by weight in mice, and 400 mg/kg by weight in rats when 
administered intravenously [131]. While dose- and time-dependant benzyl alcohol 
cytotoxicity has been observed with retinal pigment epithelial cells [132], [133], tests 
with other cell types are not present in the literature. Considering the photo-cured 
networks will be extracted and dried as a standard procedure to remove the solvent used 
to formulate the resin, it is expected that if any solvent would remain, that it would be in 
residual quantities and therefore pose a minimal risk of adverse toxic effects. However, 
the risk of adverse effects can be reduced further by using a solvent that has been 
demonstrated to display low toxicity. Benzyl alcohol fulfils the desired criteria by 
demonstrating the highest soluble concentration of macromer, one of the lowest vapour 
pressures, and low toxicity.   
In the present literature, dioxane is the most commonly used non-reactive diluent in for 
formulating photo-curable resins of low molecular weight (<2,000 g/mol) PCL 
macromers [88], [90], [97], [134]. Dioxane was one of the solvents eliminated from this 
study due to being an ICH class 2 solvent with a very low pharmaceutical product residual 
solvent concentration limit of 380 ppm. It is also regarded as a class 2B carcinogen by 
the International Agency for Research on Cancer (IARC). The database from Bordes et 
al regards benzyl alcohol within the same PCL oligomer solubility bracket as dioxane. 
With respect to the findings within this chapter, benzyl alcohol should be strongly 
considered as an alternative solvent featuring lower toxicity and lower vapour pressure. 
3.4.4 Conclusions 
PCL macromers of 10,000, 2,000 and 900 g/mol molecular weights with 100 % degree 
of functionalities have been synthesised. A method for the purification and recovery of 
<1,500 g/mol PCL macromers was developed and may offer a cleaner product and higher 
recovery yields. A series of solvents were evaluated regarding suitability for solubilising 
the macromers as liquid resins. Benzyl alcohol was determined to be able to solubilise 
the greatest quantity of 10,000 g/mol macromer, while possessing a low vapour pressure, 
and being of low toxicity. Therefore, benzyl alcohol will be used as the solvent of choice 
in the subsequent chapters of this thesis for the formulation of photo-curable PCL resins. 
Additionally, it is suggested that benzyl alcohol should replace dioxane as the 
solvent/diluent of choice for PCL-based photo-curable resin formulations due to being 
less toxic and having a lower vapour pressure. 
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 – Bimodal networks for stereolithography and network 
characterisation 
4.1 Introduction 
3D printing is a diverse field that offers highly versatile manufacturing suitable for 
numerous materials and applications, including polymeric biomedical implants [135], 
[136]. Digitally designed structures can be 3D printed reproducibly, while easily 
facilitating design iterations during prototyping. Stereolithography (SL) techniques 
(especially twin photon polymerisation [2PP]) offer superior accuracy and resolution to 
any other 3D printing techniques [137]–[139]. In SL techniques, spatially controlled light 
exposure photo-polymerises a liquid resin into a chemically cross-linked solid in a layer-
by-layer fashion. SL resins are typically composed of low molecular weight 
multifunctional monomers or oligomers, which either are already liquids, or combined 
with reactive or non-reactive solvents to produce a liquid resin. Such compositions 
provide excellent reactivity, but result in materials that are brittle, which is a common 
trait of amorphous polymer networks [137], [140]. The number of stereolithography 
resins suitable for biomedical applications is limited, with biodegradable or bioresorbable 
resins suitable for implantation being even rarer [141], [142].   
Polycaprolactone (PCL) is a promising resorbable polymer platform for biomedical 
applications. PCL is a hydrophobic, semi-crystalline polymer, with a low melting point 
(~60 oC) and glass transition (-60 oC) [79], [143]. Most notably, PCL possesses a slower 
rate of degradation over other typical resorbable-polymer counterparts, which naturally 
lends itself to long-term implantable medical devices [79]. Printing of PCL structures 
have previously been demonstrated using mainly FDM, and SLS techniques, and to a 
lesser extent, SL [144], [145]. Elomaa et al were first to prepare tissue engineering 
scaffolds composed of PCL using a DLP printer. The PCL macromers used were 
trifunctional (three-armed) and had a molecular weight of 1500 g/mol, and were 
processed in the melt at a temperature of 43-46 oC [91]. More recently, Green et al 
demonstrated DLP printing of dumbbell-like structures from a 1250 g/mol bifunctional 
and 300 g/mol trifunctional PCL macromers at room temperature by using dioxane to 
formulate a liquid resin [88]. The structures printed by both groups are amorphous and 
rubbery, with tensile strengths a full magnitude lower than that of non-crosslinked 45,000 
g/mol PCL.  
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Based on working examples from the development of tough cross-linkable 
poly(trimethylene carbonate) networks, similar improvements of PCL networks could 
potentially be achieved through utilisation of macromers with higher molecular weights 
than previously demonstrated [146]. However, high molecular weight macromers 
typically are solids at room temperature, and therefore require diluent to form a liquid 
resin suitable for SL. Use of large quantities of diluent introduces new complications with 
structures during the printing process being more fragile than solvent free resins, which 
can result in partial or complete delamination and detachment of subsequent layers [147].  
Early investigations into unimodal and bimodal poly(dimethyl siloxane) (PDMS) 
networks demonstrated that large improvements in maximal tensile strength, elongation 
at break, and toughness can be achieved by varying the distribution of network chain 
lengths through preparation of bimodal networks from a mixture of short- and long-chain 
molecules [148]–[152]. This approach was utilised by Bochove et al to produce bimodal 
PTMC networks via SL that displayed greatly improved mechanical properties over the 
unimodal networks [153]. 
Photo-curable resins containing linear PCL macromers with higher (~10,000 g/mol) 
molecular weights and crystallinity are expected to enable production of networks with 
tougher mechanical properties than those previous demonstrated. We hypothesise that 
due to utilisation of higher molecular weight macromers, the resins will be less reactive 
due to the lower concentration of reactive C=C bonds and will suffer from poor 
mechanical properties in the green state during printing. To combat the lower reactivity, 
bimodal resins will be formulated that include smaller multifunctional crosslinkers 
alongside the larger linear macromer to raise the concentration of available C=C bonds, 
and therefore resin reactivity. Pentaerythritol tetraacrylate will be used as a crosslinker, 
however we hypothesise that networks containing the tetraacrylate will be non-
degradable, and therefore a small three-armed PCL macromer will be tested in an attempt 
to maintain degradability. For comparison, a unimodal resin with linear 2,000 g/mol PCL 
macromers will be formulated to contain the same concentration of C=C bonds as the 
bimodal PCL resin. We hypothesise that the bimodal resin will demonstrate greater 
reactivity and mechanical properties than the C=C matched unimodal resin, despite a 
similar average length between crosslinks.  
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4.2 Materials and methods 
4.2.1 Materials 
10k-2MA, 2k-2MA, and 0.9k-3MA macromers were synthesised and purified as 
discussed in Chapter 3. 45,000 g/mol Mn PCL, diphenyl(2,4,6-
trimethylbenzoyl)phosphine oxide, 2,5-Bis(5-tert-butyl-benzoxazol-2-yl)thiophene, 
hydroquinone and pentaerythritol tetraacrylate were obtained from Sigma Aldrich (UK). 
Benzyl alchol was obtained from Alfa Aesar (UK). Formlabs flexible (FL Flex) resin was 
purchased from an authorised UK formlabs vendor GoPrint3D.co.uk. Kudo3D Black 
DLP resin was acquired from Kudo3D (USA) (discontinued). Verowhiteplus PolyJet 
resin was obtained from Stratasys (USA).  
4.2.2 Resin formulation 
The required amount of macromer was weighed and added to a suitably sized wide neck 
RBF. The required amount of diluent (BnOH) was added, while being magnetically 
stirred and a gentle heat of 35-40 oC applied. The mixture was kept under heat and stirring 
until the macromer was completely dissolved. The required amount of photoinitiator 
(TPO), UV-absorber (BBOT), and inhibitor (HQ) were weighed out, added to the flask, 
and stirred until completely dissolved. The flask was typically covered in aluminium foil 
to avoid exposure to ambient light. A composition was deemed different if any component 
or component concentration was changed. Photo-curable resins were utilised in the 
injection moulding of samples for mechanical, degradation and cytotoxicity 
characterisation, as well as directly within stereolithography apparatus. 
The core resin formulations used to make injection moulded photo-cured networks 




Resin Formulation component (% wt) 
10k-2MA 0.9k-3MA PTOL-4A 2k-2MA BnOH 
xPCL10k 45 x x x 55 
xPCL2k x x x 46.8 53.2 
xPCL10k0.9k 30 15 x x 55 
xPCL10k+4A 30 x 15 x 55 
Table 4.1:- List of resin formulations for injection moulding used within Chapter 4. The photoinitiator was added 




Any adjustments to the resin formulations above, such as change of photo-initiator 
content, or addition of photo absorber, or inhibitor will be detailed in the relevant results 
section. Formulations were largely dictated by solubility. In particular, the xPCL10k resin 
contains as much 10,000 g/mol macromer as possible without precipitating or forming a 
highly viscous liquid which would make printing and moulding difficult. The 
xPCL10k+4A resin formulation was determined by replacing 10,000 g/mol macromer 
with PTOL-4A until a suitable reactivity was achieved for printing. The xPCL10k0.9k 
formulation follows a similar logic, however it was felt that reducing the content of the 
10,000 g/mol macromer further would negatively affect mechanical toughness. The 
xPCL2k resin was used as a unimodal comparison to the bimodal xPCL10k0.9k and was 
therefore formulated to contain the same double bond content as the xPCL10k0.9k resin. 
The importance of the double bond content on reactivity and mechanical properties is 
explored later in this chapter. 
4.2.3 Tensile sample preparation 
Custom mould inserts to create ASTM D638 type IV dumbbells with scaled geometry to 
fit our modular system were produced. Details of the dumbbell geometry are shown in 
Figure 4.1. The absence of dust or other contaminant material from within the mould was 
checked during assembly of the mould systems.  
 
Figure 4.1:- Schematic of dumbbell shape above, with target dimensions shown in the table below. W = width of narrow 
section; L = length of narrow section; T = overall thickness; WO = overall width; LO overall length; R = radius of 
inner fillet; RO = radius of outer fillet. Schematic is an edited version from ASTM 638b.  
Resins for injection mould-curing were formulated with the absence of UV-absorber to 
ensure light was able to fully penetrate the depth of the resin in the mould. Resin of the 
 Properties 
 W L T WO LO R RO 
Dimensions (mm) 5 22 2 13 72 8.6 15.3 
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desired formulation was injected into the mould using a luer lock syringe fitted with a 14 
Gauge adhesive dispensing tip. The moulds were then moved to a UV crosslinker oven 
(VWR International, UVP CL-1000, 365 nm) and irradiated for the 90 mins, removed 
from the mould and flipped over and irradiated on the other face for another 30 mins. 
Post-cured networks were weighed, placed within cellulose thimbles, and then extracted 
with isopropanol (Fisher Scientific, UK) using Soxhlet apparatus for at least 96 hours. 
The extracted networks were left to dry in their thimbles while in any excess isopropanol. 
When dry, samples were placed on a smooth flat PTFE sheet (RS Components Ltd., 
opaque fluoroplastics sheet 3 mm thick) and placed in an oven at 80 oC (SciQuip, SQ-
4845). Samples were periodically removed from the oven and weighed until a steady mass 
was obtained. Dried samples were stored flat in sealed bags until use. 
 
For the non-crosslinkable 45kg/mol PCL, tensile dumbbells with the same geometry as 
the crosslinked specimens were generated by melt compressing moulding. The apparatus 
consisted of a manually operated hydraulic press with two electrically heated plates (top 
and bottom) as the compression surfaces.  The dumbbell moulds were machined into a 
steel plate. DuPont Kapton™ film was positioned underneath the steel mould, and the 
vacant mould spaces filled with excess polymer pellets. Another sheet of Kapton™ film 
was placed on top, so that now both open sides of the moulds were between the film. The 
film/mould sandwich was placed on a solid steel plate and positioned on the lower plate 
of the hydraulic press. A further solid steel plate was gently balanced on top of the upper 
film layer of the mould. The heating controls of the press surfaces was set at 120 oC, and 
the upper surface of the press lowered to be close, but not touching, the upper steel plate 
of the mould sandwich. The heat from the surfaces slowly melts the PCL pellets, floating 
the upper steel mould plate on molten polymer and allowing some trapped air to escape. 
Once the upper steel plate rested on the mould, a series of compression, holding, and 
partial relief steps, increasing in force each time, were performed to help expel any further 
trapped air. After no bubbles were noticed in the excess polymer material along the mould 
edges during compression of the mould, a final compression force of 15 tons was held, 
while the heating was turned off and the press and mould allowed to cool. Once cold 
enough to touch, the compression force was released, and the mould sandwich moved 
under running cold water. The Kapton™ film was peeled away carefully, and excess 
polymer material removed from the steel mould plate by scalpel and bladed screwdriver. 
The dumbbells were then pushed out of the mould, and trimmed of any further excess 
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material before being cooled on the lab bench. Dumbbells were inspected for air bubbles 
and were reprocessed or excluded if they were found to have air bubbles present. 
4.2.4 Universal testing apparatus setup and procedure 
Tensile testing of dumbbell samples was performed using a universal testing system 
(Instron chassis No.: 5567), fitted with a 500 N load cell and side-action grips. An 
extension rate of 5 mm/min was used. All samples were tested at room temperature and 
humidity. Starting distance between grips was 30 mm. Raw data was exported from 
Instron Bluehill 2 software and processed in Microsoft Excel and OriginLab OriginPro 
2018b. 
4.2.5 DSC and degradation sample preparation 
Disc shaped samples of a diameter of 5 mm and thickness 1.6 mm were produced using 
injection moulding and UV curing in a similar fashion to the dumbbell tensile specimens. 
Disk specimens were subjected to the same curing, extraction and drying regime as the 
dumbbells described in 4.2.3. For evaluation of degradation, the disk specimens were 
used in their full form, while for DSC the appropriate mass was cut from the disk and 
loaded into the pans. 
4.2.6 DSC methodology 
Differential scanning calorimetry (DSC) was performed using a Netzsch DSC 214, with 
aluminium pans and pierced lids. The calorimetry was performed under a nitrogen flow. 
Samples of oligomers, macromers, and photo-cured networks with a target mass of 10 mg 
were used, with the exact weight measured for each run. Samples were stabilised at -20 
oC before performing a heating ramp at 5 oC/min to 100 oC. The samples were then cooled 
back to -20 oC at a rate of 10 oC/min and held for 5 mins, prior to a second identical 
heating ramp.  The data was analysed using Netzsch Proteus Analysis, with melting and 
crystallisation peaks determined using the peak tool, and their associated enthalpies 
calculated with respect to temperature using the integration tool.  
4.2.7 Autodesk EMBER DLP printer features and calibration 
Ember is an open source stereolithography printer that is no longer in production or 
supported by Autodesk. It features a 405 nm centred LED light source, which produces 
an irradiance of 22.5 mW/cm2. Light is reflected 90 degrees off a digital mirror device 
(Texas Instruments DLP4500 .45 WXGA) with a XY plane resolution of 50x50 µm and 
projected through a glass window. Model files are processed using Autodesk’s 
45 
 
proprietary software Print Studio, which packages the print settings and model slices into 
a .zip file which is sent to the printer by USB or Ethernet connection. The available XY 
plane print area is 64x40 mm with a maximal Z-axis height of 134 mm. Resin is contained 
within a tray constructed of polypropylene, with a PDMS window for the light to shine 
through. The Z-axis stepper motor provides a minimum step increment of 10 µm. The 
build head has an anodized aluminium print surface. The head is attached to the frame via 
a ball and socket, which enables multi-axial adjustment. The beginning of each new print 
job involves a largely manual calibration of the build head. Here the print head is lowered 
into the resin to the starting height above the PDMS window stipulated by the print 
settings. The user must orientate and lock the build head, after which the printer will carry 
out the rest of the print instructions automatically. The printer features a relatively unique 
layer peeling method, where the tray rotates around an arc, peeling laterally, followed by 
upwards movement of the build head. This in theory reduces the suction force seen with 
other peeling techniques that involve only Z-axis movements alone, but introduces its 
own unique problems. The peeling should be aided by the oxygen buffer provided by the 
PDMS window to reduce the risk of jamming during peeling. 
4.2.8 EMBER: working curve 
The build head was removed from the EMBER printer. Resin was dispensed on to an 
approximately 1 mm thick microscope slide and positioned within the resin tray over the 
PDMS window. A print job was created that would expose a 10 mm2 square for every 
layer, with each layer being able to be assigned a different exposure time. After each 
layer, the cured material was removed from the slide and replaced with a fresh slide and 
resin. The cured material belonging to each printer layer was measured for its thickness 
(Mitutoyo Dial Thickness Gauge 7301) and the process was repeated multiple times for 
each exposure time. The average thickness for a given exposure time was plotted against 
the irradiated maximal dose (time ∙ power), and logarithmic fitting was performed to 
obtain the equation for the working curve. 
4.2.9 EMBER: stereolithography printing  
Models for printing were created using Autodesk AutoCAD, or Autodesk Fusion 360, 
and exported as .stl files. Initial print settings were estimated from the working curve data 
for that particular resin composition. A small waffle-like structure, with an outer 
rectangular shape of 5x9 mm and 1 mm2 square pore/channels through its entire Z-height 
(5 mm), was preferred as the initial test print model, due to its simple geometry and the 
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pores providing areas for early feedback regarding resolution. During the initial 
printability tests, the window was checked by eye after each layer had printed and peeled 
to ensure the layer had adhered to the build head. If print failure was detected, the print 
was cancelled, print settings changed, and then reinitiated with the new settings. 
Persistent issues usually resulted in appropriate changes to the resin composition. Once 
suitable printing settings were identified, the printer could be operated with less user 
input, and other print geometries could be printed successfully. For complex structures 
with features overhanging the base area, or without at least one flat face, supports were 
added through PrintStudio. Print settings shall be detailed in the appropriate results 
sections. 
After printing, models were post-cured in the UV box while still attached to the print head 
surface. Post-cure times varied depending on the resin composition used. Post-cured 
models were cut from their supports with fine bladed pliers or detached from the build 
head using a thin bladed spatula. Printed models were then extracted using Soxhlet 
apparatus and dried as previously described in 4.2.3. 
4.2.10 UV-rheometry 
UV-rheometry was performed on an Anton Paar MCR302 rheometer, which featured a 
quartz lower plate that allowed light from a 365 nm LED mounted underneath to shine 
through and illuminate the sample area. Additionally, use of a Peltier hood provided fine 
temperature control, and protected the sample from ambient light.  The LED was powered 
by an external laboratory power pack, set at an output of 3.1 V and 0.33 A, which resulted 
in an irradiance of 1.54 mW/cm2 at the sample contact surface of the quartz plate.  
Irradiance measurements were performed using a Solar Light PMA2100 data-logging 
radiometer coupled with a MA2180-440-40 (S/N: 22535) sensor. With this setup, the 
sample was irradiated uniformly while being subjected to constant oscillatory small 
amplitude stress.  A parallel plate of 15 mm diameter was used as the upper geometry. A 
gap size of 0.1 mm was maintained. All measurements were performed at a controlled 
temperature of 25 oC. Resin gelling behaviour was monitored throughout a time sweep 
where constant oscillations were applied at a fixed frequency of 40 rad/s with a target 
strain of 0.3 %, which was in the linear viscoelastic region of the materials. Rheological 
measurements were performed in duplicate. The gel point is considered to reside at the 
time where the storage (G’) and loss moduli (G”) are equal providing G’ is increasing 
over several orders of magnitude. 
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4.2.11 Autoclave degradation method 
Accelerated degradation of our materials and photo-cured networks were performed 
within an Astell ASB 270 BTO autoclave. A modified 5-stage sterilisation cycle was 
used, with a target temperature and pressure of 120 oC and 2.25 bar respectively. The 
stages involved are, an intermediate temperature and pressure-building phase, a 
temperature ramp to sterilisation temperature, the sterilisation stage, a cooling stage, and 
lastly, a drying stage. For simplicity, we regard only the length of the sterilisation stage 
as our period of degradation. The length of time the sterilisation stage lasted could be 
adjusted from 1 second to 4.25 hours. For periods longer than 4.25 hours, multiple cycles 
were performed on the same sample(s). Disk shaped samples were each weighed and 
immersed separately in small glass vials containing 4 mL of 1 M NaOH solution. The 
collection of vials was placed within a large glass beaker and positioned in the centre of 
the autoclave. After the autoclave cycle was performed, the vials were inspected, and any 
remaining mass noted and weighed. This is performed until no retrievable mass was 
available. In the absence of recoverable mass, autoclave cycles were continued until no 
gel fragments or other indicators of residual sample material could be seen. A material or 
network was regarded as fully degraded when the solution was completely clear at room 
temperature. 
4.2.12 RBF boiling degradation method 
Accelerated degradation was also performed by immersing samples within boiling 1 M 
NaOH within an RBF. A 50 mL RBF was placed within a suitably sized thermal block 
on a hotplate stirrer. Approximately 30 mL of 1 M NaOH solution was poured into the 
RBF, and a water condenser fitted. Prior to sample addition, the NaOH solution was 
brought to boil. Disk shaped samples were weighed prior to immersion. The disks were 
removed at various time points, re-weighed and then returned to the RBF. This is 
performed until no retrievable mass was available. In the absence of recoverable mass, 
boiling was continued until no gel fragments or other indicators of residual sample 
material could be seen. A material or network was regarded as fully degraded when the 
solution was completely clear at room temperature. The evaluation criteria in the absence 





4.3.1 Tensile testing 
Mechanical properties such as the Young’s modulus, ultimate strength, elongation at 
break, toughness, and yield stress of the materials were determined. The stiffness was 
determined from the stress gradient over the initial 0.3 mm of elongation (i.e. 1% of the 
initial grip-to-grip distance). Yield stress was obtained by calculating the peak stress 
value over the first 7.5 mm of elongation, with the exception of the xPCL10k+4A group, 
which did not show a peak. Instead the yield appeared as a gradual gradient transition, 
and so the point of yield was estimated from the interaction between two trendlines, the 
first of which was determined from the first 0.6 mm of elongation, and the second from 
between 4-10 mm of elongation.  Toughness was calculated from the area under the curve 
of the sample profile. Ultimate strength, and elongation at break was defined as the stress 
or elongation, respectively, at which sample break occurred. Representative tensile 
profiles from each material group are displayed in Figure 4.2. Average properties for each 
material group are shown in Table 4.2. Each group typically contained 10-15 individual 





Figure 4.2:- Representative tensile profiles of all investigated material groups, with inclusion of a commercial flexible 
resin (FL Flex) for comparison. PCL45k is non-crosslinked PCL polymer. xPCL refers to photocured PCL materials, 
where xPCL10k is comprised of only 10,000g/mol macromers. xPCL10k0.9k, and xPCL10k+4A indicate the inclusion 
of another crosslinking component, where the 0.9k refers to a 900 g/mol PCL macromer, and the +4A refers to PTOL-
4A. Samples are dumbbell shaped. Initial grip-to-grip distance was 30 mm. One sample of each group is shown out of 
a population size of at least 15 samples (n = >15), with the exception of PCL45k where n=10, and FL flex where n = 
4. Extension rate was 5 mm/min. Samples were extended until break. 
Table 4.2:- List of key mechanical properties determined from tensile testing for each material composition. PCL45k 
is non-crosslinked PCL polymer. xPCL refers to photocured PCL materials, where xPCL10k is comprised of only 
10,000g/mol macromers. xPCL10k0.9k, and xPCL10k+4A indicate the inclusion of another crosslinking component, 
where the 0.9k refers to a 900 g/mol PCL macromer, and the +4A refers to PTOL-4A. Samples are dumbbell shaped. 
Initial grip-to-grip distance was 30 mm. Each group average was calculated from a population size of at least 15 
samples (n = >15), with the exception of PCL45k where n=10, and FL flex where n = 4. Extension rate was 5 mm/min. 















PCL45k 15.84 ± 0.50 31.4 ± 2.6 308 ± 45 174 ± 22 22 ± 0.7 
xPCL10k 15.62 ± 0.38 23.9 ± 2.9 112.9 ± 24 79 ± 17 24 ± 1.2 
xPCL10k0.9k 4.70 ± 0.47 12.6 ± 1.5 42.9 ± 6 14 ± 3 9 ± 1.0 
xPCL10k+4A 2.92 ± 0.19 14.0 ± 0.7 43.9 ± 3 11.4 ± 1.3 3 ± 0.4 
xPCL2k  0.09 ± 0.01  2.3 ± 0.5 67 ± 9 2.89 ± 0.9 n/a 
FL Flex 0.37 ± 0.01 1.08 ± 0.05 4.9 ± 0.45 0.04 ± 0.01 n/a 
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It was observed during testing that the PCL45k, xPCL10k and xPCL10k0.9k materials 
displayed stable necking after yielding until break. The non-cross-linked PCL45k 
material displays substantial toughness, largely attributed to a high stress and elongation 
at break, and an extensive strain-hardening phase. The xPCL10k cross-linked material 
displays an initial profile and Young’s modulus that is highly similar to the PCL45k 
material but possesses shorter cold drawing and strain-hardening stages, and 
stress/elongation at break. The xPCL10k0.9k profile shows similarities to the xPCL10k 
material, but with approximately half the stress and elongation values throughout. 
Additionally, the xPCL10k0.9k network does not display the large peak-like yield point 
that the PCL45k and xPCL10k materials shown, and instead smoothly transitions between 
elastic and plastic deformation regions. The xPCL10k+4A material shows a similarly 
smooth transition but yields at a lower stress. The xPCL10k+4A strain hardens 
significantly, with slightly greater ultimate stress and elongation at break that the 
xPCL10k0.9k material. This combination results in the xPCL10k+4A material being 
marginally less tough than the xPCL10k0.9k. The xPCL2k material profile displays no 
yield point and breaks at a similar elongation to the xPCL10k0.9k group but at 
substantially lower stress. The FL Flex dumbbells break after only small amounts of 
elongation with low ultimate strength. 
4.3.2 Thermoanalytical investigation of photo-cured networks 
DSC was performed to determine the melting temperatures (Tm(n)) and enthalpies (Hm(n)) 
from both heating ramps, and the crystallisation temperature (Tc) and enthalpy (Hc) from 
the cooling ramp, for each oligomer, macromer, and photo-cured network composition. 
The positions (Tm(1)) and enthalpies (Hm(1))  of the macromers and networks are 
representative of the thermal history of the materials resulting from our synthesis and 
manufacturing processes. Oligomer Tm(1) and Hm(1) are representative of the thermal 
history from the manufacturer’s synthesis, transport, and storage processes. The value of 
Hm(1) can be inferred as proportional to the sample crystallinity. Sample Tc positions and 
ΔHc enthalpies are highly dependent on the cooling rate and temperature used during the 
DSC cycle, and as such directly affect the following Tm(2) and ΔHm(2) values. 
The melting and crystallisation temperatures and enthalpies of the oligomers, macromers, 
and networks are listed in Table 4.3. Example DSC traces of the 2 kg/mol oligomer, 
macromer and network are shown in comparison to the xPCL10k0.9k network within 





Figure 4.3:- DSC traces displaying the 1st melting peaks (Tm(1))  of the 2 kg/mol (2k) PCL oligomer (black), 
macromer (red), and network (blue), the bimodal xPCL10k0.9k network (green), and the xPCL10k (10k) network 
(pink). The xPCL10k0.9k network is composed of both 10,000 (10k) and 900 g/mol (0.9k) macromer units. (n=1) 



























Olig Mac Net Olig Mac Net Olig Mac Net Olig Mac Net Olig Mac Net Olig Mac Net 
45k 67   280   61   197   27   -203   
10k 67 60 64 318 335 262 57 57 59 256 239 205 26 34 28 -247 -247 -212 
2k 58 52 40 280 302 67 45/51 42/50 30 239 219 28 22 18 n/a -234 -220 n/a 
0.9k 38 34  109 77  29 20  131 86  -21 -7  -5 -60  
10k0.9k   57   167   54   118   -4   -75 
10k+4A   52   23   n/a   n/a   n/a   n/a 
Table 4.3:- List of values for melting temperature (Tm), melting enthalpy (ΔHm), crystallisation temperature (Tc) and crystallisation enthalpy (ΔHc) for each oligomer (Olig), macromer 
(Mac), and network (Net). 10k0.9k, and 10k+4A indicate a bimodal network with the inclusion of another crosslinking component alongside the main 10,000 g/mol (10k) PCL backbone, 
where the 0.9k refers to a 900 g/mol (0.9k) PCL macromer, and the +4A refers to PTOL-4A. The number in the brackets of the Tm and Hm headers indicate the 1st or 2nd heating ramp 
the values have been acquired from. Tc and ΔHc were determined from the cooling ramp between the heating ramps. “xx/xx” indicates the presence of a clear twin peak and represents 
the positions of both of these peaks individually. (n=1) 
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The Hm(1) of the 10k and 2k macromers were higher than their equivalent oligomers, 
while the 0.9k oligomer and macromer show the opposite trend. However, the difference 
in Hm(1)  between oligomer and macromer forms of the same backbone composition is 
small.  The Hm(1) of the crosslinked networks were lower than their equivalent oligomers 
and macromers. The networks can be arranged in order of the largest Hm(1), where 
xPCL10k > xPCL10k0.9k > xPCL2k > xPCL10k+4A. When comparing the crystallinity 
retained by the crosslinked networks against the non-crosslinked PCL45k, the xPCL10k, 
xPCL10k0.9k, xPCL2k, and xPCL10k+4A networks retain 94, 60, 24, and 8% 
crystallinity, respectively. Macromers typically possess a Tm(1) lower than their non-
functionalised oligomers. Tm(2) peak positions are generally at lower temperatures than 
their Tm(1) values for all materials. Associated Hm(2) are also typically lower than Hm(1) 
values for all materials except 0.9k where an increase is observed. An exothermic 
crystallisation peak is present for all oligomer/macromer materials, and the 10k and 
bimodal networks during the cooling ramp. For the linear oligomers, macromers, and 10k 
network, the magnitudes of Hm(2) and ΔHc are highly similar. The xPCL2k and 
xPCL10k+4A network samples exhibited no Tc peak.  The xPCL10k+4A material 
displays no thermal signature after the initial heating ramp. The PTOL-4A monomers 
demonstrated no noticeable thermal signature.  
4.3.3 The working curve  
Working curves of each resin formulation were generated for use as a tool to aid resin 
formulation, but also for the selection of initial print settings. The Jacobs working curve 
is a semi-logarithmic plot of cure depth (Cd in µm) versus light irradiation dose (E in 
mJ/cm2) used to describe the fundamental variables associated with stereolithography 
such as, the depth penetration (Dp) of light, and the critical dose (Ec) to gelation [111]. 
Generation of a working curve should result in a linear relationship, which can be 
described by Equation Equation 4-1: 
𝐶𝑑 = 𝐷𝑝ln 
𝐸
𝐸𝑐
 Equation 4-1 
The gradient of the slope of the working curve trendline is the depth penetration of the 
resin at that UV source wavelength. The x-intercept of the trendline corresponds to the 
critical dose required for the resin to reach the gel point.  The critical dose can be 
converted into the critical irradiation time by dividing the Ec by the irradiance of the UV 
source, which for EMBER is 22.5 mW/cm2 or 22.5 mJ/cm2 per second.  The lowest 
possible exposure time to generate a crosslinked layer with sufficient strength to survive 
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manipulation is defined as tmin.  The working curves of uni- and bimodal resins tested 
alongside a commercial resin (PR-48) are shown in Figure 4.4, and the values of  Dp, tc, 
and tmin shown in Table 4.4. 
 
 
Figure 4.4:- Working curves of PCL-macromer-based resins compared with a commercial resin (PR-48) on the 
Autodesk EMBER DLP 3D printer. 2k is comprised of only 2,000g/mol PCL macromers. 10k0.9k, and 10k+4A indicate 
the inclusion of another crosslinking component, where the 0.9k refers to a 900 g/mol PCL macromer, and the +4A 
refers to PTOL-4A. Trendline formulae shown in figure legend for each.   
Resin name 
Resin functionality Resin properties 
C=C conc. (mM) Dp (µm) tc (s) tmin (s) 
PR-48 5,310 116 0.16 2 
xPCL10k+4A 1,760 96 2.5 6 
xPCL10k0.9k 467 161 7.6 10 
xPCL2k 438 236 9.2 13 
xPCL10k 89 n/a ~120 a n/a 
Table 4.4:- Lists the resin depth penetration (Dp), critical time to gelation (tc), and minimum time to form a viable 
layer (tmin) determined from the performing the working curves on the printer. PR-48 is a highly reactive commercial 
resin. xPCL refers to photocured PCL materials, xPCL10k is comprised of only 10,000g/mol macromers. 
xPCL10k0.9k, and xPCL10k+4A indicate the inclusion of another crosslinking component, where the 0.9k refers to 
a 900 g/mol PCL macromer, and the +4A refers to PTOL-4A. a Gel point estimated from working curve attempts.  
 
PR-48 demonstrates substantially greater reactivity than the PCL-based macromer resins, 
which can be seen from very low values of tc (0.16 s) and tmin (2 s). Both bimodal PCL-
based resins (xPCL10k+4A and xPCL10k0.9k) are more reactive than the unimodal 
xPCL2k resin, demonstrated by lower values of tc and tmin. In particular, considering the 
similar C=C bond concentration within the xPCL10k0.9k and xPCL2k formulations, the 
bimodal xPCL10k0.9k resin indicates a clear reactive advantage. This trend in reactivity 
was also shown from the UV-rheometry results in 4.3.4.  The Dp of the xPCL10k+4A and 
y = 115.61ln(x) - 412.45
R² = 0.9739
y = 95.593ln(x) - 386.47
R² = 0.9884
y = 161.28ln(x) - 829.99
R² = 0.9966






























PR-48 formulations are very similar, with the xPCL10k0.9k and xPCL2k resins Dp being 
approximately 50 and 100 µm deeper, respectively. A working curve of the xPCL10k 
only resin (listed in Table 4.1) was also attempted, but required extremely long exposure 
times of greater than 120 s (> 2700 mJ/cm2), which were tacky gels that were difficult to 
handle and measure.  
4.3.4 UV rheometry determination of the critical time 
To further evaluate the reactivity of the different resin formulations, UV rheometry was 
performed. Referring back to Table 4.1, the xPCL2k, xPCL10k, and xPCL10k0.9k resins 
contained 5 wt% of TPO, with macromer/diluent composition remaining as shown.  Each 
resin composition was repeated in triplicate, with the average critical time (tc), maximal 
storage modulus (G’max), and time to 95 % maximum storage modulus (tplat) determined. 
The G’/G’’ crossover while G’ is displaying an exponential increase was used to 
determine the tc.  For comparative purposes, the average critical times of three 
commercial photo-curable materials were also determined.  Representative rheological 
profiles of the resins during UV curing are shown in Figure 4.5, and the average tc, G’max, 
tplat listed in Table 4.5.  
 
Figure 4.5:- Representative rheological profiles of sample G’ and G’’. Sample resin groups are comprised of PCL 
macromers of various molecular weights. 2k refers to PCL macromers of 2,000 g/mol, with 10k being macromers of 
10,000 g/mol. The 10k0.9k formulation contains both 10,000 g/mol and 900 g/mol macromer units. The critical time to 
gelation can be determined from the crossover of the moduli, where G’ has become larger than G’’. UV curing begins 







Resin C=C (mM) tc (s) G’max (MPa) tplat (s) 
xPCL10k0.9k 467 11.2 ± 0.6 275.1 ± 7.2 73 ± 1 
xPCL2k 438 17 159.9 ± 2.5 106 ± 15 
xPCL10k 89 34 ± 0.6 8.1 ± 0.2 82 ± 4 
Table 4.5:- Average critical time (tc), maximal storage modulus (G’max), and time to G’ plateau (tplat) for each resin 
composition determined from UV rheometry.. Sample resin groups are comprised of PCL macromers of various 
molecular weights. xPCL2k refers to PCL macromers of 2,000 g/mol, with xPCL10k being macromers of 10,000 g/mol. 
The xPCL10k0.9k formulation contains both 10,000 g/mol and 900 g/mol macromer units. n=3. 
The xPCL10k material featuring the lowest C=C concentration, demonstrated the largest 
tc of 34 s. The xPCL2k and xPCL10k0.9k resins with higher C=C concentrations featured 
substantially shorter tcs of 17 and 11 s, respectively. The commercial resins demonstrated 
very quick tcs of sub-five seconds. Kudo3D black DLP resin had a tc of 2 s, while the 
Formlabs flexible (v1) had a tc of 3.6 s. The verowhite Polyjet 3D printing material 
returned a tc of 2.6 s. The xPCL10k0.9k resin had the highest G’ Max, followed by the 
xPCL2k, then the xPCL10k resins. The xPCL10k0.9k resin was also the quickest to reach 
tplat, followed by xPCL10k, and finally xPCL2k resins. 
4.3.5 Stereolithography 3D printing 
SL printing of the xPCL10k+4A formulation was performed. The xPCL10k+4A core 
resin within Table 4.1 contained the same quantities of macromer and diluent, but 
contained 5 wt% TPO, 0.2 wt% BBOT, and 0.1 wt% HQ, relative to the total macromer-
diluent weight.  The layer exposure times used for the xPCL10k+4A resin were split into 
3 groups, an individual first layer of 20 s, a set of 10 burn in layers at 13 s, and the 
remaining model layers at 8 s. The peel rotation was set to the slowest speed of 1 rpm for 
the entire printing process. A series of structures were printed, including 70 % porosity 
gyroid tissue scaffolds, square-based pyramids, and Voronoi D towers. Images of the 








Figure 4.6:- DinoLite microscope camera images of (a) 1cm2 square based pyramid, (b) 70 % porosity gyroid tissue 
scaffold, (c) and (d) Voronoi D towers (two different sizes). All models were printed on EMBER using the xPCL10k+4A 
(PCL 10,000 g/mol macromer and PTOL-4A) formulation. Line markings in (a), (b) and (d) are 1 mm apart. 
Models produced from the xPCL10k+4A resin were generally well-formed. The initial 
layers tended to have slightly poorer resolution due to the overexposure required for good 
attachment. Slight damage was also caused by the bladed spatula used to remove the 
models from the build head surface, as can be seen most evidently by the bases of the 
pyramid and gyroid models.   
 
Printing of the xPCL10k0.9k was also attempted. Unfortunately, prior to completion of 
the first 11 layers, the models typically tore around the trailing edge in reference to the 
peel direction. An example of this tearing is shown in Figure 4.7, from attempts at printing 
the square-based pyramid model. Print settings for this particular attempt were an 
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individual first layer of 120 s, a set of 10 burn-in layers at 80 s, and the remaining model 
layers at 60 s. Detachment or damage occurred during the burn-in layers. 
Similar delamination/tearing of printed layers was noticed with other model geometries 
too, such as the waffle-like cuboid, which was typically used for print setting 
optimisation. Over the course of the next few layers, the damaged/delaminated area would 
grow until new layers no longer adhered to the model. Debris from the damaged area 
often was dragged within the print area during peeling, compounding difficulties for 
attachment of the next layers. Various print exposure times were tested, as well as 
different positioning and rotation of the model in attempts to improve survivability, but 
none achieved any meaningful improvement. 
Figure 4.7:- Photograph showing the damaged model on the build head surface during the initial burn-in layers, 
while attempting to print with the xPCL10k0.9k (PCL 10,000 g/mol and 900 g/mol macromers) resin. Damage 




4.3.6 Degradation: pressurised 
Degradation samples were weighed after each autoclave sterilisation cycle to establish 
mass profiles for each material type. The average wet mass (only superficial fluid 
removed) at each time point was determined from triplicate samples. The mass profiles 
during accelerated degradation are shown in Figure 4.8, and the approximate rate of mass 








Figure 4.8:- Average mass of non-crosslinked, and crosslinked networks during accelerated degradation. PCL45k is 
non-crosslinked PCL polymer. xPCL refers to photocured PCL materials, xPCL10k is comprised of only 10,000g/mol 
macromers. xPCL10k0.9k, and xPCL10k+4A indicate the inclusion of another crosslinking component, where the 0.9k 
refers to a 900 g/mol PCL macromer, and the +4A refers to PTOL-4A. Average is calculated from the mass of 3 




Mass loss rate 
(% per hour) 
Extrapolated time 
to m = 0 (h) 
Approximate time 
to clear solution 
(h) 
PCL45k 7.4 13.6 18 
xPCL10k 8.5 11.8 14 
xPCL2k 6.1 16.5 20 
xPCL10k+4A 48.6 2.1 2 
xPCL10k0.9k 324.8 0.3 0.5 
All tested samples fully degrade within 20 hours. Bimodal xPCL10k0.9k and xPCL10k-
4A materials rapidly lose mass, with complete degradation occuring within 0.5, and 2 
hours respectively. The xPCL10k0.9k The PCL45k non-crosslinked material appears to 
increase in mass prior to steady mass loss. The PCL45k discs melt during the autoclave 
cycle and reform into polymer spheres after the cooling stage.  The profiles of the 
xPCL10k and xPCL2k materials start very similarly, but the xPCL10k nework 
degradation settles at a steeper rate and degrades quickest out of the 3 unimodal materials, 
while the xPCL2k material ultimately becomes the slowest material to fully degrade. The 
xPCL10k networks fragment and no longer resemble disks beyond the 8 hour mark, The 
xPCL10k+4A and xPCL2k disks appeared thinner as degradation time increased, while 
retaining their circular cross-sectional shape until no measureable mass was found. Due 
to the rapid degradation of the xPCL10k0.9k networks the disks disintegrate after 15 mins 
and form a cloudy solution, which becomes a clear solution at the 30 min time point.  
4.3.7 Degradation: atmospheric 
Degradation of samples from xPCL10k0.9k, and xPCL10k resin formulations were tested 
alongside xPCL10k+4A networks that contained different amounts of the PTOL-4A 
(4A). The overall sum of macromer content always equates to 45 wt% of the total resin 
weight, therefore quantities of PTOL-4A replace a wt% of 10k-2MA macromer; 4A 
concentrations of 5, 10, and 15 wt% were tested. The mass profiles during degradation 
are shown in Figure 4.9, and the approximate rates of mass loss and times to complete 
degradation indicated in Table 4.7. 
Table 4.6:- Rate of mass loss, extrapolated time to complete mass loss, and the experimentally determined 
approximate length of time required to obtain a clear solution. PCL45k is non-crosslinked PCL polymer. xPCL 
refers to photocured PCL materials, where xPCL10k is comprised of only 10,000g/mol macromers. xPCL10k0.9k, 
and xPCL10k+4A indicate the inclusion of another crosslinking component, where the 0.9k refers to a 900 g/mol 
PCL macromer, and the +4A refers to PTOL-4A.Values determined from the trendlines fitted to the averages of 






Mass loss rate 
(% per hour) 
Extrapolated 
time to m = 0 
(h) 
Approximate 
time to clear 
solution (h) 
xPCL10k 3.2 31.4 48 
xPCL10k0.9k 108.0 0.9 5 
xPCL10k+5%4A  23.5 4.3 n/e 
xPCL10k+10%4A 27.0 3.7 n/e 
xPCL10k+15%4A 27.2 3.7 5.5 
Table 4.7:- Extrapolated time to complete mass loss and the experimentally determined approximate time required for 
a clear solution. PCL45k is non-crosslinked PCL polymer. xPCL refers to photocured PCL materials, where xPCL10k 
is comprised of only 10,000g/mol macromers. xPCL10k0.9k, and xPCL10k+4A indicate the inclusion of another 
crosslinking component, where the 0.9k refers to a 900 g/mol PCL macromer, and the +4A refers to PTOL-4A. “n/e” 
= not evaluated. (n=1) . Values determined from the trendlines fitted to samples of each group. 
The rate of mass loss is fastest for the xPCL10k0.9k disks, while slowest for the xPCL10k 
group. The PTOL-4A containing networks degrade relatively quickly, with the amount 
of PTOL-4A appearing to make little difference to the degradation rate.  
Figure 4.9:- Degradation profiles of photo-cured networks during boiling in 1M NaOH in a RBF. PCL45k is non-
crosslinked PCL polymer. xPCL refers to photocured PCL materials, xPCL10k is comprised of only 10,000g/mol 
macromers. xPCL10k0.9k, and xPCL10k+4A indicate the inclusion of another crosslinking component, where the 
0.9k refers to a 900 g/mol PCL macromer, and the +4A refers to PTOL-4A. Each data series follows the mass loss 








To prepare degradable PCL structures by stereolithography, a bimodal resin composed of 
10k-2MA and PTOL-4A macromers and benzyl alcohol non-reactive diluent, was 
prepared. Tough degradable semi-crystalline structures of various geometries were 
printed via SL using the bimodal PCL10k+4A photo-curable resin. Networks of unimodal 
and bimodal macromer resin compositions were also produced by injection moulding and 
UV curing. The tensile, thermo-mechanical, and degradation properties of the networks 
were investigated. It was demonstrated that the bimodal networks offered greater 
strength, toughness, and faster degradation over unimodal PCL networks of comparable 
reactive group concentration. Unimodal xPCL10k networks demonstrated superior 
toughness to the bimodal networks but were not printable.  
4.4.2 Network thermo-mechanical properties 
The mechanical properties of polymer materials are highly dependent on the method of 
processing, sample crystallinity, degree of crosslinking (if any), and the molecular 
weight(s) [154], [155]. The mechanical properties of the materials were assessed through 
tensile experiments, while the material crystallinity was determined by DSC. All the 
photo-cured networks are semi-crystalline in nature, containing between 8.2 – 93.6 % of 
the crystallinity associated with non-crosslinked PCL45k.  Samples with a greater extent 
of crystallinity, demonstrated greater network toughness during tensile testing. 
Interestingly, the bimodal xPCL10k0.9k networks retained over double the crystallinity 
of their xPCL2k counterparts and were more than 10x tougher. The other bimodal 
network, xPCL10k+4A, returned the lowest retention of crystallinity, which is likely due 
to the PTOL-4A units being unable to crystallise, combined with lower overall network 
crystallinity from denser crosslinking.  
The tensile data for the xPCL2k material appears in good agreement to the tensile 
behaviour of linear 1250 g/mol PCL diacrylate (PCLDA) studied by Green et al [88]. 
Both materials have a Young’s modulus of approximately 3 MPa, and show a similar 
elastomeric-like tensile profile, with the xPCL2k networks being tougher as a result of 
greater ultimate elongation and stress. Previously reported ultimate tensile strengths of 
approximately 45,000 g/mol Mw PCL processed by compression moulding range between 
16 – 21.6 MPa, with Young’s moduli ranging between 251.9 and 400 MPa [156]–[158]. 
PCL45k material tested in this study demonstrated a greater ultimate tensile strength of 
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31 ± 2.6 MPa, with a stiffness of 15.84 ± 0.50 MPa/mm. These values are expected to be 
partially inflated due to the dumbbell specimen shape having a non-homogeneous cross-
section between the grips, as opposed to standard rectangular tensile specimens, and so 
the values appear to be within the expected range. At this time, literature concerning 
crosslinked networks of PCL macromers close to 10,000 g/mol could not be found. 
Therefore, the xPCL10k networks appear to be the first demonstration of networks 
produced by photo-crosslinking PCL macromers of greater molecular weight than 2000 
g/mol (bifunctional) [129], and 6000 g/mol (trifunctional) [91]. Flexible bimodal PTMC-
based photo-curable networks were demonstrated by Bochove et al, which appear to be 
the only other current example of bimodal stereolithography networks. The resins were 
composed of various ratios of 700 and 10300 g/mol tri-methacrylate macromers and 
solubilised with propylene carbonate. Following extraction and drying, the bimodal 
networks of the compositions shown demonstrated 3-4x the toughness of the unimodal 
networks from each of the macromers individually. Comparing the most similar bimodal 
PTMC network (in terms of large:small macromer ratio) to our xPCL10k0.9k, the overall 
network toughnesses are very similar (PTMC700/10300 (31/69) = 15.52 ± 3.92 J/cm3, 
xPCL10k0.9k = 14 ± 3 J/cm3. The tensile profiles are considerably different however, 
with the PTMC bimodal network profile representative of a highly elastic material, with 
toughness being a feature of its high elongation at break (531 %) despite its low ultimate 
stress (5.4 MPa) [153]. In previous investigations with PDMS elastomeric networks, 
increases in both elongation and stress at break were observed from the bimodal networks, 
over the unimodal networks of each component [150]. The bimodal PTMC networks 
performed differently, with their increases in toughness being derived from an increase 
in only one factor (elongation or stress). The bimodal PCL-based materials also appear to 
perform differently from both the PDMS and PTMC bimodal networks. The 
xPCL10k0.9k networks show a decrease in both elongation and stress at break when 
compared with a unimodal network of xPCL10k. It is anticipated that the reduction in 
overall toughness of the bimodal xPCL10k0.9k network is largely attributed to the 
reduced crystallinity regained in comparison to the xPCL10k network. While we did not 
produce networks purely from 0.9k-3MA, based on similarly sized tri-functional PCL 
macromers from Elomaa et al [91], we can assume that such networks would possess low 
toughness. Considering this, and the low ultimate stress and toughness of the xPCL2k 
materials of similar crosslinking density, the xPCL10k0.9k networks offer a significant 
improvement in mechanical properties. 
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Overall, our results do suggest that use of larger linear molecular weight macromers has 
potential to substantially increase the toughness of PCL-based networks. Bimodal 
formulations utilising a combination of large linear macromers with small multi-
functional macromers would likely be useful to maintain an adequate level of reactivity, 
and structural integrity during printing.  
4.4.3 Reactivity and the development of mechanical properties during curing 
The reactivity of the xPCL10k0.9k, xPCL10k, and xPCL2k resins were investigated by 
dynamic UV rheology and through the Jacobs working curve. Both methodologies 
demonstrate through the time to gelation (tc), that the bimodal xPCL10k0.9k formulation 
is more reactive than the unimodal xPCL2k resin, and with the xPCL10k resin 
consistently the least reactive. From rheological measurements, the bimodal 
xPCL10k0.9k resin was approximately 3x faster to gelation than xPCL10k, and 1.5x 
faster than xPCL2k. The gel point during photo-rheology was determined to occur at the 
G’/G” crossover, accompanied by an exponential increase in G’ over several orders of 
magnitude. The scattering of G’ and G”, especially from the xPCL2k resin, during the 
early stages of curing are ignored, and are likely related to the low viscosity of the resin 
and/or inertial effects from the top geometry. While this method has been shown to have 
a dependence on frequency for some materials by Winters [159], for many other material 
systems the G’/G” crossover has been demonstrated to be a reasonable indicator of 
gelation [160]–[163].  
Evaluation of a new photo-curable resin via the Jacobs working curve has become a 
standard procedure, and is particularly useful due to the information gained regarding the 
depth penetration, cure depth at a specific exposure, and curing speed through gel point 
dose and the time to gel point. For fast curing resins, information from the Jacobs working 
curve is largely sufficient for effective translation to stereolithography due to their rapid 
increase in mechanical strength as a direct result of quick double bond conversion. For 
formulations composed of comparatively large macromers with lower crosslinking 
density potential, more time is needed after establishment of gelation to develop such 
mechanical strength. Therefore, the information gained from the Jacobs working curve 
alone is not sufficient to suggest, in a reliable manner, the printability of these slower, 
less densely crosslinked formulations. Use of rheology to determine the gel point and 
provide an insight into the development of the mechanical properties during the curing 
stage was first demonstrated by Khan et al [164]. More recently, photo-rheology 
combined with simultaneous real-time near infrared spectroscopy was used to relate 
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curing speed, mechanical properties, and double bond conversion of a resin sample 
simultaneously in order to aid resin optimisation [165]. The photo-rheology in this work 
was performed with a 365 nm UV LED as no 405 nm variant was readily available, which 
makes direct comparison to the EMBER-derived exposure doses not possible. 
Additionally, it was not possible to monitor the curing process with simultaneous Fourier-
transform infrared spectroscopy (FTIR); therefore, no measurement of double bond 
conversion was taken either. Despite this, the dynamic rheology measurements were still 
useful in their own right. The rheological measurements confirmed resin reactivity trends 
seen from the Jacob’s working curves, and provided an insight into post-gelation 
development of mechanical properties during curing. The storage modulus is an 
indication of the material’s ability to store deformation energy in an elastic manner, and 
is directly related to the degree of crosslinking [165], [166]. Networks produced from 
resins with higher concentrations of reactive groups did demonstrate greater G’max values, 
shown in Table 4.5, as would be anticipated. The bimodal xPCL10k0.9k material 
possessed the highest G’max value, indicating that it may offer the greatest print 
survivability compared with the xPCL2k and xPCL10k formulations, based on its greater 
crosslinking degree [165]. Ideally, future dynamic rheology with a 405 nm light source 
and monitoring of double bond conversion with FTIR would enable better crossover with 
the Jacobs working curve data, which in turn should enable a more complete resin 
characterisation, and assist in optimising formulations as described by Hofstetter et al 
[165]. It should be noted that rheology on the xPCL2k formulation shown in Figure 4.5 
and Table 4.5, was performed in triplicate, despite the tc determined from the G’/G” 
crossover being a singular value. In the other two rheology runs, the initial pre-exposure 
G’ signal appears artificially high in comparison to the G’ curve from the other sample, 
and do not cross their G” curves rendering determination of tc via this method not 
possible. Interestingly, the profiles of G’ after 0.5 mins, and the G” profiles over the entire 
time course are identical to the sample that did feature a valid G’/G” crossover.  The 
rheometer appeared to struggle to maintain a precise measurement of G’ and G” during 
the initial liquid resin state, indicating that this particular formulation would likely have 
benefited from a larger diameter upper plate or a smaller gap size. Due to the small errors 
(± 0.6 s) in calculated tc between repeated measurements of the other materials, it seems 
reasonable to expect that the singular 17 s tc remains valid and will be subject to a similar 
degree of error.     
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4.4.4 Stereolithography fabrication of tough semi-crystalline structures 
Several structures were printed on the EMBER printer using the PCL-based 
xPCL10k+4A resin formulation, as shown in Figure 4.6. Printing using the xPCL10k+4A 
formulation was reliable and repeatable between batches of resin. From tensile tests, the 
xPCL10k+4A resin possesses significantly tougher mechanical properties to previous 
PCL-based materials that are capable of printing via stereolithography. Amorphous PCL 
structures printed in the melt via SL by Elomaa et al were of low toughness, with an 
ultimate stress at break of 2.55 ± 0.5 MPa, and an elongation at break of 19.5 ± 0.5 %, or 
the equivalent of approximately 10 mm [91]. Green et al used a non-reactive diluent in 
the form of dioxane to formulate a series of 1:1 (w:w) low molecular weight PCL-
macromer/dioxane resins capable of being printed at room temperature by SL. The 
acrylated macromer molecular weights ranged between 300-1250 g/mol, and were either 
bi- or tri-functional. Amorphous networks were produced from these resins, with all of 
the networks demonstrating < 1 MPa stress and < 40 % strain at break. The 1250 g/mol 
diacrylate formulation possessed the greatest toughness at 0.15 ± 0.02 J/cm3 [88]. Our 
xPCL10k+4A resin exhibits an ultimate stress of 14.0 ± 0.7, an elongation at break of 
43.9 ± 3 (equivalent to approximately 147 %), and a toughness of 11.4 ± 1.3 J/cm3.  Photo-
cured parts produced from the xPCL10k+4A formulation retained approximately 8 % of 
the crystallinity associated with parts moulded from 45,000 g/mol non-crosslinked PCL. 
As such, we believe that this is the first demonstration of a tough semi-crystalline PCL-
based stereolithography resin.  
4.4.5 Advantages of bimodal photo-cured networks 
The main advantage of the bimodal networks from a stereolithography point of view is 
their greatly improved reactivity, while retaining a degree of the mechanical properties 
offered by the larger macromer unit. The xPCL10k resin, while resulting in networks with 
excellent toughness when injection moulded and UV cured, was limited by its ability to 
be solubilised in large enough quantities to offset its low mole content of reactive groups, 
and as such required long exposure times to form viable layers. The resulting cured layers 
possessed poor mechanical properties in the solvated state, which frequently resulted in 
jamming and layer/model damage (shown in Figure 4.7) or detachment during printing 
attempts. With the substitution of 15 wt% of 10k-2MA with PTOL-4A to form the 
xPCL10k+4A resin, the curing behaviour changed vastly. The xPCL10k+4A resin was 
able to form layers with sufficient strength to survive the printing method, possessing a 
working curve tc of over 48x lower than the xPCL10k only resin. Similarly, the 
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xPCL10k0.9k resin, which features substitution of 15% 10k-2MA with 0.9k-3MA, also 
demonstrated a sharp reduction in working curve tc of approximately 16x when compared 
with the xPCL10k resin. However, the xPCL10k0.9k resin appears to be more fragile than 
the xPCL10k+4A during printing, demonstrated by frequent print failures. Substitution 
of a portion of the 10kg/mol bi-functional macromer with the smaller, multi-functional 
macromers results in a reduction in network toughness. Although, the toughness of the 
bimodal resins are still significantly higher than typical stereolithography resins [167]–
[169]. The bimodal networks also offer substantially faster rates of degradation over the 
unimodal networks and oligomers of all compositions. 
4.4.6 Network degradability 
 In this study, the xPCL10k and xPCL2k networks degrade at a similar rate to non-
crosslinked PCL45k material, taking between 14 and 20 hours using the autoclave method 
to produce a clear solution. Both bimodal network compositions degrade rapidly, with the 
xPCL10k0.9k and xPCL10k+4A networks producing clear solutions within 0.5, and 2 
hours. The ~20 oC higher incubation temperature gained from the autoclave enabled 
further acceleration of the degradation process over the typical boiling method in a flask 
at atmospheric pressure. The increase in degradation temperature from the autoclave 
affected the network degradation rates during the linear-like state to different extents 
depending on the network composition, with the xPCL10k0.9k network being 
approximately 3x faster, and the xPCL10k+4A degradation rate being ~1.8x faster than 
the RBF method. There appears to be no obvious correlation to average molecular weight, 
cross-link density, or initial degree of crystallinity in the networks for this behaviour. 
Previous work comparing the degradation rates of non-crosslinked and crosslinked films 
of PCL noted that the network films degraded faster than the non-crosslinked films. 
Hoglund et al attributed this to the lower degree of crystallinity within the network films 
facilitating a greater rate of hydrolysis through easier migration of water into the material 
[170]. Another study reached the same conclusion when investigating the effect of 
crystallinity and degradation rate for melt blends of PCL with various wt% of 
poly(glycerol-succinate)(PGS). Samples with a higher content of PGS possessed reduced 
crystallinity, and demonstrated an increased sample degradation rate [171]. In contrast, 
due to the degradation temperatures surpassing the melting temperatures of all the 
materials, it would be expected that no crystallinity remains, and that the differences in 
rates of degradation between samples degraded using the same method therefore arise 
from factors other than crystallinity. Chain molecular weight for the PCL45k oligomer, 
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or the molecular weight between crosslinks for the xPCL2k and 10k networks, appear not 
to significantly influence the rate of degradation under these conditions, with rates being 
within a few %/h of each other. Introduction of either 0.9k-3MA or PTOL-4A crosslinkers 
drastically increase the degradation rate compared with the unimodal oligomer, and 
networks. However, the mechanism for this phenomenon is not clear.  
Due to the elimination of sample crystallinity, it is important to note that the order in 
which samples fully degrade via these methods may not be the same order that they would 
degrade in via more physiologically related degradation methods. Therefore, it is 
recommended that the accelerated degradation methods used within this Chapter are most 
suitable for rapidly determining whether a network is entirely degradable, and to produce 
degradation products for analysis or toxicology purposes.  
4.4.7 Stereolithography challenges 
A drawback of the DLP stereolithography approach is the layer separation methods used 
to peel the printed layer from the optical window, which often result in the layers or 
structures being subjected to high mechanical forces during the printing cycle. Printing 
difficulties with low functionality or high molecular weight macromers during attempts 
to produce networks with improved mechanical properties, has been reported for multiple 
biopolymer formulations [91], [147], [172]. Resins with the highest macromer molecular 
weights possessed the lowest molar concentrations of reactive groups and required the 
greatest amount of diluent. The diluent-laden structures generated from such resins during 
printing were of low crosslinking density and demonstrated fragility. 
In this work, the xPCL10k and xPCL10k0.9k formulations are composed of 
predominantly diluent, which led to the production of weak structures during printing. 
When combined with the rough printer movements during layer peeling, these highly 
solvated layers were easily damaged, preventing successful printing. Ideally, the resin 
formulations would contain a greater quantity of reactive components, which in our case 
only consists of the combination of macromers, with the BnOH not being incorporated 
into the network. Commercial open vat stereolithography resins often contain reactive 
diluents combined with the main backbone monomers to formulate a resin that consists 
completely of reactive network forming components, such as Autodesk’s PR48 [173]. 
Other formulations can be composed of monomers that are liquid at room temperate, 
therefore not requiring any diluent at all. Such formulations offer quick curing times and 
sufficient network strength during printing, such that print failures will mainly occur from 
attempting to print highly complex structures with insufficient supporting sub-structure. 
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Unfortunately, all the resins were formulated essentially at the maximum soluble 
macromer concentration in BnOH. Due to the PCL macromers being crystalline, 
dissolution is thermodynamically less favourable. A solvent with a greater capacity for, 
in particular, the 10k-2MA macromer may enable formulation of a resin that produces 
structures of greater strength during printing. Potentially lowering the molecular weight 
of the large linear macromer, perhaps to 6 – 8 kg/mol could be considered. This would 
increase solubility and concentration of reactive groups simultaneously, while retaining 
a degree of the mechanical properties shown by the 10 kg/mol macromer. Alternatively, 
a heated resin tank would increase solubility, enabling the resin to contain a greater 
proportion of macromer at saturation that may be sufficient to strengthen the network 
during printing.  Regarding printer technology, utilisation of a different printer that 
features a gentler peeling system that the EMBER may help improve printability of 
existing resin formulations.  However, it was not possible to find a printer on the current 
market that is fully open source and has a substantially improved peeling system over the 
EMBER system. 
4.5 Conclusions 
In this work, a bimodal PCL and PTOL-4A photo-curable liquid resin was developed and 
used to print a series of structures of ranging complexity. The resulting networks were 
semi-crystalline, and offered substantially tougher mechanical properties to previous SL 
printed PCL networks.  A series of photo-cured uni- and bimodal networks were prepared 
from a variety of bi- and tri-functional PCL macromers of various molecular weights, and 
were characterised in terms of their reactivity, printability, crystallinity, tensile properties, 
and degradability. It was confirmed that unimodal networks produced from greater 
molecular weights of macromer, possessed greater crystallinity and mechanical toughness 
than those composed of lower molecular weight macromers. Networks composed of 
purely 10,000 g/mol were shown to be exceptionally tough, but offered poor printability, 
due to low reactivity and inadequate mechanical properties in the solvated state during 
printing. Bimodal networks composed from 10,000 g/mol macromer and either 0.9k-
3MA PCL or PTOL-4A, demonstrated good reactivity, and maintained a portion of the 
toughness shown by the 10,000 g/mol networks, while being vastly tougher than 2,000 
g/mol macromer networks of similar crosslinking potential. Under accelerated conditions, 
the bimodal networks degraded faster than the unimodal networks, with all networks 
completely degraded within 20 h. As far as we have found, the networks demonstrated 
here offer superior toughness to any previously photo-cured PCL networks in the current 
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literature. Additionally, we propose benzyl alcohol as a suitable solvent for PCL-
macromer SL resin formulations for printing at ambient temperatures. The PCL and 
PTOL-4A resin provides a new tough material option for biomaterial stereolithography. 
71 
 
– Network cytotoxicity evaluation 
5.1 Introduction 
This chapter evaluates the in vitro cytotoxicity of photo-crosslinked networks produced 
from the polycaprolactone-based photo-curable resins developed in Chapter 4. 
The proposed vaccine delivery implant is to be constructed from PCL-based macromers 
crosslinked together to form a solid network. PCL is a well-studied resorbable polymer, 
and is a commonly used material in tissue engineering and other biomedical fields. It is 
largely accepted that PCL is able to constitute an intrinsically biocompatible system when 
interacting with various cell types and tissues [174]–[177]. The term “biocompatibility” 
has historically had numerous definitions, but is currently defined as “the ability of a 
material to perform with an appropriate host response in a specific application” [178], 
which takes into account the interactivity between the material and the host. Evaluation 
of in vitro cytotoxicity is the first step in assessing the suitability of new materials for 
biomedical purposes. Similarly, with many other polymeric biomaterials, while the 
compatibility of non-crosslinked PCL is well studied, evidence to support the 
compatibility of networks derived from end-functionalised PCL macromers is not well 
documented. Of the studies that have been performed on crosslinked PCL networks, the 
results have been shown to be positive, with cell proliferation appearing equivalent or 
only slightly poorer than tissue culture polystyrene [90], [179]. Similar testing of photo-
crosslinked PDLLA networks demonstrated cell proliferation equivalent to high 
molecular weight (HMW) polymer and tissue culture polystyrene controls by 11 days of 
culture [120].  Photo-crosslinked PTMC networks also appeared to show good cell 
proliferation, however no comparisons to controls were made [122]. Overall, the evidence 
suggests that crosslinked networks derived from biomaterials will perform similarly to 
their non-crosslinked HMW counterparts in short-term in vitro studies.  
As per international standards, new medical devices and their constituent materials must 
be evaluated in a manner that reduces the risk of harm to the patient/animal as much as 
possible. Such investigations typically consist of both in vitro and in vivo testing to 
provide sufficient information [180]. For the purposes of toxicity testing under ISO 
10993, medical devices are characterised by their nature of contact to the body and their 
contact duration. For an implantable vaccine delivery device of the nature that is proposed 
within this thesis, the device would be classed as an implant device and falls into duration 
category “C” (Permanent [>30 days]). For implantable medical devices in this category, 
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the necessary requirements to be satisfied are extensive. Such necessary testing areas 
include cytotoxicity, sensitisation, irritation, acute systemic toxicity, subacute/subchronic 
toxicity, genotoxicity, carcinogenicity and local effects after implantation [99]. Naturally, 
a comprehensive analysis of all the above areas for a material/device would take 
significant time and financial backing. For early stage development, it is generally 
preferred to perform initial in vitro pilot evaluations into the more general areas, such as 
cytotoxicity. Cytotoxicity evaluations are favoured due to being simple, fast, having high 
sensitivity, and save animals from testing by replacing in vivo testing at early stages [101]. 
The in vitro cytotoxicity assessments within this chapter use dermal fibroblasts as the 
subject cell type. This cell type was chosen due to fibroblasts being abundant in the sub-
cutaneous region the device would be implanted, being a widely studied and utilised cell 
type for in vitro studies of this type, and also due to the group having extensive knowledge 
and experience in working with these cells. Additionally, due to the short-term nature of 
my travel scholarship, a cell type was required that already had ethical and health and 
safety approval.  
 
In this chapter, direct contact evaluations were performed by culturing fibroblasts on 
photo-cured PCL networks for up to 11 days. The WST-1 assay was used to indicate cell 
viability. WST-1 is a tetrazolium colourimetric assay, which therefore develops a colour 
in response to the degree of metabolic activity of viable cells as the tetrazolium is reduced 
to formazan, enabling measurement of viability via spectrophotometer. The WST-1 
tetrazolium salt is reduced non-enzymatically to water soluble formazans by NAD(P)H, 
in the presence of intermediate electron acceptors. The reduction of the WST-1 
tetrazolium occurs at the cell surface, rather than intracellularly [181]–[183], thus WST-
1 reduction is actually a measurement of net extracellular membrane redox activity. The 
extent of the colour change is proportional to this net metabolic activity, which in turn 
can theoretically be proportional to the number of viable cells present [104].  For 
visualising the cells and their morphology, dual staining of fixed cells with DAPI and 
TRITC-phalloidin was performed. DAPI is a cell permeable, fluorescent dye that binds 
to the minor groove of double-stranded DNA, which enables staining the nuclei of fixed 
and permeabilised cells [184].  DAPI has excitation/emission wavelengths of 358/461 
nm.  TRITC-phalloidin is a fluorescently labelled phallotoxin cyclic peptide that interacts 
with polymeric actin, producing a stabilising effect that cause the actin filaments to resist 
depolymerisation and assembly [185], [186].  The conjugated TRITC label provides a 
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red-orange fluorescence, with an excitation at 540 nm and emission at 565 nm. DAPI and 
phalloidin are commonly used together, where DAPI aids assessment of cell density, 
while phalloidin enables characterisation of cell morphology indicated through the 
arrangement of cytoskeletal actin filaments [187]–[189]. 
 The following sample groups were investigated: non-crosslinked 45 kg/mol PCL 
(PCL45k), photo-cured bimodal networks produced using the xPCL10k0.9k formulation 
(xPCL), and glass coverslips. The inert glass coverslips were used as a non-polymeric 
positive control. With non-crosslinked PCL being well characterised as non-cytotoxic and 
performing similarly to tissue culture plastics, the PCL45k was used as a polymeric 
positive control. The experimental groups consisted of 3 variants of the xPCL networks. 
Extracted networks, non-extracted networks, and benzyl alcohol (BnOH) swollen 
networks were used. The extraction process for the extracted networks is expected to 
remove the leachables required as part of the photo-curable resin formulations such as 
unreacted photo-initiator and macromers, as well as residual BnOH. Of these, TPO is the 
only well studied component and has been shown to be cytotoxic to a variety of cell types 
[190]. While BnOH has been shown to be cytotoxic to cell types localised in the eye 
[132], [133], the solvent is in frequent use in skin-applied cosmetics and as a vehicle for 
parenteral drug delivery and is therefore expected to be less toxic to skin localised cell 
types. Unreacted macromers have been shown to have cytotoxic effects [191], [192].  If 
extraction is performed correctly, the potentially toxic leachables should be removed; 
therefore, the extracted networks are expected to perform similarly to the PCL45k. The 
rationale behind investigating the non-extracted and swollen networks comes from the 
work of developing the vaccine delivery devices (detailed later in Chapter 6). Our current 
method of sealing the devices involves injection of ~10-15 µL of resin into the open ends 
after filling with payload, which is then cured with UV. Extraction of the sealed devices 
to remove leachables from the small quantities of resin at the end caps would lead to 
solvent exchange between the internal payload solution and the isopropanol used in the 
extraction process, and is therefore not feasible. Therefore, small quantities of potentially 
toxic leachables will remain in the non-extracted end caps. The non-extracted sample 
group aim to replicate this scenario. The BnOH swollen sample groups are intended to 
assess the toxicity specifically related to leaching of the solvent.    
5.2 Materials and sample preparation 
Glass disc coverslips of 5 mm diameter were purchased from Thomas Scientific (USA). 
10k-2MA, and 0.9k-3MA macromers were synthesised and purified as discussed in 
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Chapter 3. Other photo-curable resin components such as photo-initiators were purchased 
and used as discussed in Chapter 4.  xPCL10k0.9k disc samples for toxicity testing were 
produced in the same manner, and from the same resin formulations, as discs used for 
degradation studies described in Chapter 4. For the purposes of this chapter, only the 
xPCL10k0.9k composition of photo-cured network is investigated and shall be referred 
to using the shorter abbreviation “xPCL”. Non-crosslinked PCL45k discs were punched 
from sheets of polymer produced by melt compression moulding, also detailed in Chapter 
4.  
 
In addition to the extracted and dried crosslinked networks, non-extracted and BnOH 
swollen xPCL networks were also assessed. The not-extracted group is comprised of discs 
formed by the photo-crosslinking procedure, but excluded from the extraction procedure 
to leave networks that still contain potentially non-crosslinked macromer, BnOH and 
unused TPO. The swollen group is composed of extracted and dried networks that were 
bathed in fresh BnOH after the ethanol washes, in an attempt to investigate any effect of 
BnOH separately from potential TPO residues. The swollen group were rinsed with PBS 
and soaked in media overnight as described for the other disc groups in 5.3.3. 
5.3  Preparation and evaluation of primary fibroblasts 
5.3.1 Materials 
Human dermal fibroblasts were isolated from split thickness biopsies from consenting 
patients undergoing abdominoplasty surgery and breast reduction surgery [193]. Ethical 
approval for human skin collection was obtained from the Queensland University of 
Technology Research Ethics Committee (1300000063) and the Uniting Healthcare / St 
Andrew’s Hospital Ethics Committee (0346). Trypsin, Collagenase-A, Dulbecco’s 
Modified Eagle’s Medium (DMEM), foetal calf serum (FCS), penicillin, streptomycin, 
L-glutamine, and tetramethylrhodaminyl-conjugated phalloidin (TRITC Phalloidin) and 
phosphate buffered saline were acquired from Invitrogen (Australia). 4’6- diamidino–2–
phenylindole (DAPI) was acquired from Life Technologies (USA). Phosphate buffered 
saline (PBS) tablets, cell proliferation reagent WST-1, Triton X-100, bovine serum 
albumin (BSA), were purchased from Sigma Aldrich (Australia). Paraformaldehyde was 
purchased from ProSciTech (Australia). 
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5.3.2 Initial culture protocol 
To allow separation of the dermis and epidermis, enzyme digestion was performed in 
0.125% trypsin at 4 oC overnight. The dermis was then comminuted and incubated in 
0.05% collagenase-A in DMEM at 37 oC and 5% CO2 for 48 hours to allow harvesting of 
the fibroblasts. The resulting solution was centrifuged at 212 g for 10 minutes prior to 
resuspension and subsequent culture of the cells in fibroblasts growth medium, which 
consisted of DMEM supplemented with 10% FCS, 50 U/mL penicillin, 50 µg/ml of 
streptomycin and 2 mM L-glutamine. All cells were used at passage 5. 
5.3.3 Sample sterilisation 
Samples for cell culture were sterilised by immersion in 80% ethanol for 60 minutes and 
dried in a laminar flow cabinet. Following 3 washes in PBS, samples were placed in 
fibroblasts growth medium overnight and were deemed ready for use the following 
morning. 
5.3.4 Cell viability assessment 
Samples for cell proliferation experiments were 5 mm in diameter and placed in a 96 well 
plate. Isolated fibroblasts, 5x103 in 10 µL, were seeded onto the samples and allowed to 
attach for 1 hour, prior to addition of 150 µL fibroblast growth medium. Medium was 
replaced every 2-3 days. Cellular proliferation on the samples was studied at 1, 4, and 11 
days using WST-1. Upon reaching day 1, 4, and 11, three samples per experimental group 
were transferred into a 48 well plate, 200 µL of fresh medium was added along with 20 
µL of WST-1 reagent. Samples were incubated in the dark for 2 hours. The supernatant 
was then transferred into a 96 well plate and readings taken on a plate reader (BioRad 
xMark Microplate Spetrophotometer) at 450 nm with the reference wavelength set to 650 
nm. The average of triplicate blank well (growth media only) absorbances were deducted 
from the sample absorbance values at each time point. The coverslip group absorbances 
were regarded as indicating 100 % cell viability. All sample group values were expressed 
as a percent of relative metabolic activity vs. the coverslip controls. 
5.3.5 Cell proliferation and morphology on the disc surface 
Samples (12 mm in diameter) to study cellular morphology were seeded with 1.2x104  
fibroblasts in 10 µL, within a 24 well plate and allowed to attach for 1 hour, prior to 
addition of 1.5 mL of fibroblast growth medium. Medium was replaced every 2-3 days. 
Cellular density and morphology on the samples was studied at 1, 4 and 11 days using 
confocal laser scanning microscopy (CLSM). Upon reaching the time points, the samples 
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for CLSM were rinsed in PBS supplemented with calcium and magnesium, and fixed in 
4% PFA for one hour at room temperature. Samples were then incubated in 0.2% (v/v) 
Triton X-100 in PBS for 5 minutes, prior to incubation for 10 minutes in 1% BSA/PBS 
(w/v) blocking solution. Samples were fluorescently labelled by placing them in a 
working solution containing blocking solution, 0.8 U/mL TRITC Phalloidin, and 5 µg/mL 
DAPI. Samples were incubated in working solution for 45 minutes on a shaker and 
protected from light. Stained samples were stored in the dark at 4 oC immersed in PBS 
until use. Samples were washed 3 times in PBS between each step above. Samples were 
imaged on an epi-fluorescent microscope (Nikon, Eclipse Tis). 
5.4 Cytotoxicity: primary dermal fibroblasts 
5.4.1 WST-1 viability assessment 
The WST-1 assay was performed on triplicate samples of each disc group after 1, 4 and 
11 days of cell culturing. Three variants of the bimodal xPCL formulation discs 
(extracted, swollen, and not-extracted) were tested alongside discs composed of glass, 
and non-crosslinked PCL45k. The relative metabolic activity in reference to the glass 




Figure 5.1:- WST-1 assay determined average metabolic activity over 14 days of culturing in relation to control group 
(glass discs). Data represents an average of triplicate samples ± SD. 
Over the course of the experiment, the average absorbance (and therefore overall 
fibroblast metabolic activity) associated with the glass positive control group cultures 
approximately doubles, indicating sustained cell viability accompanied by cell 
proliferation during the 11-day incubation. The average relative metabolic activities of 
the fibroblasts on the PCL45k, xPCL extracted, swollen and non-extracted groups in 
relation to the control group were 66 ± 2, 40 ± 23, 40 ± 16, 43 ± 4 % at day 1, 64 ± 7, 75 
± 7, 24 ± 2, 23 ± 2 % at day 4, and 130 ± 12, 114 ± 21, 15 ± 7, 39 ± 9 at day 11, 
respectively.  
Initially, all experimental disc groups show reduced cell viability in relation to the control 
group. The xPCL extracted group average viability appears to climb steadily, matching 
the control group by around approximately day 8/9, and surpassing the control group at 
day 11. While the non-crosslinked PCL45k reaches a similar endpoint by day 11, but 
appears to indicate a slight decrease in average viability at day 4. The swollen and non-
extracted networks both start at approximately the same level of viability at day 1, but 
viability reduces almost by half at day 4. By day 11, the swollen networks continue to 
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show decreased cell viability, while some recovery of viability appears to be occurring 
for the not-extracted group.   
5.4.2 DAPI/phalloidin proliferation and morphology assessment 
Fibroblasts on the surfaces of the glass, PCL45k and extracted xPCL discs were fixed and 
stained on days 1, 4 and 11 of the experiment. Representative microscope images of each 
disc group at the three time points is shown in Figure 5.2. 
 
Figure 5.2:- Microscope images of DAPI/phalloidin-stained fibroblasts cultured on top of glass, PCL45k, and extracted 
xPCL  discs, after 1, 4 and 11 days of culturing. Magnification 20x. 
Cell nuclei are stained blue by the DAPI, while the TRITC-phalloidin stains the actin 
filaments yellow/green. During merging of the DAPI and phalloidin images, the 
phalloidin channel was assigned to a different colour, in this case red, which enhances the 
contrast. The glass positive control disc shows a substantially larger population of cells 
present on the surface at day 1 than the other discs, but the actin filaments appear 
unordered. By day 4, a similarly high population of cells is apparent on the glass disc, but 
the fibroblasts are now highly ordered and confluent, displaying a pattern of cells side-
by-side with actin filaments arranged vertically. Unfortunately, the day 11 glass disc 
sample was damaged during processing and was unable to be imaged. The PCL45k and 
xPCL samples show much fewer fibroblasts present on the disc surface at day 1, and 
additionally appear to show a different morphology. By day 4 the fibroblasts on the 
PCL45k sample appear to have reached a similar density level to the day 1 glass disc 
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population, also showing the same unordered arrangement of actin filaments. The 
fibroblasts on the PCL45k discs at day 11, are displaying an ordered pattern arrangement 
of actin filaments and appear confluent. The xPCL image shows a similar trend to that 
seen in the PCL45k images, with an initially low cell density at day 1 progressing to a 
confluent, dense population by day 11. The fibroblasts on the xPCL disc at day 4 appears 
to be proliferating slower than the fibroblasts on the PCL45k disc, based on the lower cell 
density in the day 4 images. 
5.5 Discussion 
5.5.1 Summary 
Cell metabolic activity of the primary dermal fibroblasts cultured on the glass, PCL45k, 
and extracted xPCL disks increases over the course of the experiment; however, the PCL 
materials both show a brief lag period in the few days after initial seeding.  The net 
metabolic activity of primary dermal fibroblasts cultured on PCL45k and xPCL discs 
matches or exceeds the glass coverslip positive control by day 11. Fluorescent imaging 
supports the view that the increase in net metabolic activity is due to an increasing number 
of viable, metabolically active cells being present on the disc surfaces, with increases in 
cell densities being shown. xPCL discs that were swollen in BnOH or not-extracted after 
curing show low or static levels of cell metabolic activity.   
5.5.2 Crosslinked networks and cell metabolism 
Over the 11 day experiment, the primary fibroblast net metabolism on the extracted xPCL 
discs increases from approximately 40 % to 114 % in relation to fibroblast net metabolism 
on the glass control discs. In conjunction, the cell density visibly increases over the 11 
day period, with the fibroblasts on the xPCL disc appearing confluent.  
This combination of results suggests that the rise in net metabolic activity measured 
through the WST-1 assay is likely due to the proliferation and growth of viable cells, 
which would indicate that the crosslinked networks are not cytotoxic under these 
conditions. Such findings are in agreement with previous literature that investigated the 
cytotoxicity of photo-crosslinked PCL networks using similar methods.  Elomaa et al 
evaluated the compatibility of human umbilical-vein endothelial cells (HUVECs) 
cultured on photo-crosslinked PCL films using an MTT assay. The optical density 
(proportional to metabolic activity and the number of living cells) increased at every time 
point within 7 days of culturing. The signal for the PCL network was only slightly behind 
the tissue plastic control. Therefore, it was deemed that the networks showed good 
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cytocompatibility. In the same study, mouse mesenchymal cells were also cultured on the 
networks, and monitored by measuring the double stranded DNA (dsDNA) content. It 
was shown that the dsDNA concentration tripled in the PCL network group, indicating 
that the cells proliferated well on the networks over 14 days of culturing [179]. A study 
by Kweon et al assessed the interaction between networks derived from 2,000 g/mol PCL 
diacrylate macromers and human MG-63 osteoblasts. It was shown that the osteoblasts 
did attach and proliferate on the crosslinked PCL scaffolds; however, their proliferation 
index was lower than the culture plastic control. The authors attributed this to poor cell 
attachment due to lack of suitable matrix, rather than a cytotoxic effect [90]. 
The swollen and non-extracted networks however, are potentially cytotoxic. Net 
metabolism associated with fibroblasts cultured on the swollen and non-extracted disc 
surfaces almost halved between day 1 and day 4, before the cells on the non-extracted 
discs appear to partially recover to day 1 metabolism levels. The cells cultured on the 
swollen discs however, continued to fall to 15 % of the glass control by day 11. The 
swollen and not-extracted xPCL disc variants were not imaged, so the cytostatic or 
decreasing net metabolism values cannot be cross-referenced. It would be expected that 
imaging of these disc variants would show low cell densities based on the low net 
metabolic activity indicated by WST-1, and/or potentially cell debris [194] from non-
viable cells. The WST-1 measurements of the non-extracted and BnOH swollen groups 
appear to demonstrate that one or more components are toxic. The non-extracted group 
will contain BnOH, TPO photo-initiator, and potentially free macromers that were not 
included into the network. Due to being derived from extracted networks, the BnOH 
swollen group should only contain BnOH. The overall low WST-1 signal from the BnOH 
swollen disks may suggest that BnOH itself is cytotoxic. While BnOH has been shown 
to be cytotoxic to human retinal pigment epithelial cells in a dose dependant manner 
[132], [133], investigations into the cytotoxicity of other cell types are not present in the 
literature at this time. It is possible that the swollen networks adsorb lower quantities of 
proteins from the culture media during the sample preparation phase, therefore leading to 
poorer initial cell attachment, and subsequently lower metabolic activity thereafter due to 
the presence of less fibroblasts in comparison to other groups. As such, the toxicity of 
BnOH on the fibroblasts is not fully proven here. Type I photo-initiators such as TPO, 
have been shown to display concentration dependant cytotoxic effects in human oral 
keratinocytes and V79 (Chinese hamster lung fibroblasts) cells [190]. Further work 
specifically investigating the extent and nature of toxicity from unreacted macromer, 
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BnOH, and TPO individually is required. The current data suggests that our method of 
vaccine delivery device sealing using un-extracted resin is likely unsuitable due to the 
evidence of cytotoxicity. The concentrations of the toxic components will be higher 
within the non-extracted and BnOH swollen groups that what would be present within 
the small volumes of unextracted resin used to cap the devices. Future work regarding the 
dose dependency of the cytotoxic effects of TPO and BnOH would provide more 
appropriate information before disregarding the current sealing/capping methodology. 
5.5.3 Crosslinked networks and cell morphology 
Primary dermal fibroblasts cultured on the xPCL material surfaces initially (days 1 and 
4) exhibited a less elongated and more spread morphology, than the fibroblasts cultured 
on the glass discs. Fibroblasts on the PCL45k discs at day 1 demonstrated similar 
morphology to those cultured on the xPCL material. This spread morphology appears 
consistent with various human fibroblasts cultured in low cell densities on different 2D 
surfaces and materials [195], [196]. As the cell density increases on the PCL45k and 
xPCL materials, the fibroblasts appear to adopt a heavily elongated and narrow 
morphology, which appears to be highly ordered. Initial cell morphology of fibroblasts 
on the glass disc show this elongated and narrow morphology too, but appear unordered 
with respect to each other. At day 4 the fibroblasts on the glass disc form a similar linear 
ordered pattern seen from fibroblasts cultured on the PCL45k/xPCL(extracted) discs at 
later culturing stages. These nematic homogeneous populations of elongated, spindle-
shaped cells are typical of well-established confluent fibroblast populations [197]–[199]. 
With the fibroblasts proliferating and adopting their expected morphology, it would 
appear that the extracted xPCL discs are not causing the fibroblasts to deviate from their 
normal behaviour.   
5.5.4 Cell attachment  
All the PCL-based disc groups start the experiment with a lower net metabolic activity, 
and primary fibroblast density than the glass control. This is potentially caused by the cell 
seeding methodology and/or poor or slow cell surface attachment at the start of the 
experiment. It is widely reported that polymeric materials, such as PCL, used in medical 
applications often require surface modifications or treatments to improve cell adhesion 
and general biocompatibility [200]–[202]. PCL tissue scaffolds produced by Wang et al 
were demonstrated to retain only 30 % of the Human adipose-derived stem cells (ADSC) 
seeded. ADSC attachment was improved to approximately 50 % by NaOH surface 
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erosion treatment and embedding of pristine graphene nano-particles [203]. Similar 
results were obtained by Recek et al, where plain PCL surfaces were the least suitable 
environment for HUVEC adhesion, while NH3 or O2 plasma treated PCL surfaces enabled 
strong HUVEC adhesion [204]. While poor initial cell adhesion presents a consistency 
issue between discs or disc groups for the purposes of the WST-1 and DAPI/phalloidin 
assays, in the case of the vaccine delivery device, the adherence or growth of cells on the 
device surface is not an aim. It is expected that preventing or reducing cell (specifically 
macrophage) adherence to the device would actually be advantageous by reducing the 
extent of the foreign body response and hindering fibrous encapsulation [205]. 
Considering this, modifications to the surface of the materials to promote cell adherence 
are not regarded as being within the scope of this project. In terms of improving the 
reproducibility and consistency of cell seeding on the discs for cytotoxic evaluation, 
future testing could consider investigating a few changes to the methodology. 
It is suspected that the two-stage seeding method used where a high concentration of cells 
in a small volume is directly added to the disc and then topped up with growth media after 
a period of time (as described in 5.3.4 and 5.3.5), may have an unintended flush-effect. 
This effect may be displacing non-adherent cells due to the forces from addition of a 
relatively large volume through the pipette into the well. Perhaps suspending the same 
number of cells in the total well volume of growth medium and adding this to the well in 
one action would allow the cells to settle without further fluid currents potentially 
washing them off the surface. While this may lead to a lower initial cell density on the 
disc from cells settling on the well plate surface itself, it should be more consistent 
between replicates and between disc groups than the current method. Another 
consideration may be to perform a prolonged disc incubation step with the FCS-
containing growth medium to allow potentially greater quantities of attachment 
promoting proteins, such as vitronectin and fibronectin, to become adsorbed on the 
material surface, which may aid initial fibroblast attachment [206], [207]. Assessments 
would have to be conducted to determine whether lack of anchor proteins is a substantial 
contributing factor to our variation in initial cell attachment. 
5.5.5 Future considerations 
While we have demonstrated that our extracted photo-cured materials perform similarly 
to PCL oligomers during direct contact in vitro cytotoxicity assessments with a fibroblast 
monoculture, looking ahead to other important factors such as the nature of the 
inflammatory response to the implant is key to further device development. Generally, 
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implantation of an object will cause injury to local tissue, initiating inflammatory, wound 
healing, and other foreign body responses [208]. However, it is possible to alleviate or 
mitigate aspects of the body’s response through the material(s) used[209], and also the 
size and shape of the implanted object [210]. 
The foreign body response (FBR) initiates a complicated signalling cascade, involving 
various cell types such as neutrophils, macrophages, and fibroblasts among others [208], 
[211]. The main purpose of the FBR is to contain or wall off the “foreign object” from 
local tissues. Initial injury begins the deposition of proteins at the materials surface and 
recruitment of neutrophils as part of the acute inflammatory response [208]. This can 
progress to chronic inflammation marked by the presence of monocytes and lymphocytes. 
Migrating monocytes can differentiate into macrophages which release inflammatory 
mediating agents such as oxygen free radicals, other reactive oxygen intermediates, 
degradative enzymes, and acids to attack the material [208], [212]. Additionally, the 
macrophages attempt to phagocytose it but will be unable to digest or phagocytose the 
implant. This leads to the macrophages undergoing fusion in an attempt to improve their 
efficiency, forming multinucleated giant cells, known as foreign body giant cells 
(FBGCs). It is thought that FBGCs generate signals to recruit fibroblasts to arrive at the 
injury site, which synthesise and deposit collagen [213]. The combination of FBGCs and 
fibroblasts develops granulation tissue which effectively isolates the implant from the rest 
of the body via a fibrous capsule [214]. The histology of the produced granulation tissue 
or fibrous capsule can vary significantly, with differences in thickness, extent of packing, 
and vasculature. In particular, the packing and vasculature aspects can affect diffusion of 
even small molecules [215] through the fibrous capsule, with tightly packed fibrous 
capsules restricting diffusion, while granular, well vascularised capsules offering greater 
permeability [216].  
Due to the FBRs complexity, it is best assessed within a suitable in vivo host model. For 
subcutaneous implantation, use of rodent models is typical, however suffer from poor 
translation to human trials [217]. Use of primates as a more physiologically relevant host 
model is preferred for long term in vivo studies, but their use is limited by strict ethical 
guidelines [209], [210]. Due to this, co-culture in vitro models have been developed to 
evaluate the FBR to materials. For example, it has been shown that in in vitro 
fibroblast/macrophage co-culture models can be a viable and useful tool to predict in vivo 
response to polymer implants [218], [219]. Other options include ex vivo which has the 
advantage of containing all the cell types found in skin [220]. However, the in vitro 
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approach is simpler, cheaper, and without the need to be processed within hours following 
collection and avoids the high donor-to-donor variability of explants [221], [222]. As 
such, well-constructed in vitro studies can continue to provide relevant information about 
the more complex in vivo environment an implanted capsule would operate in. 
 
Photo-initiated crosslinked networks are formed through the polymerisation of the end 
groups via an addition type reaction. The carbon-carbon chains that result from these 
addition polymerisation reactions are referred to as kinetic chains. While it is generally 
accepted that the main polymeric backbone of networks constructed from such 
degradable biomaterials will degrade and show low toxicity, the leftover kinetic chains 
are typically insoluble and of variable molecular weight, and therefore may accumulate 
in the body [223], [224]. Various studies have been performed with the aim of 
characterising and/or controlling the kinetic chain lengths [225]–[227], but few proceed 
to perform cytotoxicity evaluations on the produced kinetic chains themselves. Jansen et 
al demonstrated a method of controlling the kinetic chain length of PDLLA-MA networks 
and performed an XTT assay with fibroblasts, which suggested that extracts of the 
PDLLA network were not cytotoxic [228]. Similar findings were suggested by Wang et 
al, where the degradation products of crosslinked poly(propylene fumarate)(PPF) 
networks were added to 4 cell lines, with no change in metabolic activity or morphology 
observed compared with a non-cytotoxic control [229]. However, this appears 
contradictory to earlier work on the degradation products of crosslinked PPF networks by 
Timmer et al [230]. At the time of writing, literature regarding the cytotoxic evaluation 
of degradation products from photo-crosslinked PCL networks was not found. Due to the 
overarching aim to use the degradable photo-crosslinked PCL networks to construct an 
implantable device, work should be performed to assess the potential cytotoxicity of the 
degradation products, with a particular focus on the kinetic chains.  
5.6 Conclusions 
Primary dermal fibroblasts cultured on the crosslinked PCL networks that have been 
extracted and dried, appear to constitute a biocompatible system. The net metabolic 
activity of the primary fibroblasts cultured on the crosslinked and extracted PCL networks 
was shown to approximately match or exceed the glass positive control and the non-
crosslinked PCL group after 11 days of culture. Moreover, culturing the fibroblasts on 
the PCL45k and xPCL extracted disc surfaces does not appear to adversely affect cell 
morphology, with the fibroblasts adopting their typical spindle morphology at 
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confluency.  The PCL discs all displayed an initial lag phase with lower cell density and 
metabolism after day 1 of culture, compared with the control group, which appears to be 
at least partly due to poor cell adherence to the disc surfaces.  Not-extracted and BnOH 
swollen photo-cured networks indicate a potential cytostatic or cytotoxic effect and 
require further evaluation to determine the root cause.  Further investigation into the 
cytotoxicity of network degradation products, including the kinetic chains, is of high 
importance prior to proceeding to in vivo characterisation. The results within this chapter 
indicate that the extracted crosslinked networks perform similarly to HMW PCL, and 
demonstrate a minimal degree of cytotoxicity under these culture conditions.  
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– Device manufacture 
In this chapter, the development of the methods for device manufacture and initial 
assessment of the prototype devices will be discussed. 
6.1 Introduction 
Thermoplastic non-crosslinked PCL devices were shown to be viable delayed release 
devices, but upon burst released only small amounts of the contents, rendering them 
highly inefficient [21], [231]. Previous work with PDMS devices by Dunker suggested 
that flexible networks could enable greater instantaneous release at burst. While the 
PDMS devices demonstrated the concept well during mechanical testing, due to their non-
degradability and significant leaking issues during in vitro osmotic burst testing this 
material was not pursed further [232]. Investigation of devices constructed from 
degradable flexible crosslinked-PCL materials will be performed to assess whether such 
photo-cured materials can provide the combination of flexibility and degradability desired 
for the delayed release vaccine delivery implant.  
We hypothesise that use of the xPCL10k0.9k formulation (characterised in previous 
chapters) will swell to a greater extent than thermoplastic PCL materials and burst 
releasing a greater amount of content, as desired. Use of a dip coating machine will enable 
production of tubes with consistent wall thicknesses, which is a key parameter that 
influences the osmotic uptake, burst pressure, and therefore the delay-to-burst of the 
tubes. We hypothesise that mechanical burst testing of the tubes will verify the greater 
ability of the xPCL tubes to flex, and swell over the PCL counterparts, and provide a 
demonstration of the xPCL tubes greater extent of burst release. Within this Chapter, use 
of dip coating and stereolithography methods to manufacture the tubular part of non-
crosslinked PCL and xPCL devices will be assessed. Dip coated tubes of both material 
types will be characterised and compared in terms of the wall thickness distributions and 
mechanical burst behaviour. The effect of capping methods on the mechanical burst 
characteristics for xPCL devices will be investigated. PCL tubes will undergo a 
preliminary osmotic burst site evaluation, with detailed investigation of the osmotic burst 
behaviour of devices composed of both materials is reserved for Chapter 8.  
6.2 Materials 
Medical grade polycaprolactone PURASORB® PCL was purchased from Corbion (The 
Netherlands). Chloroform was purchased from Sigma Aldrich (Australia). Macromers 
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from Chapter 3 were used to formulate a liquid resin as was performed in Chapter 4 and 
Chapter 5. For dip coating, the crosslinked material formulation used was the 
xPCL10k0.9k formulation, while for stereolithography printing the xPCL10k+4A 
formulation was used. The details regarding the compositions of both formulations are 
listed in in Table 4.1 of Chapter 4. 
Here, the non-crosslinkable PURASORB® PCL will be referred to as PCL, while the 
crosslinked xPCL10k0.9k material will be referred to as xPCL. 
6.3 Methods 
6.3.1 Dip coating  
Dip coating of PCL and xPCL was performed on a custom-built automatic dip coating 
apparatus. The PCL material was dissolved in chloroform to produce a solution that 
contained 15 % w/v of PCL. The xPCL was used as formulated. The apparatus, shown in 
Figure 6.1, features a movable stage with a vat of resin attached, and a motor that rotates 
a shaft connected to a 2 mm diameter rod. The machine is controlled through G-code 
scripts interpreted via Mach 3 CNC software.  
 
Figure 6.1:- Mark 1 auto dip coater. The stage on the linear ball screw rail moves up and down control the depth and 
speed of dipping or removal. The rod is fitted directly to a separate motor shaft via an aluminium shaft coupler. Note 
resin container is not attached to the stage in this image. 
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The rod acts as the substrate upon which material is deposited. Dip coating of both 
materials involves a repeated dip cycle that consists of 4 stages. The first stage is the 
raising of the vat, which coats the rod. The second stage is a holding step while the rod is 
submerged. The third step features the lowering of the vat, so that the coated rod is open 
to air. The fourth and final stage is another hold step. Throughout all stages the rod is kept 
rotating. These 4 stages are repeated 4 times for the PCL material and 3 times for the 
xPCL material. While the overall layout of the dip cycles is highly similar, the specific 
settings for each stage and final processing is different for each material type. 
The PCL material setup maintains a rod rotation of approximately 10 rpm and features 
short residence times during the 2nd stage hold step, which decrease with each dip from 
6, 3.5, 2.5 to 2 s. The fourth stage of each cycle enables evaporation of chloroform to 
allow deposition of the PCL to the rod. The length of this evaporation step was maintained 
at 3 mins for all dips. The complete G-code file for this procedure is listed in Appendix 
B. After the dip coating cycle was completed, the PCL coated rods were prepared for 
annealing to improve the surface quality of the deposited material. The rods were 
positioned vertically into a block of Teflon, and placed within an oven at 70 oC.  
Annealing in the oven was performed for 1 hour, after which the Teflon block and 
samples were removed and allowed to cool on the benchtop.  
For the crosslinkable material, a UV (365 nm) light source (OmniCure® S2000) was 
positioned in a manner so that the emitted light covered the entirety of the coated rod. 
The arrangement of the dip coater and UV source is shown in Figure 6.2.  
The dip coating cycles listed above were determined from some initial preliminary testing 
runs using knowledge gained from previous work [231], [232] as a starting point. The 
number of dips for a particular formulation was determined by measuring the wall 
thickness of a tube produced with a calliper. The target wall thickness was 200 µm. If the 




Figure 6.2:- Mark 1 dip coater with OmniCure UV system positioned for photo-crosslinking of xPCL tubes. 
The UV source was manually turned on and off for the curing stages of the xPCL material 
dip cycle. Instead of facilitating evaporation, the final hold step of each cycle was the 
curing stage, where the UV source was enabled for 7 mins. The last curing stage time was 
doubled to 14 mins. After removal of the rod from the dip coater, the rod was placed 
within a Teflon block and positioned within a UV crosslinker for 1 hour of post-curing.  
After completion of the annealing or post-cure stages, the coated rods of both material 
types were submerged in ethanol to facilitate swelling and easier removal from the rod. 
Approximately 5 mm was cut from the top and bottom ends of the tube, as these regions 
tended to be thicker (bottom) or thinner (top) due to gravity and material flow. The 
remaining central portion was cut into 30 mm lengths where the wall thicknesses appeared 
most homogeneous and defect free. Typically, 1 or 2 viable 30 mm long tubes could be 
cut from a single dipped rod. The g-code for producing the xPCL tubes is shown in 
Appendix B. 
The xPCL tubes require Soxhlet extraction to remove all resin components not part of the 
photo-cured network. Extraction with IPA was performed for 3 days. Extracted tubes 




The xPCL10k+4A resin formulation that was used to print the various structures in 
Chapter 4, was also used to print the tubular parts of the devices on the EMBER 
stereolithography printer. Print settings and exposure times were the same as detailed in 
Chapter 4 4.3.5.  
6.3.3 Assessment of wall thicknesses 
A SCANCO µCT 50 micro-computed tomography (microCT) scanner was used to 
determine the wall thicknesses of dip coated tubes. Tubes were positioned vertically 
within the sample holder, and scanned in 3.4 µm voxels, at 45 kVp, 200 µA, and using an 
integration time of 1.2 s. Tubular samples either were scanned along the majority of their 
length, or were scanned in 3 particular zones at the top, centre and bottom of the sample. 
These regions are in reference to the position of the material on the rod during dip coating, 
with the top being the region furthest from the resin vat, and the bottom being the end of 
the rod that is first to come in contact with the resin during dipping. Each zone consisted 
of 250 slices. For tubes that were scanned over the majority of their length, at total of 
7060 slices were analysed covering 24 mm, with the 3 mm at each end (30 mm long tube) 
not scanned. Slices were exported as .TIF files for measurement within ImageJ. A batch 
processing measurement script (shown in Appendix B) was produced, which measures 
the wall thickness of a ring slice at 1o intervals around the circumference of the ring. The 
measurements were then exported and analysed within Excel. 
6.3.4 Thermoplastic PCL device sealing 
The PCL tubes were sealed using a thermal welding technique, where a plug of PCL is 
melted and fused with the open end of the tubular part. A custom sealing device was used 
to position the PCL tubes and plugs during the process. A design render of the device is 




Figure 6.3:- The custom made sealing device. The blue are red components are blocks of copper machined to 
accommodate the tubes and caps. Alignment between the main body (blue) and heat transfer block (red) is maintained 
by the 4 grey rods fixed within the main body. Image reproduced from [232]. 
This device had been made and used previously as part of the proof of concept work [21], 
[232]. The sealing device consists of a copper main body where the tubes are positioned, 
while also functioning as a heat sink, and a removable copper top section that transfers 
heat to the tube and plug. The main body has 5 channels drilled through its entire length 
with a diameter of 3 mm. The channels are threaded for approximately half their length, 
where grub screws enable height adjustment for each channel individually. The top heat 
block features 5 cone indentations aligned with the channels within the main body, which 
aid heat transfer around the plug and the end of the tube, while also shaping the polymer 





Figure 6.4:- Example of a sealed PCL tube end. The melted plug is shaped and folded down over the end of the tube. 
 PCL plugs 3 mm long and 2 mm diameter were punched from a block of PCL using a 2 
mm biopsy punch.  A plug was inserted exactly 1.5 mm into the open end of the tube. 
The tube outer surface is marked with a pen 2.5 mm from the tip of the plug, which is 
used to make the height consistent between tubes within the main body of the device. The 
tube is then positioned within the main body and the grub screw adjusted so that the pen 
mark is visible. The top heat block was placed indentation side face down on a hot plate 
set at 100 oC for no less than 5 mins. The hot top block was placed onto the main body 
and held firmly for 20 s, and then the entire unit is held under running cold water until 
cold to touch. The top block was then carefully removed as the fused tube/caps typically 
adhered to it. The stuck tubes were gently agitated to detach them from the top block.  
If the tube was being used for osmotic burst testing, after one side was sealed a filling 
step was performed before repeating the sealing process for the remaining open end. The 
filling process is described in Chapter 8 8.2.2. Tubes for mechanical burst testing were 
only sealed on one side, and were therefore ready for use after one side was successfully 
sealed.  
6.3.5 Photo-crosslinked device sealing 
Different sealing methods were used with the xPCL tubes to determine the most suitable 
method for future studies. The following methods were used: 1) Injection of 15 µL of 
xPCL10k0.9k resin into the open end, followed by 10 mins of curing using the Omnicure 
UV source. 2) Injection of 15 µL of medical grade cyanoacrylate glue and left to solidify 
overnight. 3) Injection of 10 µL of cyanoacrylate glue, and insertion of a 3 mm long, 2 
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mm diameter PCL plug with 4 µL of glue dispensed around the barrel of the plug, then 
being left of cure overnight. Similarly to the PCL tubes, the xPCL tubes for osmotic 
release studies require filling after sealing of the first end, followed by sealing of the 
remaining end, while tubes for mechanical testing only require a single end to be sealed. 




6.3.6 Mechanical burst pressure testing 
The burst pressure of the tubular parts was assessed using a custom syringe-holding setup 
and an Instron 5567 universal mechanical tester.  Images of the setup are shown in Figure 
Figure 6.5:- Images of tube capped with the different 
sealing techniques. Cyanoacrylate glue only a) side 
view, and b) end view. xPCL10k0.9k resin injection c) 
side view and d) end view. PCL plug and cyanoacrylate 




6.6 , where a) shows the general setup, b) shows a close up of the syringe in the mount, 
and c) shows a tube mounting arrangement.  
 
Figure 6.6:- Mechanical burst pressure testing setup. a) Shows the whole setup, b) the syringe mounted in the holder 
being depressed, c) an example of a tube mounted to the needle. Note that images a) and b) show the setup connected 
to a catheter rather than a tube from this study. 
A vertical mount for a 1 mL glass syringe was laser cut from acrylic. The tube to be tested 
was sealed/plugged on only one of the open ends. The remaining open end was mounted 
on to a blunt 14-gauge stainless steel needle, which had two 2 mm inner diameter O-rings 
pre-mounted. The O-rings were rolled over the mounted portion of the tube. A small 
clamshell clamp was placed over the O-rings and tightened to help hold the tube in place 
and form a good hermetic seal.  The mounted tube and needle were submerged in water, 
and syringe was filled with water. The needle/tube arrangement was mounted to the 
syringe underwater to prevent air bubbles. The syringe and mounted needle/tube was then 
placed in the syringe holder and centred under the crosshead of the Instron chassis.  The 
Instron chassis was fitted with a 500 N load cell, which had a small piece of billet 
aluminium attached so there was a flat surface for depressing the syringe plunger. The 
syringe plunger was depressed at a rate of 5mm/min during the burst experiments and 
was continued until briefly after the burst event. Burst was detected by ejection of water, 
a sharp drop in force reported, and sometimes an audible crack or pop.  Average force 
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due to friction was determined over 3 runs using the syringe filled with water and with 
the needle mounted, but without any tube attached. Sample force curves had the average 
friction force curve subtracted.  The hydrostatic pressure exerted on the samples was 
determined by dividing the force measured by the syringe plunger’s surface area (16.6 
mm2). It was calculated that to displace 1000 µL of water, 60 mm of travel was required. 
Using this, the volume required to burst a tube was calculated from the distance travelled 
by the crosshead. The burst sites of tubes were also imaged under a microscope.  
6.3.7 Osmotic burst site investigations 
PCL tubes were filled with 4 M glucose and dye solution and sealed prior to being 
submerged in 15 ml of 1x PBS solution within a screw top glass vial. The vials were 
placed in an oven at 37 oC until bursts were identified by release of the blue dye into the 
PBS solution. Burst devices were removed, wiped of superficial solution, before the burst 
site being investigated under a microscope (Zeiss Stemi 2000-C with axio cam 105 
camera). 
6.4 Results 
6.4.1 Tubular part wall thickness 
One tube from each of the material groups was selected at random and scanned over the 
majority of their lengths. The distribution profiles of the data obtained from the tubes 
scanned in their entirety are shown in Figure 6.7. The average, minimum, and maximum 





Figure 6.7:- Histograms of the PCL and xPCL full tube scans. Bin size is 2 µm increments. The number of counts within 
each bin is expressed as a percentage of the total number of counts. Both groups feature 2,541,600 measurements each 
determined from a single tube. 
Tube material 
Average 






PCL 127 ± 13 64 243 
xPCL 335 ± 29 196 588 
Table 6.1:- Average, mimimum, and maximum thicknesses determined from the complete tube scans of one PCL and 
one xPCL tube.  Each average and standard deviation is determined from, 2,541,600 measurements on slices from a 
single tube. 
The wall-thickness distribution profiles from Figure 6.7 show two distinct populations, 
and that the xPCL devices are thicker and more variable than the PCL devices. The PCL 
histogram distribution appears to be gaussian.  Considering only 95 % of the data points 
centred around the mean of the full tube scans we can determine that the PCL tube 
thicknesses range predominantly between 102-148 µm, while the xPCL range over 282-
384 µm. Comparing the full tube scan data in Table 6.1, the xPCL tube is approximately 
2.6x thicker (335 µm) on average than the PCL tube (127 µm). The average, minimum, 



























































































































Table 6.2:- Lists the average, minimum, and maximum wall thicknesses measured from the microCT images using the 
ImageJ script. For each sub-section scan, the average and standard deviation is determined from 90,720 
measurements. 
 
The sub-region scans for the PCL 1 and 2 tubes appear to show a trend where the average 
thickness of the top and bottom regions appear similar and thinner than the centre 
portions. While PCL tube 3 bottom and top regions are similar, the centre region is 
thinner. The xPCL tubes appear to show a trend of increasing thickness from top to 
bottom. 
6.4.2 Mechanical burst characterisation 
The friction forces were found to vary as the plunger was depressed over a distance of 40 




and region  
Average 









1 Top 201 ± 22 125 250 
1 Centre 219 ± 25 132 264 
1 Bottom 201 ± 39 108 277 
2 Top 118 ± 7 61 159 
2 Centre 123 ± 10 64 142 
2 Bottom 116 ± 11 64 135 
3 Top 197 ± 16 136 233 
3 Centre 117 ± 11 64 135 
3 Bottom 192 ± 25 105 240 
     
xPCL 
 
1 Top 335 ± 7 318 358 
1 Centre 410 ± 11 382 436 
1 Bottom 411 ± 17 368 473 
2 Top 298 ± 7 264 345 
2 Centre 328 ± 11 294 432 
2 Bottom 344 ± 5 314 362 
3 Top 293 ± 5 257 307 
3 Centre 333 ± 7 297 351 




Figure 6.8:- The average friction force generated from expelling water from the syringe through the blunt needle with 
no tube attached. (n=3). 
As the crosshead makes contact with the plunger, the force required to maintain crosshead 
speed briefly spikes before gradually declining as compression continues. The average 
friction forces were deducted from the forces recorded for each tube specimen tested prior 
to the calculation of pressure. No tubes required plunger compression of more than 20 
mm and therefore the data above covers the entire friction range required. 
 
Burst pressure testing was performed on 5 PCL, 2 xPCL – Glue, 2 xPCL Plug + Glue, 
and 1 xPCL - Resin device. The yield point was defined as the point of peak pressure 
where burst does not occur. The burst moment was identified by expulsion of water from 
the tube, accompanied by a rapid drop in pressure. Representative burst profiles from 
each group are shown in Figure 6.9. The average pressure and volume displaced at yield 





















Figure 6.9:- Representative burst pressure profiles of PCL and xPCL tubes featuring each of the three xPCL tube 




Yield at: Burst at: 
Pressure (bar) Volume (µL) Pressure (bar) Volume (µL) 
PCL 7.4 ± 1.4 11.6 ± 1.4 5.3 ± 0.4 22.3 ± 1.4 
xPCL – Resin 21.3 32.2 7.7 277.2 
xPCL – Plug + 
Glue 
24.5 ± 0.2 44.1 ± 0.7 13.2 ± 0.7 89.3 ± 9.2 
xPCL – Glue n/a n/a 19.6 ± 0.9 19.2 ± 2.5 
Table 6.3:- The average pressure and displaced volume at yield and burst for PCL and xPCL tubes determined by 
mechanical burst testing. PCL n=5. All xPCL groups n=2, except xPCL- Resin where n=1. 
With exception of the xPCL – Glue tubes, all displayed bursts along the tubular part and 
feature a 2-stage profile, as shown in Figure 6.9. The 1st stage involves the building of 
pressure prior until peaking followed by a steep decline in pressure, which is accompanied 
by visible localised material deformation, generally in the form of a bulge at a position 
on the tubular part. The 2nd stage features growth of this deformation zone during a period 
of gradual pressure decline until burst. From visual observation, the deformation areas 
were largest for the xPCL Resin device, followed by the xPCL Plug + Glue devices, and 
finally the PCL devices. The extent of deformation coincides with the magnitude of the 
volume of water required to burst each device type. When the PCL devices burst, a narrow 
jet of water was forcefully, but briefly, expelled from the area of deformation. The xPCL 
Resin and Plug + Glue devices burst akin to bursting of a water filled balloon, with water 

























phase as the pressure peaks, with a small volume of water ejected from around the cap or 
through the cap itself. 
 
Images of representative mechanical burst sites from PCL and xPCL tubes are shown in 
Figure 6.10. 
 
Figure 6.10:- Representative burst sites from mechanical burst testing of a a) PCL device, b) xPCL cyanoacrylate glue 
sealed device, c) xPCL plug and glue device, and d) xPCL sealed with resin device. Scale bars indicate 1 mm. 
The PCL tubes (a) feature what looks like a large (5.8 mm long) fissure, positioned 
longitudinally on the tubular part. However, this large deformation is deceptive, with only 
a small pinhole in the centre of the deformed zone forming a channel through the device 
wall. While it was observed that the xPCL – Glue devices (b) burst from the cap region, 
it was not possible to detect the nature of the burst site via microscope. The xPCL plug 
and glue devices (c) displayed a clear bulbous deformation (estimated diameter ~3 mm) 
with a gaping longitudinal tear approximately 2.5 mm in length. The xPCL resin sealed 
device displayed a larger zone of deformation (estimated diameter ~5 mm), combined 
with a longer tear of approximately 5 mm.  
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6.4.3 PCL tube osmotic burst sites 
Microscope images of the PCL device burst sites were taken following osmotic 
experiments. Out of 8 devices tested, 5 demonstrated bursts along the tubular section, 
while the remaining 3 devices featured bursts around the sealed cap regions. Images from 
devices that burst along the tubular part reveal that small pinholes are formed at burst 
allowing flux of dye into the surrounding solution. An example of such pinhole bursts are 
shown in Figure 6.11.    
 
Figure 6.11:- Osmotic burst induced pinholes on the tubular part of a PCL device. Upper images shows the tube 
squeezed between fingers to enable easy identification of burst sites, while in the lower image the dye is wiped away to 
show the size and shape of the burst sites. Scale bars indicate 1 mm. 
Multiple pinholes were found on all 5 of the devices that were noticed to burst along the 
tubular part. The burst sites appear significantly different to those found after mechanical 
burst testing.  
Of the 3 devices that burst around or directly through the cap, 2 are considered to be 




Figure 6.12:- PCL devices with burst sites inside the cap. Both appear to be from defects. The cap in image a) featured 
a large hollow space, potentially from an air bubble trapped in the molten polymer during capping. The cap in right 
image b) appears severely damaged, possibly from attempted removal from the sealing device before the polymer had 
fully cooled and re-solidified.  The red arrows indicate the hole or channel from which the dye flows.  
The cap of the device in Figure 6.12 a) featured a hollow space within the cap, rather than 
being solid throughout. A small channel was present at the outer surface of the hollow 
space through which dye was able to travel. The cap in device b) is malformed with a 
narrow channel through the cap that enables premature leaking of dye into the 
surrounding solution.  
The final device burst between the edge of the cap and the tubular part, as shown in Figure 
6.13. 
 
Figure 6.13:- PCL device with burst site at the interface between the end of the tube and skirt of the plug/cap. Red 
arrow indicates position of the burst site. 
It is difficult to determine whether this was due to a defect introduced during capping or 




6.4.4 Stereolithography printing of devices 
Production of devices was performing using stereolithography using the xPCL10k+4A 
resin. For the first attempt at printing tubular devices using the EMBER printer, 3 30 mm 
long 2.4 mm overall diameter (200 µm wall thickness) tubes were positioned vertically 
on the build head directly without supports. The freshly printed tubes are shown in Figure 
6.14. 
 
Figure 6.14:- Vertically positioned tubes printed by stereolithography. Resin and air can be seen through the 
transparent walls while the material is still solvent-laden. The centre tube can be seen to be shorter than the tubes 
either side of it.   
The print process proceeds without issue until the tubes reach approximately >15 mm in 
length. During the rotating peel process after this milestone, the tubes begin flexing and 
struggle to remain completely straight. The middle tube in Figure 6.14 did not return 
properly for the next layer to be added, which then left debris on the build window, which 
disrupted further layers. The print was stopped after this point to prevent potential damage 
to the other tubes also. Aside from this flexing issue, the tubes were well formed and 
without defects. 
In a second attempt, 4 tubes were placed at the tips of an ‘X’ shaped central support in 
order to provide greater resistance to flex during peeling. Photographs of the printed 




Figure 6.15:- a) CAD design of the tubes and support structure. b) side view and c) top view  of the printed model. 
Again resin is held within the internal space through capillary forces, and is washed out prior to post-curing. 
This print layout worked well, with the print completing with all tubes at full length 
without defect. 
 
Typical supported layouts were also investigated. Within the print software, the tube 
model was positioned at 45o with one open end 1.5 mm above the surface of the build 
head. This allowed a series of supports to be added along the length of the tube. The first 
attempt of this layout failed as shown in Figure 6.16. 
 
Figure 6.16:- Failed attempt at a tilted tube printed with typical stereolithography support structures. A blob of 
supports and collapsed initial layers of tube can be seen to the left side, with support ‘trees’ having been printed well 
but without the tube to link up with. 
The support density was not high enough during the critical initial layers of the lowest 
portion of the tube. Another attempt was made featuring greatly increased support density 




Figure 6.17:- Increasing the support density and a more gentle overall tilt angle on the tube led to a successful print. 
The support structure underneath the lowest part of the tube are so close together that it essentially generates a single 
solid supporting piece along the initial length of the tube. Resin held in by capillary forces can be seen towards the 
left-most (lower) open end. 
This print layout could be printed successfully with the tube being printed in full length 




Viable osmotic devices were able to be produced easily using automated dip coating 
apparatus. Tubular devices were able to be printed via stereolithography, but were 
susceptible to damage during post-print processing. Mechanical bursting of xPCL devices 
sealed with resin or a cap and glue technique lead to explosive-like bursting, releasing 
water in an immediate manner from a zone of local deformation. Such devices also require 
a greater displacement of water to burst than PCL or xPCL devices sealed with glue alone. 
The xPCL device sealed with resin required over 10x more water to be displaced to burst, 
than the PCL devices. Images of the burst sites confirm what was witnessed during 
mechanical burst testing. From these preliminary tests it appears that the method of 
capping can influence the overall burst behaviour of the xPCL devices. For future osmotic 
burst testing, xPCL tubes sealed with resin were chosen as the preferred method of 
capping due to the greater extent of swelling and volume of water released at burst shown 
from mechanical burst testing. MicroCT measurement of the wall thicknesses of the 
tubular parts produced from dip coating methods of both PCL and xPCL tubes show that 
the PCL tubes are thinner but feature a more consistent wall thickness distribution 
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throughout their overall length than the xPCL tubes. Images taken of devices burst during 
osmotic methods indicate that devices burst via osmotic and mechanical methods show 
different burst site characteristics, and may suggest that use of mechanical techniques to 
predict osmotic burst behaviour may not be directly suitable. Stereolithography printing 
of tubes was successfully demonstrated.  
6.5.2 Dip coating and wall thickness 
Dip coating enabled relatively easy production of both thermoplastic and photo-cured 
tubes. As shown most clearly in Figure 6.7, the average tube wall thicknesses between 
the PCL and xPCL devices are quite substantially different. The target wall thickness for 
both types of devices was intended to be approximately 200 µm. There appears to be two 
separate issues, the first of which is that out of the 4 PCL tubes scanned, 2 show an 
average thickness of approximately 130 µm, while the remaining 2 are on the target of 
200 µm. This is perhaps due to differences in polymer solution viscosity as the chloroform 
solvent evaporated slightly through the day causing differences in the deposited polymer 
layer thickness on the rod. It was not intended for the xPCL tubes to be up to 2.6x thicker. 
It is expected that the issue arose from improper care while measuring prototype tubes 
produced during the basic exploratory phase, where calipers were used to measure wall 
thicknesses. It is likely that too much force was applied while closing the calipers around 
the specimen, returning a smaller thickness value that led to underestimation of the 
sample wall thicknesses. Based on previous work that showed that there was a strong 
correlation between wall thickness and burst pressure strength, it is highly likely that the 
difference in wall thicknesses between material types may have contributed to some of 
the differences observed from mechanical burst pressure testing. Future work should 
ensure that when comparing tubes of different materials that the wall thickness is kept 
similar between groups, to allow determination of material specific behaviour from other 
aspects. The dip coating sequences were not fully optimised, which is most evident from 
the variance in average wall thicknesses between tubes of the same material type, and 
even from different regions of the same tube. The dip coating methodologies for the PCL 
and xPCL materials result in the xPCL tubes featuring approximately 2.6x thicker walls 
on average, as determined from the full tube microCT scans. The full tube scans also 
indicate that the PCL tube wall thicknesses are more homogenous than the xPCL tube. 
When considering the regional scans, the opposite appears true, particularly when 
comparing the thicknesses at different positions of the same tube. In comparison to 
previous wall thickness measurements of a PCL tube, the particular method used here 
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appears to generate tubes with a similar level of wall thickness variance (171 ± 21 µm) 
[21], [232]. Recent investigations conducted after the work detailed in this chapter was 
complete identified the withdrawal speed of the rod as a critical controlling factor for wall 
thickness variation when using the PCL material [233]. Ideally, the dip coating cycle 
should be investigated and optimised for each different polymer solution/resin with 
particular considerations regarding the withdrawal speed, rotation speed, and 
evaporation/cure time. The main drawback to the dip coating curing method specifically 
was the non-automated nature of the UV source. This then required the user to be present 
at all times, and concentrating on setting timers to alert the user to turn the light on or off 
as required. A disadvantage of that particular dip coating machine was that it was only 
able to dip coat a single rod, which limited throughput and overall efficiency. Both 
drawbacks were addressed when constructing the new variant of the dip coater as detailed 
in Chapter 7. 
6.5.3 Effect of sealing method on mechanical bursts 
Mechanical burst testing of xPCL tubes suggest that the capping/sealing method can have 
a significant effect on the extent of deformation and ultimately burst behaviour of the 
tubes. xPCL tubes sealed by cyanoacrylate glue, plug and glue, or resin required different 
displaced volumes of water and displayed different internal hydrostatic pressures to yield 
and burst. Overall, the xPCL devices required a greater pressure and displaced volume to 
yield and burst, than the PCL devices. However, the PCL and xPCL - Glue devices burst 
after a similar volume displacement, which appears primarily due to the xPCL – Glue 
tubes bursting where other xPCL counterparts would typically only yield. The xPCL – 
Glue tubes were the only tubes to burst around the cap region, indicating that perhaps 
there is a poor interface between the cyanoacrylate glue plug and the inner-barrel walls 
of the xPCL tubular part, providing a suitable weakness to cause burst at the first instance 
of material yield/deformation. The rigidity of the capping method of the xPCL tubes 
appears to affect the ability of the tubular part to freely deform, as shown by the reduced 
displacement at burst and greater pressure required to yield by the xPCL- Plug + Glue 
devices versus the Resin sealed tubes. The xPCL – Resin device was capable of 
accommodating the greatest volume displacement prior to burst, and was shown to burst 
in the desired manner, visibly expelling the greatest volume of water immediately upon 
burst. The xPCL – Resin devices would require a 10x greater volume uptake than the PCL 
devices, and therefore suggests they would take longer to burst in an osmotic test 
environment. From the favourable observations regarding the nature of burst, use of 
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xPCL10k0.9k resin was chosen as the sealing method of choice for the xPCL devices. 
The xPCL – Resin sealed tubes possess a similar mechanical burst profile to the PDMS 
walled tubes tested by Dunker [232]. The xPCL tubes feature a more prominent yield 
peak due to being composed of a stiffer material than the soft PDMS tubes, but the PDMS 
tubes required displacement of approximately 800 µL of water to burst, which was more 
than double that of the xPCL - Resin tubes. The xPCL tubes offer an intermediate between 
the PCL and PDMS devices in terms of their swelling during mechanical testing, and still 
demonstrate an explosive-like release at burst while being fully degradable. Critical 
analysis of the mechanical testing methodology and relating mechanical bursts here to 
osmotic bursts in Chapter 8, will be evaluated in Chapter 9. 
6.5.4 Burst sites 
The mechanical burst sites of the xPCL – Resin, and Plug + Glue devices were similar, 
while the xPCL – Glue, and PCL devices displayed very different appearances. The 
overall size of the deformation zone and tear of the Resin sealed tubes were approximately 
twice are large as the Plug + Glue sealed tubes. This appears to relate back to the effect 
of more rigid Plug + Glue sealing method hindering yield and deformation of the tubular 
part, as discussed above. While the cyanoacrylate glue sealed xPCL tubes were witnessed 
to burst through the glue cap, it was not possible to identify the hole from which the 
contents were expelled from the microscope images. An added complication was that as 
the glue cured, it formed a concave crystalline structure requiring focusing at various 
depths to search for a crack or hole within the cap. It is possible that perhaps the xPCL 
material around the glue cap deformed under load to eject the material around a portion 
of the cap, which returned to its original shape after the reduction in pressure following 
burst, hindering identification of the burst site. It was shown that the PCL device burst 
sites released water from a pinhole around a superficial fissure, which provides the reason 
for the narrow jet of water expelled from the device at the moment of mechanical burst. 
This pinhole burst behaviour was described by Dunker from similar PCL devices [232]. 
The PCL device osmotic burst sites appear quite different, with no evidence of the fissure-
like surface deformation, but displays multiple discreet pinhole bursts on the tubular part. 
While it was expected that osmotic bursts of the PCL material devices would still be in 
the form of a pinhole, it was not anticipated that there could be multiple simultaneously. 
It is not known if all the pinholes on a device occurred at the same instant, or staggered 
over time. It is perhaps possible for the device to burst at multiple points at the same time 
through similar defect areas, such as areas with thinner walls from defects introduced 
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during dip coating, or bubbles. Staggered pinhole development may be possible if the 
initial pinhole is very small and unable to support sufficient ejection of material and/or 
relieve internal pressure, where internal pressure then continues to rise. However, it does 
not seem probable considering some devices show up to 4 individual pinholes, which 
would require multiple instances of the behaviour. Referring to burst site images of the 
xPCL – Resin sealed devices tested in the osmotic studies of Chapter 8 (Figure 8.7 b), 
again some differences to the mechanical bursts are evident. Both osmotic and mechanical 
bursting of xPCL – Resin tubes result in similar longitudinal tears long the tubular part, 
however no evidence of the bulbous deformation around the tear remains in the 
osmotically burst devices.  This would suggest that the deformation during the 
mechanical test is predominantly plastic in nature, while the osmotic bursts are mainly 
elastic in nature. This switch in dominant deformation from plastic to more elastic in 
nature is likely caused by the elevated temperature environment combined with the slow 
increase in applied strain during the osmotic studies. 
6.5.5 Stereolithography printing of tubes 
While stereolithography printing of the xPCL10k+4A resin produced defect free tubes, 
the printed parts were prone to being damaged during post-processing, such as rinsing of 
excess resin from the internal space, and removal of supporting material. The 
xPCL10k+4A resin was used instead of the xPCL10k0.9k resin due to previous printing 
successes reported in Chapter 4, where the xPCL10k+4A resin offered greater reactivity 
and survivability during printing. The post-processing damage here was in retrospect 
predominately due to poor methodology, but also partly due to the weak nature of the 
‘green’ part during printing due to the resin composition (as discussed extensively in 
Chapter 4). Prior to post-curing, removal of the trapped resin within the inner space of 
the tube was performed by flushing the part with isopropanol using a syringe and needle, 
or by sucking the resin out also with a syringe and needle. A long blunt needle in a small 
enough gauge was not immediately available and therefore a sharp needle was used, 
making it easy to perforate the tube walls if proper care was not taken. Another source of 
preventable damage occurred during cutting of the tube from the supporting structures. 
Cutting of the supports was performed after rinsing, and post-curing, but without 
extraction and drying. Therefore, the material was still in the weaker solvated state rather 
than the tough crystalline state. Particularly with the ‘X’ shaped support structure it was 
challenging to remove the linking material at the extremities of the ‘X’ without tearing 
the tube wall. Such issues could likely be negated or at least reduced substantially by only 
110 
 
removing supports after extraction and drying of the entire structure prior to support 
removal.  
For production of larger numbers of tubes, the vertically positioned layout offers greater 
scaling than the flatter angled layout. If utilising the full build area that the EMBER offers, 
an interconnected array of approximately 140+ tubes could be printed simultaneously 
(based on an outer diameter of 2.4 mm per tube and considering the spacing of the support 
structures). With the DLP projector of the EMBER, the print time for such a quantity of 
tubes would not increase from the demonstration print of 4 tubes, as the entire build area 
is illuminated at once, without requiring consideration of laser raster speeds. However, 
caution is advised due to the non-homogeneous irradiance over the entire buildable area. 
6.5.6 Device sterilisation 
Sterilisation is an essential process in the manufacture of medical devices to render them 
safe for patient use. Sterilisation itself is defined as the process by which all-living cells, 
viable spores, viri, and viroids are either destroyed or removed from an object [234]. 
Various sterilisation techniques can be utilised, such as more traditional methods of 
autoclaving, and gamma irradiation, or newer novel techniques such as microwaves or 
sound waves. The sterilisation process suitable for a medical device can be limited by 
compatibility with the construction materials, active compound, or the nature of the 
device. For example, metal medical devices and equipment are often sterilised using 
gamma irradiation due to its simplicity, speed, and efficiency. However, it is known that 
this type of sterilisation processing results in physical changes via chain scission or cross-
linking, that ultimately affect mechanical properties and/or induce premature degradation 
[235]. Other considerations should include that the production of a medical device 
suitable for patient trials would have to be manufactured in accordance with ISO 13485 
and under general good manufacturing practice (GMP) conditions. 
Determining suitable sterilisation processes for our capsule requires consideration of the 
stage or stages that a sterilisation process would be used. One of the main advantages of 
our capsule is that it is manufactured separately from the payload, which allows methods 
of sterilisation during manufacture that may have otherwise damaged the active 
compound in an integrated system. For example, while Soxhlet extraction of the tubular 
part with hot IPA will provide a sterilisation effect during manufacturing, after the later 
filling process such an extraction process would result in penetration of solvent into the 
central compartment of the device. This could potentially denature the active compound 
due to the heat or solvent itself. In addition to the sterilisation provided by extraction, the 
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UV curing processes during manufacture will also exert a sterilisation effect on the 
surfaces that are illuminated. 
It is envisioned that manufacture of this device would require sterilisation of the 
components as they are manufactured (as mentioned above), with assembly and filling 
under aseptic conditions, followed by one or more terminal sterilisation processes. 
Terminal sterilisation processes are generally preferred as it is considered to remove 
reliance on aseptic processing and therefore incorporates a safety margin  [236]. For our 
device, typical terminal processes such as autoclaving, gamma radiation, dry heat, and 
ethylene oxide sterilisation are not suitable, due to destructive effects on the polymer or 
an active compound. In this regard, novel techniques using UV light or sound waves (non-
contact ultrasound [NCU]) are likely to be more appropriate [234].  
6.6 Conclusions 
Devices composed of the xPCL10k0.9k photo-cured material were shown to 
accommodate up to 10x the volume of the PCL devices before burst via mechanical 
means. As the displaced volume increases, the xPCL devices were shown to swell more 
than those made from PCL and upon burst were observed to expel a greater volume of 
water. The xPCL mechanical bursts also demonstrate that the rigidity of the sealing 
mechanism affects the ability of the tube as a whole to swell and distribute stress, which 
in turn can affect the manner in which the device bursts. An xPCL tube sealed with resin 
featured significant swelling during displacement of 277 µL of water, prior to an 
immediate explosive burst through a 5 mm long tear at the site of swelling. Mechanical 
and osmotic bursting of PCL devices show little swelling in comparison, and result in 
small pinholes that limit content release. While dip coating was a simple and effective 
method for production of viable devices, better optimisation for each individual material 
type would help make the tubular part walls more homogeneous and less variable between 
dip cycles. Printing of tubular structures was performed using the xPCL10k+4A resin, 
and shows potential as an alternative tubular part production method. Further work should 
be performed characterising the water permeability, swelling, and burst behaviour of 
printed tubes and compare them to dip coated specimens of the same material. Overall, 




– Development of a fully autonomous dip coat curing 
apparatus for the mass production of the tubular part 
In this Chapter, the development of an improved custom-built dip coating machine is 
detailed. 
7.1 Introduction 
From earlier dip coating work performed in Chapter 6, the mark I machine worked well 
and was easy to operate but was relatively time consuming and inefficient. This was 
primarily due to only being able to coat one rod at a time, yielding one tubular part per 
15/20 mins. Additionally, the machine had no ability to automate photo curing, requiring 
the user to operate the light source manually when coating with photo-crosslinkable 
materials, making the process even less efficient.  
To improve the efficiency, and reduce user involvement in the process, an improved dip 
coating machine was devised.  Use of a single motor and gear system to support rotation 
of up to 10 individual rod substrates will enable a 10x increased throughput in a simple 
manner. Building the electronic control system of the machine around an Arduino will 
provide a cheap and expandable system capable of controlling a UV lighting circuit in 
addition to the motors required for the dip coating movements. 
7.2 Design overview 
The updated variant of the dip coater expands upon the first-generation automatic dip 
coater shown in Chapter 6. The dip coater mark II consists of two separate structures; one 
is the dip coating system itself and the other is the UV lighting gantry. When using non-
photo-crosslinkable materials the dip coater unit can be used without the light gantry. 
Alternatively, when using photo-crosslinkable materials, the gantry can be simply placed 
over the top of the dip coater unit and plugs in directly to the dip coater unit without any 
further need for cables. The dip coater unit contains the majority of the components, with 
the light gantry being simply a frame with the bulbs and ballast attached. Affixed to the 
main unit is the Arduino and RAMPS 1.4, LCD screen and integrated controls, ball-screw 
rail and stage for mounting the resin vats, stepper motors for the rail and rod rotation, and 





Figure 7.1:- The main dip coater unit shown with the UV light gantry placed over it.  
The frames for both structures are composed of 20x20 mm extruded aluminium struts 
with 5 mm wide grooves for mounting of parts via t-slot nuts. The struts are connected 
by mainly 90o brackets, with 45o brackets used to produce the wedge shape. Most of the 
joint brackets were custom designed and printed using a Formlabs Form 2 SLA printer 
with the Clear v4 resin. All the mounts and housings for the electronics were also 
produced using this printer/resin.  
7.2.1 The dip coater main body 
The multi-rod capability was developed using a simple gear system. Spur gears were 
mounted on 5 mm diameter steel shafts and sandwiched between two 10 mm thick acrylic 
plates spaced using 9.5 mm tall chlorinated polyvinyl chloride (CPVC) spacers to provide 
support. The plates were designed in CAD and laser cut.  A total of 11 gears were arranged 
horizontally, with the centre gear being mounted on the stepper motor shaft instead. Each 
shaft other than the drive gear itself was fitted with a brass “5 mm to 2 mm” shaft coupler 
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for attaching the substrate rods. The shaft couplers utilise grub screws to affix firmly to 
both shafts. The open central tunnel of the sandwich plate allows the linear ball-screw rail 
and its associated motor to fit snugly underneath. The rail is mounted directly down the 
centre of a 3 mm thick aluminium sheet. The sandwich plate assembly is positioned over 
the rail and fixed to the aluminium sheet through 3D printed 90o mounts. 3D printed end 
stop towers were also mounted to the aluminium sheet at the lower-most point of the rail 
and just prior to the sandwich plate mounts to prevent collision of the stage. The 
aluminium sheet with the aforementioned parts fitted to it was fixed to the sloped edge of 
the wedge frame. A riser for mounting 10 15 mL falcon tubes was designed and printed 
on a Stratasys FDM printer and mounted on the stage. Mounts and cases for the LCD 
screen, Arduino/RAMPS 1.4, relay and 12 V power supply were designed and printed. 
All mounts affix directly to the aluminium struts of the wedge-shaped frame via t-slot 
nuts. Annotated images showing the overall layout and key components are shown in 
Figure 7.2 – Figure 7.5. 
 




Figure 7.3:- Dip coater main unit rear view. 
 




Figure 7.5:- Front view of fully loaded dip coater with 10 falcon tube polymer resin vats and 10 2mm steel shafts fitted. 
7.2.2 The UV lighting gantry 
A labelled diagram of the gantry is shown in Figure 7.6.  
 
Figure 7.6:- UV lighting gantry side (left), front (centre) and underneath (right) views. 
The gantry consists of the aluminium strut frame fitted with an acrylic sheet at a 45o angle 
to which the bulbs and ballast are mounted. The UV-A lights are in the form of Philips 8 
W T5 fluorescent bulbs with a peak emission wavelength at 365 nm. This type of bulb is 
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typically used to attract houseflies in insect killing equipment. These particular bulbs have 
no UV-B output, making them safer for general use than wide band UV emitting bulbs. 
The four bulbs are positioned evenly over the width of the acrylic sheet, and the height of 
the bulbs from the substrates can be controlled by sliding the mounting points up or down 
the vertical struts.  The Philips HF-P 3/418 TL-D III ballast was chosen to power the 
bulbs and modulate power during the programmed start-up due to being marketed for this 
type of tube. The bulbs are held in place by T5 rotating tombstone fittings, which are un-
shunted to match the wiring requirements of the ballast. The power cable to the ballast 
from the main body uses IEC plugs to allow separation of the gantry from the main body 
when not required for use. 
7.3 Control electronics and g-code  
7.3.1 Mega2560 and RAMPS 1.4 setup and wiring 
The Arduino Mega2560 is a microcontroller board that is capable of controlling complex 
machines though a vast number of digital and analogue pins and expanded memory over 
smaller microcontrollers like the Arduino Uno.  The Mega2560 is required for direct 
mounting of the RAMPS 1.4 adapter.  The RAMPS 1.4 shield is specifically designed to 
fit over an Arduino Mega2560 unit and serve as the interface between the Arduino and 
the 3D printer hardware, such as the motors, sensors, and screens. The RAMPS 1.4 shield 
features connections for more hardware than required for the dip coater, but comes with 
the ease of compatibility, and capability for future expansion. With this machine, two 
bipolar 4-wire stepper motors with 1.8o stepping angles were used. The motor for driving 
the linear rail was wired to the X-axis motor output on the RAMPS 1.4 board, while the 
rod rotating motor was wired to the Y-axis output. A4988 Polou stepper motor drivers 
are used (1 for each motor), each with 3 jumpers to enable the most accurate 1/16th micro 
stepping. The motors are powered through a 12 V power connection wired directly to the 
5 A power inputs on the RAMPS 1.4 board. The Arduino is powered separately through 
the USB 5 V connection to a PC or through a 5 V A/C to USB wall adapter. The full 
graphic smart controller features an LCD screen, push-button rotary encoder, and SD card 
reader grouped as one unit, and plug into the entirety of the AUX-3 and AUX-4 banks of 
pins on the RAMPS 1.4. Upper and lower limit end stops (MakerBot mechanical 
microswitch type) are fitted to prevent the stage crashing into the bottom of the rail or the 
gear system mounts, and also for setting of the zero-position of the x-axis. While risk of 
crashing is reduced by setting hard limits within the firmware, such a method only works 
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when operating the machine in absolute coordinate mode. Use of relative coordinates can 
be useful, especially for the y-axis rod rotation of long dip coating cycles, and so the end 
stops would serve as emergency stops if these limits were breached. The end stops are 
connected to their appropriate pins in bank S annotated on the RAMPS 1.4 board. The 
lighting circuit is controlled by the Arduino through a relay (SONGLE SLA-05VDC-SLC 
30A 240VAC), which has a 5 V control side with low (2-4 mA) trigger current suitable 
for use with an Arduino. The load side is suitable for the mains voltage required for the 
ballast and bulbs. The control side of the relay has 3 inputs, a DC+, DC- and IN. The DC+ 
is wired to one of the 5 V VCC outputs adjacent to the D2 diode on the RAMPS 1.4. The 
DC- is connected to the ground (GND) pin on the AUX-2 bank. The IN or input signal is 
wired to pin 44 on the AUX-2 bank. A pinout diagram of the RAMPS 1.4 board detailing 
all the utilised connections is shown in Figure 7.7. 
 
Figure 7.7:- Pinout diagram of RAMPS 1.4 board. Colour legend details what is associated with each pin(s) by 
matching to colour of box on the image. This is a modified pinout diagram of the original found at 
reprap.og/wiki/RAMPS1.4. The RAMPS 1.4 board is open source hardware under the General Public License v3.0.  
When the input pin signal is low the relay remains open with the lights off. When the 
input pin signal is high the relay closes allowing current to flow to the ballast, turning the 
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lights on. Mains power to the relay is taken from a standard 3-pin UK plug to an IEC plug 
isolated but mounted on the main frame. At the output side of the mounted IEC plug, the 
neutral and ground wires travel up to a second IEC plug, while the live wire goes via the 
relay. The live input is connected to the COM relay terminal, and the output wire 
connected to the NO (normally open) terminal, which is then routed up to the second IEC 
plug.  The live, neutral, and ground wires on the other side of the second IEC plug are 
connected directly to the appropriate terminals on the ballast. Use of two sets of IEC plugs 
makes the main body tidier by allowing complete disconnection of the lighting circuitry 
when not required. The ballast and bulbs are then powered by 230 V A/C when the relay 
input signal is high. This is the safest wiring option, keeping the live side as short as 
possible before interruption by the relay. On the output side of the ballast, the wiring to 
the bulbs follows the directed scheme for 4 bulbs as shown in Figure 7.8 below. 
 




The Arduino runs on the highly popular open source Marlin 3D printer firmware. Marlin 
is a community driven printer driver specifically designed for use with Arduino 
Mega2560s and RAMPS 1.4 hardware (used here), but can be edited to accommodate 
other combinations of hardware if necessary.  The main motivation for using Marlin is 
that it offers easy integration of an LCD screen and controls, alongside the ability to read 
g-code scripts directly from an SD card. The latest Marlin firmware can be found at 
https://marlinfw.org/meta/download/. The Marlin firmware code is extensive and 
therefore only the edited parts and changes will be discussed here. 
Firstly, the Arduino integrated development environment (IDE) must be configured to 
communicate with the Arduino Mega 2560. This can be selected via 
Tools>Board>Arduino Mega or Mega 2560. Connect the Arduino via USB to the PC and 
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ensure the correct COM port is chosen. Most of the other changes are within the 
“configuration.h” sketch. The communication baudrate is set to the fastest speed of 
250000 by #define BAUDRATE 250000. The RAMPS board version must be defined. 
The board used in this project should be defined as #define MOTHERBOARD 
BOARD_RAMPS_14_EFB. For homing the axis, due to only the x-axis having end stops 
those listed for the Y and Z axis should be commented out. The x-axis motor was 
determined to have 800 steps/mm, while the y-axis motor was 500 steps/mm, and were 
defined through the #define DEFAULT_AXIS_STEPS_PER_UNIT line.  The max 
feedrates of the motors were also defined separately with the x-axis being capped at 10 
mm/min and the y-axis at 1 mm/s (which is equivalent to approximately 9 rpm). As an 
extra safety feature for if the x-axis max end stop failed in absolute coordinate mode the 
max x-axis position was defined as 235 mm, which is just before the stage collides with 
the spur gear sandwich mounts.  
Typically, printers are used in absolute coordinate mode and therefore typically use a 
single end stop per axis to home against during start-up, after which the end stop stops 
being polled by the CPU. This is also generally desirable as polling the end stop(s) 
constantly utilises CPU cycles and can cause printers to slow down. The dip coater is only 
operating a maximum of two motors and will therefore be operating at a relatively lower 
CPU load in comparison to an FDM printer running 3+ motors, extruders, and heated 
nozzles or beds all at once. Additionally, due to the potential use of relative coordinates 
preventing damage to motors or other parts is highly important. Enabling 
ENDSTOPS_ALWAYS_ON_DEFAULT within the ‘Configuration_adv.h’ sketch 
allows constant polling of the end stops, which will cut motor movement and end the 
script if triggered.  
For calibration verification, or troubleshooting the Arduino was connected via USB to a 
PC running Pronterface, which is a graphical user interface (GUI) host used to manage 
3D printers. Within Pronterface, commands to the motors can be given through the GUI 
or through a text window in which g-code commands can be given instead. 
7.3.3 G-code commands 
G-code exists in various flavours, with some firmware being able to interpret more G-
code commands than others or interpret the same command in different ways. The 
extensive list of G-code commands compatible with Marlin is listed on the reprap wiki 
(https://reprap.org/wiki/G-code). The commands commonly utilised within this project 






G1 G1 Xnnn Ynnn 
(G1 X-120 Y40) 
Linear move 
G28 G28 n 
(G28 X) 
Homes the listed axis.  
The example homes X axis only. 
G90 G90 Set to absolute coordinates 
G91 G91 Set to relative coordinates 
M42 M42 Pnnn Snnn 
(M42 P1 S255) 
Switches a general purpose I/O pin to a set value. 
M400 M400 Wait for current move to finish 
Table 7.1:- Table of key G-code commands used during typical dip coater operation. n represents an integer, a 
minimum of 1 integer must be used for such commands to function. Valid integers for the S component of the M42 
command are either 0 or 255, where 0 is off(low), and 255 is on (high).  
The rotation of the rods and movement on the resin vat attached to the stage is primarily 
dictated by the G1 command line. The speed upon which the axis move is defined by the 
feedrate set within the firmware. The feedrate can be overridden by introducing an Fnnnn 
parameter as part of the G1 command line (e.g. G1 X10 F10), providing it is within the 
min/max range defined within the firmware. Movement commands are interpreted by the 
Arduino on a line by line basis, but certain M commands including M42, are not 
synchronised with the movement commands and are executed immediately as they are 
read.  The lighting circuit relay is operated by the M42 command raising the IN pin to 
high, which triggers the relay coil closing the AC circuit. The command used to turn on 
the circuit is M42 P44 S255, and off is M42 P44 S0. Due to M42 commands being 
executed immediately after being read, regardless of current and planned move orders 
listed prior to the M42 line, use of M400 before a M42 command is required. M400 waits 
for the movement command immediately above to be completed fully prior to proceeding, 
allowing control of the lights at the desired time.  
7.4 Typical usage 
7.4.1 File preparation 
A text editor program such as notepad should be used to generate the script that the dip 
coater should follow.  The file must be saved as a compatible g-code type file, with file 
extension suffixes such as .g, .gco or .gcode. The file is then loaded on to a SD card that 
supports SPI (serial peripheral interface) protocol and of a capacity no larger than 2 GB 
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(limit for a 16-bit computer), using FAT 16 formatting. Keep filenames short (< 8 
characters) and ensure no more than 10 layers depth of sub-folders are present. 
7.4.2 Example g-code script 
A 3-dip cycle for a photo-curable resin is shown in Figure 7.9. 
 
Figure 7.9:- G-code file for the dip coat curing of a photo-curable resin. For more dips, the lines between the red lines 
can be copied multiple times to achieve however many dips desired. All commands used as listed in Table 7.1. 
The first 3 lines prepare the dip coater to start the sequence, homing the x-axis and 
switching to relative coordinates after being zeroed. For a single complete dip coat cycle 
as described in Chapter 6, 8 lines of code are required, indicated in Figure 7.9 between 
the red lines. These lines of code involve keeping the rods constantly rotating while 
raising the stage/falcon tubes to dip the rods. Due to the firmware of the system being 
setup to control a 3-axis 3D space, where motors work in synergy to move a machine 
tool, or print head, here the x and y motors also remain linked. Therefore, the motors work 
together to trace a virtual hypotenuse of a length defined by Pythagorean theorem 𝑐 =
√(𝑥2 + 𝑦2), where c is the length of the virtual hypotenuse, and x and y are the distances 
in the g-code for the requested x and y motor movements. Due to the difference in max 
feedrates, providing the x distance is no more than 10x greater than the y distance, the 
movement will be limited by the slower y-axis maximum feedrate resulting in the rods 
spinning at a constant speed while the x-axis feedrate adjusts to suit. This is exploited in 
the code above to maintain a constant rotation of the rods of the max y-motor feedrate, 
equating to approximately 9 rpm. Alternatively, if the x distance is greater than 10x of 
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the y distance, then the x-motor operates at maximum feedrate while the y-motor will turn 
slower to accommodate, resulting in a variable rod rotation speed. 
The rods stay immersed in the falcon tubes for approximately 4 full rotations before the 
tube are lowered, withdrawing the rods slowly from the polymer solution. An M400 
command is issued to ensure the dip coater waits for the tubes to be fully lowered prior 
to activating the lights in the next line. While the lights are active, the rods are kept turning 
to cure them evenly all round. Another M400 command is issued to keep the coater 
waiting for the cure stage to be complete, after which the lights are deactivated. The cycle 
described above is then repeated a number of times to make the coating on the rod the 
desired thickness. The final dip cycle is similar but features a longer curing stage to post 
cure the rods in situ. 
7.4.3 Dip coater setup 
Mount the number of rods desired and fill the associated number of 15 mL falcon tubes 
with resin and place them within the holder. Plug in the 5V power for the Arduino and 
the 12V power for the motors. If using the lighting gantry, position it over the dip coater 
and plug the IEC connectors first, prior to turning on at the mains.  
7.4.4 Start the print 
Insert the SD card into the card reader on the back of the LCD screen. Upon insertion of 
the card, the screen should read “SD card inserted“. Use the rotary encoder to access the 
menu: print from SD card > select file name. Upon pushing the rotary encoder in while 
having the file name selected will initiate the dip coating cycle. The script will be 
performed until completion or an error occurs. 
7.5 Proof of concept 
While the author and builder of this machine has not been able to use the machine 
extensively yet, the new dip coater has been heavily used by the group postdoc and an 
undergraduate student. Both have been successful in producing photo-cured polymer tube 
networks from resins containing lactide-caprolactone (LA-CL) and trimethylene 
carbonate-caprolactone (TMC-CL) macromers. An image of the TMC-CL tubes 




Figure 7.10:- TMC-CL tubes produced from a 5 dip cure cycle using the new dip coater. Tubes have been post-cured, 
extracted via Soxhlet apparatus and dried, as is reported in previous methods sections. 
7.5.1 Dip coating of LA-CL photo-curable resins 
Here I will present the work of Esmat Jalalvandi, who used the new dip coater to produce 
tubes of both TMC-CL and LA-CL networks, as a proof of concept/functionality of the 
new dip coater. 
A series of TMC-CL tubes were produced using a 5 dip and cure cycle, and 5 tubes were 
selected at random. The outer diameters and wall thicknesses were measured at three 
positions along the tube, near the bottom (resin vat side), middle and top. The calculated 
averages and standard deviations of both outer diameter and wall thickness are presented 





Figure 7.11:- TMC-CL tube average outer diameters and wall thicknesses. Error bars represent standard deviations. 
n=3 
  Outer diameter (mm) Wall thickness (µm) 
Tube number 
1 2.07 ± 0.04 336.7 ± 15.3 
2 2.09 ± 0.04 350.0 ± 36.1 
3 2.06 ± 0.07 346.7 ± 11.5 
4 2.13 ± 0.04 370.0 ± 36.1 
5 2.11 ± 0.03 383.3 ± 30.5 
Table 7.2:- The average ± standard deviation of the TMC-CL tube outer diameters and wall thicknesses, n=3. 
The tubes produced show consistent outer diameters and wall thicknesses with overall 
averages of 2.10 ± 0.04 mm and 357.3 ± 25.9 µm, respectively. While outer diameter 
measurements have not been made before, the variance in wall thickness is comparable 
to the xPCL tubes produced in Chapter 6 (335 ± 29 µm), and to tubes from Melchels et 
al [21] (171 ± 21 µm). Here the dip cycle takes approximately the same time to complete 
as the original dip coater, but dips 10 rods instead of 1, making it vastly more efficient. 
Similarly to what was discussed in Chapter 6, the TMC-CL tubes above were produced 
from the author’s firmware settings and thus the consistency of the outer diameters and 
wall thicknesses may have the potential to be improved further following some 
optimisation work on that specific resin formulation. TMC-CL tubes that were produced 
using this dip coater were sealed and tested using mechanical and osmotic means. The 










































demonstrated mass gain through the osmotic uptake of water during osmotic studies, 
which demonstrate that the tubes produced could be used to construct viable devices.   
7.6 Closing remarks 
7.6.1 Future improvements 
While the dip coater works well in its current form, limiting the users’ exposure to the 
UV-A light is the first priority for improvement. Concave reflective shrouds will be fitted 
to direct all the light down to the rods, combined with spraying the acrylic sheet with a 
thick layer of matt black paint to eliminate light penetration and prevent reflections. 
It has been noticed that some incident light is curing resin near the open end of the falcon 
tubes. As a temporary fix a rectangular piece of cardboard was used to block direct entry 
of light into black/amber falcon tubes. The cardboard was mounted to the top of the falcon 
tube holder and acts similarly to the bill of a baseball cap. It’s height and length are 
enough to provide a meaningful effect without touching the rods during dipping/retraction 
or blocking light from the coated resin during the curing phase. For future use a more 
permanent removable shroud that will provide a greater resin-protecting effect while not 
interfering with falcon tube loading/positioning, will be designed and 3D printed. Lastly, 
editing what is displayed on the screen prior to and during the print to be more relevant 
to the dip coater actions specifically rather than keeping the generic FDM printer display 
functionality would offer a more professional quality of life improvement for users. While 
this change does not affect safety or critical functionality, much of what is shown on 
screen is irrelevant such as FDM nozzle temperature, fan status, heated bed temperature, 
which all aren’t in use on the dip coater. Ideally the initial home screen would just display 
the state of readiness of the dip coater, while during the cycle a countdown timer to 
completion as well as an indicator of what part of the cycle it is on would be useful to the 
user. Due to the linked nature of the motors, creating a g-code script that results in the 
movements the user wants can be hard to understand depending on their background. A 
MATLAB script could be made to assist with this, where the user inputs the desired 
outcomes, for example the rotation speed, vat raising/withdrawal speed, hold/exposure 
times, and number of dips. The script would then determine the required X and Y 
coordinates and feedrates to correspond to the real-world numbers desired and output a 
complete g-code file read for use. An alternative, but substantially more involved option 
is to completely rewrite the firmware so that the motors work independently. If such a 
route was taken it would be worthwhile to generate an equivalent to the MATLAB script 
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described above within the firmware, and have a GUI using the full graphic smart 
controller.   
7.6.2 Conclusion 
An improved dip coater with multi-rod dipping capability and autonomous UV light 
control was designed and built. The new dip coater was able to produce viable tubular 
parts with wall thickness variations similar to that of previous dip coating apparatus, but 
with up to 10x greater efficiency through the capacity to dip up to 10 rods. Additionally, 
the integrated UV light circuit will enable more consistent exposure times during the 
curing stages than the previous manually controlled systems. The Arduino-based system 
allows adjustments of essentially every function of the dip coater by any user, while use 
of g-code provides a simple format for customisation of the dip cycle. Further 
improvements have been highlighted and will be implemented prior to future work.  
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– Osmotic burst release study 
In this Chapter, we describe in-vitro osmotic burst studies of tubular capsules 
manufactured from the techniques used and discussed in Chapter 6.  The following work 
was conducted at the Institute of Health and Biomedical Innovation (IHBI) at Queensland 
University of Technology, Brisbane, Australia. 
8.1 Introduction 
We conducted in-vitro burst studies with the aim of determining device burst profiles in 
terms of the delay to burst, reliability, reproducibility, and the rate-of-release of payload 
after burst, that result from adjustment of particular critical variables, such as material 
type and osmogent concentration, as a prerequisite to future in-vivo device testing.  
Devices were immersed in PBS and incubated over 72 days, with periodic visual checking 
for dye release, sampling of the external PBS solution, and weighing. 
This study was primarily setup to compare the difference in burst release delay between 
devices made from solvent-evaporation-formed 70,000 g/mol PCL (PCL) and dip-coat-
UV-cured bimodal PCL resin (xPCL), as well as comparing the differences between 
osmogent loading concentrations and payload type.  Experimental groups were firstly 
divided by material type (PCL, xPCL), then by payload type (dye, tetanus toxoid), and 






Figure 8.1:- Schematic displaying the breakdown of the experimental groups and subsets for the osmotic burst 
experiment. ”TT” is shorthand for tetanus toxoid. 
Detection and analysis of the rate of payload release was performed based on the payload 
type. The external PBS solutions that devices from both payload groups were immersed 
in were regularly sampled. Solution taken from the dye group and toxoid group devices 
were analysed using UV spectrophotometry and micro-bicinchoninic acid (BCA) assay, 
respectively.  The BCA assay is a well-established method for protein quantification and 
has largely replaced other quantitative colourimetric methods, such as the modified 
Lowry, or Coomassie assays [237].  The micro-BCA assay has been optimised for dilute 
protein samples and features an improved limit of detection (2 µg/mL), which will enable 
early detection of device protein payload leaks or bursts.  Quantification of dye release 
using UV spectroscopy is based on the principles of the Beer-Lambert law, shown in 
Equation 8-1. 
𝐴 =  𝜀𝑙𝑐 Equation 8-1 
Where A is the absorbance, ε is the molar absorptivity of the absorbing species, l is the 
path length of the light through the absorbing solution, and c is the concentration of the 
solution [238].  When samples are processed in the same manner (the same dye is used, 
within the same buffer solution, with the same path length) variance in dye concentration 
is the only cause for differences in absorbance.  The dye-containing devices were also 
gravimetrically monitored throughout the experiment, with its main objective to 
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determine the profile and rate of water uptake during the initial stages following 
immersion.  Evidence of payload leakage or device burst of the dye-containing devices 
could also be visually identified. Due to a series of problem such as glucose interference 
with the MicroBCA assay, the tetanus toxoid work is presented within Appendix A.  
 
It is hypothesised that the xPCL devices will release more payload at the point of burst 
than their PCL counterparts. The flexibility of the xPCL material will enable a greater 
extent of swelling under loading, and its cross-linked nature will provide a greater degree 
of shape recovery than the non-crosslinked PCL material. Therefore, at the point of burst 
the swollen xPCL devices should return, at least partially, to their original shape, ejecting 
payload in the process. It is expected that the quantity of payload ejected from the xPCL 
devices will greatly exceed what is released at burst from the PCL devices. This 
hypothesis will be investigated by assessing the payload ejection at point of burst, which 
can be confirmed i) visually, ii) from detection and quantification of a loss of mass, and 
iii) by quantification of the payload release. Additionally, this hypothesis would be further 
supported by evidence of a visible increase in xPCL tube swelling during water uptake, 
combined with a larger burst site than shown from the PCL devices. 
We hypothesise that tubes constructed out of the more flexible xPCL material will feature 
a longer delay to burst over their more rigid/tough PCL counterpart, due to their indicated 
ability to swell and accommodate a larger volume increase (from mechanical burst 
testing) prior to reaching the burst pressure. This hypothesis will be evaluated through the 
comparison of the delay to burst times between devices constructed from each type of 
material. 
We hypothesise that the permeability of the xPCL network will be greater than that of 
PCL due to possessing a greater volume fraction of amorphous regions for water uptake 
to occur.  However, we expect this to be partly counteracted by the xPCL tubes featuring 
thicker walls over the PCL tubes.  As a result, this factor may cause xPCL tubes of 
comparable osmolarity to uptake water faster than their PCL equivalents, and perhaps 
hinder burst delay extension gained from other material properties discussed below. This 
hypothesis will be tested through comparison of the water uptake rates during the initial 
stage after immersion. 
It is hypothesised that the time to burst of a device, regardless of material type, can be 
tuned by adjustment of the initial osmogent loading concentration. Devices with a higher 
initial loading concentration of osmogent will feature a greater rate of water uptake as a 
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direct result of a greater osmotic driving force, and will therefore burst quicker than 
devices with lower osmogent loading concentrations. This hypothesis will be assessed by 
comparison of the water uptake gradients from first phase of mass monitoring data, and 
the comparison of visual, mass related, and payload detection indicators of burst. 
8.2 Materials and methods 
8.2.1 Material compositions and device production 
The tubular part of the devices were produced using the dip coating methodologies 
presented and discussed in Chapter 6. PCL tubes were formed from Purasorb PC12 with 
a claimed Mn of 70,000 g/mol, using the solvent evaporation dip coating technique. Cross-
linked xPCL tubes were produced using the UV curing dip coating technique, utilising a 
resin composed of 30 wt% PCL-2MA, 15 wt% PCL-3MA, 55 wt% BnOH, and 2 wt%* 
of TPO (*where the wt% of TPO is considering the total mass of the formerly mentioned 
components). Details of device manufacture and preparation can be found in Chapter 6. 
8.2.2 Device loading 
Tubes for osmotic release experiments were sealed on one end using the methods detailed 
in Chapter 6 6.3.4 and 6.3.5. For the xPCL tubes, only the xPCL10k0.9k resin sealing 
method was used.  Stock solutions of 3, 3.5 and 4 M glucose, and either food dye or 
tetanus toxoid (TT) material (depending on the required payload type) were prepared. 
Concentration of each payload was kept equal between solutions of differing osmolality.  
The target TT protein concentration for the solutions was 8000 µg/mL. The raw undiluted 
food dye was assigned to be 2 arbitrary concentration units (AU), which was diluted down 
to the target concentration of 1 AU to form the glucose/dye solutions. Devices were 
loaded with 70 µl of the appropriate glucose/payload stock solution using a syringe fitted 
with a 22-gauge blunt needle. Due to capillary forces, care had to be taken to position the 
needle tip at the bottom of the tube to prevent trapping an air bubble at the base of the 
tube. After filling, the capping process was repeated on the remaining open end. 
8.2.3 Device incubation and immersion 
Filled and sealed devices were submerged within 15 mL falcon tubes containing 10 mL 
of PBS. The tubes were kept within an incubator set at 37 oC for the total duration of the 
experiment, and were only removed briefly for analysis.  
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8.2.4 Device evaluation and data acquisition 
Device behaviour was monitored over 72 days by gravimetric (dye only), UV 
spectrometry (dye only), and microBCA assay (TT only) measurements. All 
measurements were taken every 2-3 days, and devices were inspected visually each time 
for signs of burst (dye groups only). Weight measurements were taken on an analytical 
balance (d = 0.0001 g). A wavelength sweep was performed to find the absorbance 
maximum of the food dye, which was determined to be at 630 nm. All future 
measurements of dye concentration were performed at 630 nm. At each time point, the 
entire volume of PBS that the device was immersed in was removed and replaced with 
fresh PBS. A quartz cuvette was filled with a sample of the removed solution. Each time 
point for every dye-containing device was performed in triplicate. Blank PBS absorbance 
readings were deducted from experimental sample absorbance values before being 
averaged for data analysis.  The microBCA assay kit was purchased from ThermoFisher 
Australia, and was used as per kit instructions for the microplate format. Similarly to the 
dye groups, at each time point for analysis via microBCA the entire PBS solution the 
device was immersed in was taken and replaced with fresh PBS. 150 µL of the taken 
sample was then used per well of the microBCA assay for each device, with each device’s 
solution being analysed in triplicate. Sample absorbance readings were blank-corrected 
prior to being averaged for data analysis.  
8.3 Results 
8.3.1 Overall gravimetric and UV profiles 
Persistent logging of mass and UV absorbance data enabled construction of charts that 
depict the mass and dye profiles over the course of the entire experiment. Device mass 
profiles from both material groups appear split into 3 phases; an initial uptake phase, a 
post-burst stabilisation phase, and a final steady-state release phase. The transition 
between the uptake and post-burst phases occurs at the point in time upon which the 
device bursts. An annotated example highlighting these 4 important aspects in the mass 




Figure 8.2:- Annotated mass (a) and dye (b) profiles of a xPCL 3.5 M device. Phases are shown as 1) water-uptake, 2) 
post-burst stabilisation, and 3) steady-state release. The point of burst is depicted by the dashed line that separates 
phase 1 and 2. 
In this example, during the initial water uptake phase (1) a steady gain in mass can be 
noticed combined with the dye absorbance signal maintained at baseline. After the 
moment of burst, and into the post-burst phase (2) the device begins to lose mass, while 
the dye absorbance signal becomes positive and sharply increases. In the final steady-
state release phase (3) the device releases dye and loses mass at a more constant rate. 
 
Further insights into different mass and dye behaviours resulting from devices produced 
from the different materials, and different osmogent loading concentrations, can be seen 





Devices of all groups display a gradual gain in mass over the initial water uptake period 
after immersion. After reaching a peak mass gain, a loss of mass occurs, signifying burst 
of the device.  The xPCL devices feature a steep loss in mass over a short period before 
stabilising, and transitioning into a more gradual mass decline.  PCL tubes typically lose 
a lesser extent of mass over a shorter period before also developing into a more gradual 
mass loss profile.  Dye release is maintained around baseline prior to devices bursting, 
with xPCL group devices showing a step-like increase in dye release upon burst followed 
by a gradual release profile, while the PCL devices only demonstrate a gradual release of 
dye after burst. The following sub-sections look more closely at each phase in turn. 
(b) 






8.3.2 The water uptake phase 
Here, the data acquired from the gravimetric measurements during the water uptake phase 
are presented. As displayed in Figure 8.2, no payload release is taking occurring during 
this uptake stage for non-defective devices.  The water uptake rate was determined from 
the gradient of the mass gain over the first 14 days after immersion for each tube within 
a group, where linearity was most clearly defined (mean R2 = 0.986 ± 0.013, min R2 = 
0.948). The peak mass gain was determined from the highest mass value returned during 
the gravimetric measurements throughout the experiment, which corresponded with being 
the last data point taken prior to burst and followed by subsequent evidence of mass loss. 










3 507.0 ± 44.7 15.5 ± 2.8 
3.5 692.1 ± 3.9 16.3 ± 3.4 
4 829.9 ± 33.8 15.3 ± 2.5 
xPCL 
3 589.7 ± 32.2 11.6 ± 10.4 
3.5 762.1 ± 58.9 13.8 ± 3.1 
4 893.2 ± 92.5 12.9 ± 1.7 
Table 8.1:- Average water uptake rate and peak mass prior to burst of all device groups. 
 
Figure 8.4:- Comparisons of the average water uptake rates (a) and peak masses (b) of devices from the three 
osmolarity groups and each material type. Error bar indicates standard deviation. Population values are indicated 
above each bar.  
The water uptake rate increases with initial osmogent loading concentration, and appears 
to be similar between device material groups with the same osmolarity.  The average peak 
mass is relatively similar and typically within standard deviation across all groups.   
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8.3.3 The delay to burst 
The burst delay time of the devices was determined by performing visual, gravimetric, 
and UV detection methodologies on each device. The PCL group contained 5 individual 
devices for each osmogent loading concentration, while the 4 and 3.5 M xPCL group 
possessed 4 devices and the 3 M xPCL group featuring 3 devices.  Figure 8.5 displays the 
burst times of the devices as determined from each type of detection methodology.   
 
The average burst delay of each subgroup is shown in Table 8.2. 
Table 8.2:- Average burst delay times of each device subgroup from each detection methodology, and their associated 
standard deviations (n=3-5). 












3 45.3 ± 7.8 43.0 ± 5.0 43.8 ± 6.8 
3.5 24.3 ± 2.4 25.5 ± 6.7 25.0 ± 5.8 
4 26.0 ± 0.0 23.0 ± 2.8 23.3 ± 1.8 
xPCL 
3 29.7 ± 19.0 29.7 ± 20.2 28.0 ± 19.9 
3.5 27.3 ± 9.8 25.0 ± 7.0 26.3 ± 10.1 
4 22.3 ± 2.2 21.8 ± 2.6 21.3 ± 2.9 
Figure 8.5:- Scatterplots displaying the burst 
delay time of the devices determined by (a) visual 
detection, (b) mass-based detection, and (c) UV 
spectrophotometry detection. Each point 
represents an individual device, grouped by 
material type and osmogent loading 
concentration. Whiskers represent standard 
deviation, horizontal line indicates the median, 





Devices demonstrated a burst range between 12-58 days.  Devices with higher osmogent 
concentration generally burst after a shorter delay, with some 3.5 M concentration group 
devices bursting within similar times to the 4 M group.  The variation within a group 
increases with lower initial loading osmolarity.  Detection through mass-based or UV 
means typically identified device bursts earlier than by eye. 
8.3.4 The moment of burst 
The release of payload immediately after burst was extracted from the gravimetric and 
UV data.  Referring back to Figure 8.3, we can define the burst event in terms of mass 
lost and dye released.  The burst events occur between 2 points, where due to the sampling 
intervals, we have a range of 2-3 days between data points.  For mass-based burst 
assessments, the burst occurs between the peak mass and the successive data point.   The 
difference in mass between these points is defined as the mass lost at burst.  Similarly, 
for dye-based detection of burst, we regard the burst to have occurred between the first 
point that displays a positive detection of dye above baseline and the preceding baseline 
data point.  Therefore, the difference in detected dye between these points is regarded as 
the dye released at burst.  The average mass released, and the average percentage of total 







at burst (mg) 
Dye released 
at burst (%) 
PCL 
3 0.5 ± 0.2 1.3 ± 1.3 
3.5 1.2 ± 0.4 1.0 ± 0.2 
4 1.8 ± 0.7 0.8 ± 0.2 
xPCL 
3 13.6 21.5 
3.5 5.8 ± 2.5 13.0 ± 1.3 
4 6.1 ± 2.6 7.6 ± 1.6 
 




Figure 8.6:- (a) average mass, and (b) average perentage of loaded dye released upon burst of the devices. Error bars 
represent standard deviation. Population sizes are indicated above each bar.  
We can notice that the xPCL groups typically lose more mass, and release a larger 
quantity of dye upon burst in comparison to their PCL counterparts.  The PCL devices 
lost more mass as osmogent concentration increased.  The xPCL 3 M group mass loss 
and dye release appear to suggest that increased mass loss may be linked to increased dye 
release.  However, this is not evident from the release data from all the other groups 
irrespective of osmolarity or material type.  The xPCL groups suggest an inverse 
relationship between loading osmolarity and dye release, but this is not shown in the PCL 
groups. 
 
The burst sites of several tubes were imaged using a DinoLiteTM Basic AM2111 digital 
microscope. Representative images of burst sites belonging to both material groups are 





Figure 8.7:- Microscope images of representative burst sites of a PCL tube (a) and an xPCL tube (b). Red circles are 
to highlight the lengths of the burst areas. Fissure lengths circa 0.7 mm (a), and 5 mm (b). 
PCL devices typically demonstrate pinhole bursts or a small fissure along the tubular part 
of the device, while xPCL devices display a fissure of longer length and with greater 
width than fissures noticed on PCL devices. On the assumption that devices of both 
material types would have partially deformed during the uptake phase, all appeared to 
have recovered their original shape. 
8.3.5 The post-burst release phases 
The rates of post-burst release were calculated from the gravimetric and UV data.  The 
rate of mass loss was calculated for each device by determining the mass gradient after 
the initial burst and post-burst stabilisation phase until day 72. Due to the differences in 
burst and post-burst mass behaviour between each group, the time interval considered 
suitable for calculation of the gradient was assessed separately for each individual group. 
A time interval was chosen by considering the mass profiles of each tube within a group, 
and determining an interval where the majority of devices were deemed to have entered 
a steady state release phase. Samples that had not burst, or were still to establish a profile 
that resembled steady state release prior to this interval, were excluded.  The dye release 
gradients were determined using the same criteria as for the mass loss gradients. PCL 
groups were assessed after day 51 (3 M), 45 (3.5 M), and 33 (4 M), while xPCL groups 
were assessed after day 21 (3 M), 40 (3.5 M), and 30 (4 M). The average mass and dye 



















3 72.0 ± 76.7 0.16 ± 0.03 
3.5 47.0 ± 9.3 0.20 ± 0.01 
4 68.5 ± 27.4 0.22 ± 0.04 
xPCL 
3 13.0 ± 11.3 0.56 ± 0.03 
3.5 69.0 ± 32.2 0.47 ± 0.03 
4 31 ± 25.4 0.48 ± 0.07 
Table 8.4:- Displays the average mass loss rate, and dye release rate of each device group. 
 
Figure 8.8:- Comparisons of the average post-burst release rates of mass (a) and dye (b) of devices from the three 
osmolarity groups and each material type. Error bar indicates standard deviation. Population values are indicated 
above each bar.  
After the burst event, mass loss rates across all groups show high variability and offer no 
distinguishable trend.  Post-burst dye release rates however, show that the xPCL devices 
were releasing dye approximately twice as fast as the PCL group devices.  The dye release 
rates also suggest that osmolarity does not determine the extent of release after burst, with 
release rates within a material-type group being highly similar. 
 
The total release of payload was evaluated by the mass lost and dye release after burst 
until day 72 (end) of the experiment.  The total mass released was calculated by taking 
the peak mass prior to burst and subtracting the mass measured at day 72.  The total dye 
released by day 72 was calculated from the summation of dye release from all data points 
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after burst detection.  The average mass lost, and dye released by day 72 is shown in Table 






Mass lost by 
day 72 (mg) 
Dye 
released by 
day 72 (%) 
PCL 
3 4.4 ± 0.5 8.2 ± 1.6 
3.5 6.4 ± 1.3 13.7 ± 0.9 
4 6.6 ± 2.0 12.6 ± 1.5 
xPCL 
3 14.9 35.2 ± 2.6 
3.5 7.2 ± 3.2 35.5 ± 3.7 
4 8.4 ± 4.3 38.1 ± 1.9 
Table 8.5:- Displays average mass lost and dye released by 72 at the end of the experiment for each group. 
 
Figure 8.9:- (a) Average mass lost at day 72 in reference to peak mass prior to burst. (b) Average percentage of total 
loaded dye released by day 72. Error bars indicate standard deviation. Population sizes are indicated above each bar. 
With the exception of the xPCL 3 M device, it can be noticed that the mass lost by day 
72 across the other groups is relatively similar. The xPCL 3 M device lost approximately 
twice as much mass than the other groups. At day 72, the xPCL devices have released 
more than double the quantity of dye that the PCL devices released at the same stage.  
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8.3.6 Defective devices 
There were 3 defective devices, which burst either immediately or overnight after initial 
immersion. The defective devices are not shown in Figure 8.5.  The mass loss, and dye 
release profiles of each of the defective tubes is shown in Figure 8.10. 
 
Figure 8.10:- Mass change (solid) and percentage of maximal dye release (open) of three defective tubes. Individual 
tube mass and dye release is paired by colour and shape. Legend identifies tubes by tube material, osmolarity and tube 
number, i.e. “PCL 3.5 M T4” refers to a non-crosslinked PCL device loaded with 3.5 M glucose and is tube number 4 
from that specific subgroup. 
 
The PCL 3.5 and 3 M groups and the xPCL 3 M group each contained one of the 
aforementioned defective tubes.   Defective tubes typically lost mass during the early 




Osmotically triggered delayed release of a dye has been successfully performed from our 
devices.  Gravimetric and UV spectroscopy measurements show that all devices follow a 
multi-stage profile of water uptake, burst, initial mass loss and payload release, followed 
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by a gradual continuous loss of further mass and payload. The xPCL devices release up 
to 16.5x more dye upon burst, combined with essentially twice the steady-state rate of 
dye release, resulting in approximately 25 % greater total release by the end of the 
experiment, than their PCL equivalents. The devices of both material types uptake similar 
mass/volume of water prior to burst, with the difference in the extent of release at all post-
burst phases appearing to be largely influenced by differences in shape recovery and size 
of the burst sites. The device delay to burst times were primarily dependent on the rate of 
water uptake determined by the osmogent loading concentration, with no noticeable effect 
from material type.  Utilisation of lower osmogent loading concentrations (3.5 or 3 M) 
introduce greater variability in the delay time to burst of the devices of both material 
types.  
8.4.2 Influence of material mechanical characteristics on the delay to burst and 
payload release  
The xPCL tubes did not feature a longer delay to burst, as shown from the data displayed 
in Figure 8.5 and summarised by comparing the sub-group averages in Table 8.2.  The 
mechanical burst tests (Chapter 6) indicated that the xPCL devices would require a greater 
volume increase than the PCL tubes to burst. In these osmotic tests, the peak mass uptake, 
shown in Figure 8.4 (b) and Table 8.1, and therefore the volume increase, was similar 
between materials and loading osmolarity groups, with the lower osmolarity groups 
taking a longer time to reach peak mass/volume uptake than higher osmolarity groups.  It 
was not anticipated that the devices composed of the different materials would take up a 
similar volume at burst, which may be due to a combination of the significantly slower 
loading rate, 37 oC temperatures, and wet material state during the osmotic test, as 
opposed to the fast loading and dry room temperature conditions during mechanical 
testing. This behaviour may suggest that the form (elastic/plastic) and extent of material 
deformation is influenced by the rate of pressure loading, and therefore in osmotic studies, 
affected by the rate of water uptake. Material hydration may also have a plasticising 
effect, but this would need to be investigated further to determine its presence and 
magnitude. 
 
The xPCL devices did eject more payload at burst than the PCL devices as shown in 
Figure 8.6 (b) and Table 8.3. The xPCL groups released approximately 16.5x (3 M), 13x 
(3.5 M), and 9.5x (4 M) more dye upon burst than their PCL counterparts of the same 
osmolarity.  Release of dye was detectable for both material groups by eye and UV 
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methods, accompanied by a drop in mass.  Comparing the mass lost at burst against the 
extent of dye release in Figure 8.6 (a) and Table 8.3, indicates that a greater extent of 
mass release did not necessarily imply a larger concentration of dye was released at burst.  
In the xPCL group, a device possessing larger peak mass was associated with greater dye 
release at burst.  This observation was true to a lesser extent for the 4 M xPCL group, 
where 1 out of 4 devices did not conform.  However, the PCL devices did not feature this 
behaviour. The lack of a consistent correlation between mass lost and dye released was 
unexpected.  While the peak mass/volume uptake of devices constructed from both types 
of material were similar (overall average 15 ± 4 mg), the manner in which the material 
responds at burst appears responsible for this difference in release at burst.  From previous 
in-vitro and mechanical burst assessments, PCL tubes feature a small degree of 
deformation leading to and at burst, which appears predominately as plastic deformation, 
along with a small pore or tear for payload flux to occur.  The xPCL tubes in comparison 
during mechanical testing displayed an overall greater extent of deformation of which 
some is elastic, resulting in a degree of shape recovery after burst. From the images of the 
device osmotic burst sites in Figure 8.7, other than the burst pinholes and fissures, no 
evidence of deformation was present. Perhaps the elevated temperature combined with a 
plasticising effect from hydration has enabled both materials to behave in a more elastic 
manner, allowing them to return to their original shape.  The xPCL material fissure shown 
in Figure 8.7 (b) is approximately 5x larger than the PCL burst site in Figure 8.7 (a), 
which may account for the greater level of release. The size of the burst sites appear to be 
the main influence regarding the rate of dye release during the steady-state release phases. 
The rates of dye release from the devices during this stage is shown in Figure 8.8 (b) and 
Table 8.4. The rates of dye release appear to be independent from the osmogent loading 
concentration, with release rates within a material group being similar. Again, it is 
interesting to note that there is a lack of a correlation between the rate of mass loss and 
the rate of dye release during this phase. The mass release rates shown in Figure 8.8 (a) 
and Table 8.4 are highly variable, with no particular trends apparent. This could perhaps 
be explained by the remaining glucose solution within the burst devices still exerting an 
osmotic pressure on its surrounding area, and therefore causing a continued uptake in 
mass, which would then hinder the usefulness of considering the behaviour of mass as a 




The different material behaviours also appear to play a role in overall payload release, 
shown in Figure 8.9 (summarised in Table 8.5) by the loss of mass, and release of dye at 
the end of the experiment. The xPCL devices have an advantage in both overall mass loss 
and dye release, due to the greater extent of dye released at burst providing a large head 
start over the PCL devices.  The xPCL devices release significantly greater dye content 
by day 72 in comparison to the PCL devices. With decreasing osmolarity, the xPCL tubes 
released 3x, 2.6x, and 4.3x more dye at day 72 than the PCL groups. The xPCL devices 
lost more mass than the PCL devices by day 72, but the average difference between the 
material types is marginal, with the exception of the 3 M osmogent concentration groups.  
Similarly with the release profiles at the point of burst, it is anticipated that the xPCL 
devices again release more content overall due to the combination of deformation and 
shape recovery characteristics and more extensive burst site.   
 
In future studies featuring flexible materials, it would be advantageous to monitor or 
image the devices periodically to determine the material behaviour during the water 
uptake phase, and to see any evidence of shape recovery upon burst.  Due to dye release 
not correlating with mass loss, monitoring of dye or any other payload target directly 
should be preferred.  
8.4.3 Effect of material permeability and device wall thickness on the water uptake 
rate  
The rates of water uptake between material groups with the same osmogent loading 
concentration are highly similar, as shown in Figure 8.4 (a).  We know from the microCT 
data (Chapter 6 6.4.1) that the xPCL tube wall thicknesses are ~2.6x larger than the PCL 
walls on average, therefore considering Equation 2-6, the permeability of the xPCL 
network must be essentially 2.6x greater than the PCL material to return such similar rates 
of water uptake for the same osmogent concentration (and therefore osmotic pressure). 
Referring back to our initial hypothesis, the data demonstrates that the xPCL material 
does indeed have a greater permeability than the PCL material. However, the effect of 
permeability on the rate of water uptake, and ultimately burst delay, is counteracted by 
the thick xPCL device walls. 
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8.4.4 Relationship between initial loading osmogent concentration and the rate of 
water uptake and its effect on the delay to burst 
The water uptake rates of devices increase with rising osmogent concentration. Higher 
initial osmolarity was also associated with a quicker time-to-burst. Burst variability was 
negatively impacted by lower osmogent concentrations. The underlying spread of data 
within the “time to burst” averages shown in Figure 8.5 suggests an increased dispersion 
as osmolarity decreases, and/or potential consistency issues with tube production. Due to 
this variation, the experiment would also benefit from larger sample populations.  It is 
reasonable to assume that tube consistency is evenly spread amongst all tube groups of 
the same material type due to being manufactured and assembled in the same way and 
being assigned to a specific osmolarity group at random.  While the burst delay time 
averages display the expected trend, there are samples in the lower osmolarity groups that 
burst around the same time as, or even sooner than, the 4 M groups.   
8.4.5 Burst delay methodology assessment 
All three detection methods generally indicate a similar burst window for each group of 
the dye-loaded tubes. From Figure 8.5, UV spectrophotometry and gravimetric 
measurements generally detect device bursts earlier than visual means.  Referring to the 
raw data, UV and gravimetric analysis on average detects bursts 3.5 ± 1.7 days earlier 
than visual identification. Out of 23 viable tube bursts, in 7 instances all burst detection 
methods agree on one day of burst, UV spectrophotometry detected bursts earliest 8 times, 
gravimetric analysis detected bursts earliest 3 times, while UV and gravimetric means 
agreed 5 times on a single day of burst. Visual identification did not detect a burst before 
UV or gravimetric methods. In terms of determining the burst delay, looking at a device-
by-device basis like this reveals that UV spectrophotometry is typically the most sensitive 
methodology, closely followed by gravimetric analysis. Based on this assessment, the UV 
spectrophotometry burst estimates were regarded as the ‘true’ burst points for all tubes. 
 
The UV and gravimetric data spread of all the tube groups, but especially the 4 M groups 
due to the relative size of their standard deviation over their entire delay to burst time, 
may be artificially high due to the relatively infrequent sampling times. For example, the 
standard deviation of the 4 M burst times across both material groups fall below 3 days, 
which was the upper sampling interval time. Therefore, it is possible that certain tubes 
burst on day 1 of that interval that were not detected until a further 2 days later. A 
demonstration of this is the PCL 4 M dye group, which were spotted to have burst on day 
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26, which was 3 days after the previous check (day 23).  UV and gravimetric data suggest 
that the same devices burst approximately around day 23 instead, again demonstrating 
the weakness of long sampling intervals and the limits of visual identification of burst for 
the thermoplastic tubes. The more flexible xPCL tubes show on average much closer 
agreement between visual detection and UV detection, which is likely due to the burst 
behaviour causing a greater and more immediate colour change, in comparison to the PCL 
tubes which release more gradually and to a lesser overall extent. 
Ideally, in future studies assessments would be made daily or more frequently by utilising 
automated means. Naturally, daily checking and sampling of approximately 80 tubes (or 
greater if using increased group n numbers) takes a significant portion of a researcher’s 
time. In this instance, it was made more complicated due to me being required to leave 
Brisbane to return to Edinburgh to continue the rest of my PhD. Therefore, the group in 
Brisbane had to take on data collection duties on my behalf, while attending to their own 
research and deadlines (see acknowledgements). 
 
For studies involving PCL or other thermoplastic devices that are expected to demonstrate 
the same “leaky” pinhole bursts, visual or time lapse imaging are likely to overestimate 
the burst delay while the dye colouring builds in the surrounding solution. For devices 
constructed from flexible or elastomeric materials that show a greater bolus release at the 
time of burst, time lapse imaging would be a less labour-intensive way to relatively 
accurately determine the burst delay times of large quantities of samples.   
It should be noted however that gravimetric and UV analysis provide useful information 
such as the overall profiles of mass and dye shown in Figure 8.3, and subsequently the 
extraction of other “functional property” aspects like the water uptake rate (gravimetric), 
and payload release rate (UV) . Perhaps for larger future studies, burst delay assessment 
of the tubes could be handled by time lapse imaging, while a smaller or less frequently 
sampled subset of devices could be subjected to mass and UV spectrophotometry 
assessments to retain generation of these other useful data sets. 
8.4.6 Defective devices 
A defective tube was defined as a tube that was found to leak dye immediately after 
submersion. We were generally able to identify leaking tubes immediately due to the 
colour change of the PBS solution, but it could also be verified from the mass and UV 
data as shown in Figure 8.10, with extensive mass loss and dye release observed.  Overall, 
the number of defective tubes were low, with only one in the xPCL group (n=11) and two 
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in the PCL group (n=15). This would suggest a manufacturing failure rate of 9% for xPCL 
tubes, and 13% for PCL tubes. This failure rate is essentially on par with what Melchels 
et al previously reported, where four out of twenty-seven tubes failed directly after 
immersion (circa 15%) [21]. These defective tubes were classed as outliers and not 
included in further analysis of their respective datasets.  
8.5 Conclusions  
We successfully demonstrated delayed burst release of a dye from manufactured devices. 
In this experiment, the material type did not generally influence the delay to burst time, 
but did affect the characteristics of the payload release after burst.  The more flexible 
xPCL devices displayed up to 16.5x greater initial release immediately following burst 
by releasing up to 21.5 % of total loaded dye, compared with up 3.5 % from PCL devices. 
Additionally, by day 72 the xPCL devices had released up to 2.5x more payload than 
comparable PCL devices. These findings would suggest that a more flexible material 
could further improve the approximate bolus release profile that we wish to achieve.  The 
delay to burst could be extended by reduction in the concentration of glucose that was 
loaded into the device during manufacture.  This was attributed to the rate of water uptake 
into the device, with faster water uptake occurring when the device was loaded with 
higher concentrations of glucose.  However, the delay to burst time was most reproducible 
when glucose-loading concentration was highest, demonstrated by comparing the burst 
delay time of 4 M xPCL device at 21.3 ± 2.9 days to 3 M xPCL devices at 28 ± 20 days.  
Due to the increase in burst variability at lower glucose concentrations, it may be advised 
to maintain a 4 Molar glucose loading concentration and use other variables such as 
material water permeability, and wall thickness to prolong/or tune the burst delay time.  
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 – Final discussion 
9.1 Main findings 
The overall aim of this work was to develop the next generation of monolithic osmotically 
triggered delayed-release vaccine delivery device as first conceptualised by Melchels et 
al. The main shortcoming of the 1st generation device was the non-bolus trickle-like 
release of payload upon burst. The 2nd generation monolithic delivery devices were 
constructed from a bimodal PCL photo-cured network, composed from long linear bi-
functional 10 kg/mol and 0.9 kg/mol tri-functional macromers. Liquid photo-curable PCL 
resins were formulated using benzyl alcohol as a non-reactive diluent, with low toxicity 
and low vapour pressure. It is recommended that benzyl alcohol should be considered to 
replace dioxane, the diluent typically used in the literature to formulate low-Mw PCL 
resins, which is significantly more toxic and has a higher vapour pressure. A series of 
photo-cured uni- and bimodal networks composed from a variety of bi- and trifunctional 
PCL macromers of various molecular weights were characterised. While networks 
composed of macromers with higher molecular weights demonstrated higher crystallinity 
and toughness, such networks possessed lower reactivity and poorer mechanical 
properties in the ‘green state’ than resins featuring lower Mw macromers. Bimodal 
networks of the 10 kg/mol PCL macromer and either 0.9kg/mol PCL or PTOL-4A 
demonstrated improved reactivity and maintained a portion of the toughness shown by 
the 10 kg/mol networks, while being vastly tougher than 2 kg/mol networks of similar 
crosslinking potential. A resin featuring the 10 kg/mol PCL macromer and pentaerythritol 
tetraacrylate (xPCL10k+4A) was shown to be suitable for stereolithography printing, and 
several intricate objects were successfully printed. All PCL-based (including 
xPCL10k+4A) networks were shown to be degradable via accelerated hydrolysis, with 
bimodal networks degrading faster than unimodal networks. During cytotoxicity 
experiments, the xPCL10k0.9k bimodal network was indicated to be of low toxicity, by 
performing similarly to non-crosslinked high Mw PCL. Prototype devices were 
manufactured using automated dip coating apparatus. A revised high-throughput dip 
coater system was designed and built to assist future work. While dip coating was a simple 
and effective method of producing the tubular part, greater optimisation of the dip coating 
cycles should be performed in order to improve the wall thickness homogeneity. 
Mechanical burst testing indicated that crosslinked-PCL devices would require a greater 
volume uptake to burst, than non-crosslinked-PCL devices. This was however shown not 
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to be the case in later in vitro osmotic burst testing. Caps with higher rigidity appear to 
affect the ability of the tubular part to freely deform. In vitro osmotic burst testing 
demonstrated that the crosslinked-PCL devices released up to 16.5x more payload than 
non-crosslinked-PCL devices at the point of burst. Analysis of the burst sites indicate that 
the xPCL devices burst through a larger tear as opposed to small pinholes or cracks shown 
from PCL devices. These findings suggest that a more flexible material could further 
improve the approximate bolus release profile that we wish to achieve. Due to increased 
burst delay variability at lower osmogent concentration, it is recommended to maintain a 
high osmogent concentration and use material water permeability and device geometry 
aspects (such as wall thickness) to adjust the burst delay timing.  
9.2 Final discussion 
9.2.1 Results in view of the proposed application 
The 2nd generation crosslinked PCL devices offer a marked improvement in bolus release 
over 1st generation non-crosslinked PCL devices. Original devices were shown to release 
approximately 1 % of the payload immediately after burst, while xPCL devices were able 
to release up to 21.5 %. The xPCL material demonstrates a proof of concept of utilising 
a crosslinked material that swells under load and features elastic recovery upon burst to 
achieve a degree of bolus release. It is hoped that by using a more elastomeric material, a 
greater extent of immediate bolus release can be achieved. 
During the initial stages of the project, consideration of the device in vivo degradation 
time was not a priority. The slow degradation rate of PCL was seen as a positive, as was 
then highly unlikely that any meaningful degree of degradation would occur prior to the 
device delivering the booster dose. However, following the more recent establishment of 
a collaboration with The Roslin Institute, where we aim to test the devices in cattle, 
degradation time becomes substantially more important. Particularly, where the cattle 
being immunised are destined for the meat industry, post-slaughter remnants of a polymer 
capsule are undesirable. While the accelerated degradation studies demonstrate that the 
photo-cured PCL networks should remain biodegradable, the conditions used make it 
difficult to relate the rate of degradation to in vitro studies under physiological conditions. 
In particular, the high temperatures will eliminate all crystallinity within the samples, 
making the samples completely amorphous and therefore much more susceptible to water 
uptake and hydrolytic cleavage. Ideally, a long-term degradation study should be 
performed using physiological conditions to determine whether the bimodal networks still 
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degrade faster than the unimodal or non-crosslinked materials when sample crystallinity 
is maintained. 
One of the main potential issues of the new photo-cured devices is that the crosslinked 
nature of the tubular part limits the available options for capping. The current method 
uses injections of resin into the ends of the device, which enables the resin to crosslink to 
available reactive groups on the inside barrel of the tubular part, covalently bonding the 
plug to the tube. These plugs of resin are not subjected to an extraction procedure, 
meaning that uncured macromer, and left-over photo-initiator will remain. It is 
demonstrated in Chapter 5 that both such components can have toxic effects. While the 
amount of resin used to create these plugs/caps is small the residual content of photo-
initiator in particular, may be enough to irritate surrounding tissue as it leaches out of the 
plug. Additionally, while it would be possible to re-extract the device after curing of the 
1st plug/cap, after filling and curing of the 2nd cap extraction is no longer suitable due to 
fluid exchange between the extracting solvent and the glucose/payload solution within 
the device. At present, this has not been resolved in a satisfactory manner and will apply 
to any future radical-based crosslink-able network system developed. Changing the 
photopolymerisation chemistry of the system to a photo-initiator-less photoclick system 
may offer a less toxic solution [239], [240]. However, photo-curable resin formulations 
of such materials typically require irradiation with < 300 nm light, with commercially 
available DLP systems generally not featuring light sources with peak wavelengths that 
short. Another potential approach would be the use of thermoplastic elastomers (TPEs). 
TPEs are a class of copolymer that typically consist of hard crystalline blocks and 
comparatively soft elastic segments, which gives them the elasticity of a conventional 
thermoset rubber with the processability of plastics [241]. The hard block components of 
various polymer chains can self-agglomerate during cooling to assemble into crystalline 
domains with physical crosslinks that resist creep and viscous flow under load, while the 
soft portion remains amorphous and elastic [242]. Use of TPEs would allow use of 
thermal fusion capping techniques used in this thesis and the previous conceptual work 
[21], while improving the elasticity that appears useful in achieving immediate bolus 
release from the devices.  
9.2.2 Mechanical burst testing as a prediction of osmotic burst behaviour 
Despite the mechanical burst assessment predicting that the xPCL tubes would require 
the uptake of a greater volume to burst, the delay-to-burst, and peak mass/volume reached 
by tubes composed of the different materials were similar. The mechanical peak volumes 
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prior to burst overestimate the volume required to burst in vitro, particularly so for the 
xPCL material. The PCL device mechanical volume to burst was ~22 µL, while the 
osmotic volume uptaken prior to burst was ~15 µL. For the xPCL – Resin tubes, the peak 
mechanical volume was 277 µL and the osmotic peak volume ~13 µL. Such a huge 
disparity between the mechanical and osmotic volumes required to burst the xPCL tubes 
clearly indicates that the mechanical test methodology is unsuitable in its current form for 
evaluating the burst nature of the devices. Use of the particular mechanical test method 
in Chapter 6 to predict in vitro osmotic burst behaviour should be used as an indicative 
assessment only, due to a few key differences. The mechanical burst testing was 
performed at room temperature, with the devices being in the dry state, and with water 
being forced into the devices at a relatively fast rate (83.5 µL/min) in comparison to the 
rate of water translocation during an osmotic test. At 37 oC in the incubator during in vitro 
osmotic tests, the materials will be more flexible and less stiff than at room temperature, 
leading to changes in the yield and deformation behaviour [243] with magnitudes being 
difficult to predict without further testing. However, 37 oC is just within the onset of the 
melting peak of the xPCL10k0.9k networks (determined from DSC), therefore only a 
very minimal reduction in crystallinity is expected. Water saturation of the xPCL network 
walls is likely to exert a plasticising effect [244], which would potentially cause further 
changes in material yield/deformation. However, based on data shown by Melchels et al, 
the effect from the state of hydration is expected to be small [21]. During osmotic tests 
discussed in Chapter 8, typical osmotic water uptake rates into xPCL devices were shown 
to be approximately 893 µg/day (xPCL 4 M), equivalent to 0.6 nL per hour. This greatly 
reduced rate of volume gain of approximately 7 orders of magnitude will generate a 
slower strain rate on the device walls, which can influence the point of yield as well as 
strain hardening behaviour [243]. Considering the expected minimal effects of 
temperature and hydration discussed above, the effect of strain rate is anticipated to be 
the main cause of the differences between in vitro and mechanical testing burst behaviour. 
Tensile and burst testing of the xPCL material at physiological temperature and water 
saturation is required to develop a more complete methodology to predict in vitro 
behaviour from the mechanical tests. The mechanical test in its current form does not take 
into consideration of potential wall thickness differences between devices. It has been 
previously shown that there is a strong correlation between wall thickness and burst 
pressure strength [21]. Additionally, the mechanical test methodology does not consider 
that devices composed of the different materials may uptake water at different rates due 
153 
 
to differences in material water permeability. This is emphasised when considering the 
delay-to-burst times, and peak mass in Chapter 8 between the PCL and xPCL devices 
containing the same osmogent concentration. As discussed above, testing of the material 
at the appropriate temperature, and with a slower rate of loading are considered key 
aspects to better correlate the mechanical predictions to the osmotic outcomes. 
For future mechanical testing, devices could be incubated at 37 oC while submerged in 
water for a few days prior to the experiment, to replicate the water-saturated state of the 
device during osmotic burst testing. During mechanical testing, a beaker of water kept at 
approximately 37 oC could be placed underneath the syringe mount for the tube to be 
submerged in throughout the test. This would maintain the tube at the most relevant 
temperature and state of hydration. To assess the effect on the manner of burst from the 
rate of loading, testing could be performed using a series of injection rates over a few 
orders of magnitude. Use of true elastomers in future work may minimise the influence 
of the strain rate, as the mechanical properties of such materials are not considered to be 
strongly dependent on strain rate.   
9.2.3 xPCL10k+4A printed tubes 
The xPCL10k+4A tubes manufactured by stereolithography may behave differently from 
their dip coated xPCL10k0.9k counterparts due to differences in their network structure 
and production technique. Most notably, the xPCL10k+4A networks contain a 
substantially lower degree of crystallinity (Table 4.3), with approximately 14 % of the 
xPCL10k0.9k network crystallinity. As previously discussed in Chapter 4 and Chapter 8, 
the degree of crystallinity plays an important role in determining both the mechanical 
properties and water permeability of the network. In an osmotic setting, the xPCL10k+4A 
network would likely offer greater diffusivity than the xPCL10k0.9k networks due to the 
greater extent of amorphous domains facilitating uptake. However, the permeability may 
be limited by the water uptake equilibrium within the polymer walls, and therefore the 
greater diffusivity may not necessarily result in a faster rate of water uptake or lead to a 
shorter delay to burst.  The xPCL10k+4A networks are also less stiff and yield at a lower 
stress but after slightly longer elongation (1.20 ± 0.15 mm vs. 0.81 ± 0.03 mm) than the 
xPCL10k0.9k networks. This would result in a greater degree of elastic deformation at 
the same internal pressure, with elastic deformation occurring over a greater 
elongation/strain potentially leading to a greater elastic response at break, but the 
magnitude of the difference between the materials would be small.  It is claimed that the 
elongation at break of the trifunctional crosslink-containing networks would be higher 
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than the tetrafunctional-containing networks, due to the trifunctional junctions imposing 
less drastic restrictions on chain motions [245]. However, the difference in elongation at 
break between the tri- and tetrafunctional crosslinkers appears negligible, based on the 
tensile testing data. There are also too many differences between the networks to isolate 
this effect here. 
9.2.4 Comparison of manufacturing methods 
Structures that are printed via stereolithography and subjected to post-curing are generally 
considered to possess no significant (< 1%) mechanical anisotropy [246], [247] This 
would imply that there should be no significant differences between tubular parts 
produced by STL or dip-coating when using the same resin formulation, providing dip-
coating also results in an isotropic part. Verification of isotropy can be performed through 
a simple experiment, where tensile specimens are printed in different orientations and 
subjected to tensile tests. If the networks are isotropic they should all perform similarly, 
in terms of ultimate strength and Young’s modulus for example, regardless of their build 
orientation. Continuing on the basis that both STL and dip-coated parts will offer the 
same mechanical properties, the quality of the parts made, the time required to 
manufacture them, and the associated costs should be considered. In terms of quality, the 
STL fabricated tubes should offer more consistent wall thicknesses throughout the length 
of the tubes and are likely to be more consistent within, and between batches. The dip-
coating cycle would need significant optimisation to achieve the same wall thickness 
consistency. Slight variance in the dimensions, surface qualities, and mounting of the dip 
coating substrate rods will also introduce further variance, although variance from these 
sources is expected be relatively acute. The time and cost to fabricate the tubular parts 
requires consideration of the number of tubes being made at one particular time, and the 
curing times required. The DLP process increases in efficiency as the number of tubes 
built within a single print cycle increases, as the print time stays the same regardless of 
the number of tubes being printed at once. DLP requires consideration of operational costs 
due to replacement of consumables such as the resin vats. EMBER has the potential to 
print approximately 140 tubes at once based on the vertical arrangement with the ‘X’ 
shaped supporting structures, but other DLP printers with larger build areas would be able 
to fit many hundreds or thousands of tubes within a single print job. Other potentially 
useful features of DLP is that mini barcodes or other manufacturing tracking marks could 
be procedurally generated and integrated on to the printed parts directly. When 
considering production of a single tube geometry on an industrial scale, a well optimised 
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dip-coating procedure will have a time/cost advantage over DLP technology. However, 
industrial DLP machines would offer a versatile manufacturing platform for the 
production of various device geometries for different vaccination programme boost dose 
delay lengths, and therefore shouldn’t be disregarded. The main challenge that remains is 




APPENDIX A: osmotically triggered delayed burst release of tetanus 
toxoid 
Protein release and quantification issues 
Introduction 
This appendix will discuss the methodology used during the setup of the microBCA 
assay, the discovery of detection and quantification issues, how the issues were 
investigated and verified, and recommendations to rework the methodology to achieve 
the original objective.  
As introduced in Chapter 8, osmotic release of vaccine material in the form of tetanus 
toxoid was one of the experimental objectives.  During the very early stages of data 
analysis, it was noticed that protein concentrations from the microBCA assay appeared to 
be influenced by the presence of glucose.  After further investigation, it was realised that 
glucose concentrations above 1 mM are known to have an interfering effect on the assay, 
and was listed within the kit’s manual.  Therefore, the absorbance values and calculated 
“protein” concentrations consisted of a protein component, and a glucose component, of 
which discerning the fraction attributed to each would be difficult and unreliable.  Due to 
this oversight, further microBCA work was halted. 
The sections below contain all the protein release work that was conducted as initially 
planned in the introduction to Chapter 8, and as such follow the same material group 
labels (PCL = non-cross-linked PCL devices, xPCL = UV cross-linked PCL devices).  
Experimental setup 
Protein release calibration 
In order to quantify the protein as a concentration, a relationship between absorbance and 
protein concentration had to be established.  The microBCA assay was initially calibrated 
against a series of BSA protein standards of known concentration provided with the kit.  
The assay was utilised in the microplate format, which provides a linear working range 
of 2-40 µg/mL for BSA containing solutions.  BSA solutions of concentrations 0, 0.5, 1, 
2.5, 5, 10, 20, 40 and 200 µg/mL were used to generate Figure A1 (a).  For quantification 
purposes, only samples within the linear working range were used to generate the 




Figure A1:- BSA standard curve (a), and the linear working range calibration curve with fitted polynomial (2nd order) 
equation (b).  
A series of dilutions of the TT stock were performed to prepare 8 TT samples which we 
could perform the microBCA on, and use to back calculate their respective concentrations 
as well as the overall concentration of the stock solution.  The main assumption is a 1:1 
assay colour response to TT as with BSA protein.  The polynomial (recommended within 
assay manual) trendline equation from Figure A1 (b) was rearranged for x 
(concentration), and the sample absorbance values entered as y values.   Five out of the 8 
samples ended up below the quantifiable range, however the difference between the 
remaining 3 samples were in good agreement with what would be expected based on the 
dilutions.  Further back-calculation estimated that the stock protein concentration was 
15,105 µg/mL. 
Results 
Osmotic tetanus toxoid release 
Release of the tetanus toxoid vaccine from the devices was performed as discussed in 
Chapter 8.  Analysis was performed on the five tubes belonging to the PCL 3.5M group.  
The cumulative protein concentrations released into the PBS samples from 7, 14, 21, 28, 
35, 42, and 49 days after immersion were determined from the microBCA assay, as shown 











































Figure A2:- Cumulative protein release from the PCL 3.5 M group devices. Each line represents the protein 
concentration profile for an individual device. 
The devices gradually release protein after burst.  Initial protein detection, and therefore 
device burst, occurred between 7-35 days (mean = 20 ± 9 days).  
Example of glucose interference 
Due to suspicions regarding glucose interference on the absorbance values returned by 
the microBCA assay, a small investigation was performed to determine whether these 
suspicions were well founded.  The stock solutions of 3, 3.5 and 4 M glucose with TT 
that were used for the loading of the tubes were diluted to 2 different theoretical 
concentrations (8 and 18 µg/mL)  that should be within the linear working range.  
Additionally, TT stock solution with no glucose was diluted down to the same 
concentrations.  Therefore, in total there were 8 experimental samples. All 8 samples were 
tested using the microBCA assay, and their absorbances (a) and calculated protein 
concentrations (b) plotted against their predicted theoretical protein concentrations, as 




Figure A3:- Sample absorbance (a), and calculated protein concentrations (b) against predicted theoretical 
concentration based on previous TT stock concentration calculations.  
The absorbance values for all the glucose-containing samples are significantly higher than 
their 0 M glucose counterparts, and therefore their calculated concentrations follow the 
same trend.  The increase in absorbance within a theoretical concentration appear to be 
linked to the concentration of glucose, with higher glucose containing samples returning 
greater absorbance and concentration values.  
Stock protein investigation 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed on samples taken from the stock solutions that the devices were loaded with 
prior to immersion.  Additionally, a positive control with 10 µg of BSA and a sample of 
the TT stock with no glucose present were included.  After separation, the gel was fixed 
and stained with coomassie blue to visualise the protein bands.  The gel image is shown 




No bands are visible in columns 1-4 indicating the absence, or very low concentration 
below the limit of detection, of protein within these samples.  The BSA positive control 
band is present between the 50 and 75 kDa molecular weight markers. 
Discussion 
Summary 
The microBCA assay did return a positive absorbance signal after a delay period, 
indicating that the devices did demonstrate osmotically triggered delayed release of their 
contents.  Mean device burst occurred after 20 ± 9 days of immersion.  However, evidence 
of glucose interference with the microBCA assay was discovered, and its extent appears 
to be linked with glucose concentration.  Protein sample solutions with glucose present 
returned absorbance values of up to 10x higher than the non-glucose containing 
equivalent.  Further attempts at characterising the TT protein stock solution failed, with 
no-protein material being detected from SDS-PAGE.  It was found in the microBCA 
assay kit manual, that the presence of glucose of concentrations over 1 mM in samples 
was known to have an interfering effect on the colourimetric mechanism of the assay.  
Technical bulletins from the supplier recommended a series of methods to remove or 
reduce the presence of interfering substances from samples, of which the protein 
precipitation methods appear most promising. 
Osmotically triggered delayed release of tetanus toxoid 
Delayed release of device contents was demonstrated from the PCL 3.5 M devices shown 
in Figure A2, which burst over a range of 7 – 35 days with a mean burst delay of 20 ± 9 
Figure A4:- Image of the gel after SDS-PAGE. Calibration ladder in leftmost column 
with units in kDa. Column contents are as follows: TT stock with no glucose (1); 




days.  In comparison to the PCL 3.5 M dye-containing devices, the TT-containing devices 
appear to burst sooner and with a greater variance.  However, the mean burst delay times 
are within standard deviation of one another (PCL 3.5 M dye-containing device burst 
delay mean = 25 ± 5.8 days).  The TT-containing device group features two device bursts 
at days 7 and 14, which are notably early when considering both payload groups of PCL 
3.5 M devices together.  Further analysis of the other (3 and 4 M) osmogent loading 
concentration groups would be necessary to draw any potential conclusions regarding any 
tendency of the protein-containing devices to burst earlier than their dye-containing 
equivalents.  Considering the general trend witnessed from the dye-containing data, 
where greater variance could be associated to lower loading osmolarities, it is likely that 
these early bursts at days 7 and 14 are within the expected variance for the 3.5 M loading 
condition, rather than any influence by the payload.  Comparing the rate of release of the 
contents of the protein- and dye-containing PCL 3.5 M devices in a qualitative manner 
shows the same gradual release characteristic, which appears typical for the PCL devices 
in general.  Due to the glucose interference effect with the microBCA assay, which will 
be discussed in the next sub-section, it is not certain if the displayed protein 
concentrations in Figure A2 are valid.  Instead, the y-axis values should be considered a 
semi-quantitative representation of content (both protein and glucose) release at best, or 
more conservatively as a qualitative indicator of device burst. 
Glucose interference with the microBCA assay 
From the brief investigation into the effect of various glucose concentrations on the 
microBCA assay results, it can be shown from Figure A3 that the presence of glucose 
leads to overestimation of the protein content of the sample solution in a glucose-
concentration dependant manner.  The presence of glucose at the concentrations used 
during device loading increased the absorbance produced by the colourimetic 
mechanisms of the assay to such an extent that all of the glucose-containing solutions 
tested greatly exceeded the linear working range of the assay.  Considering that the 
glucose-containing samples are out with the linear working range, care should be taken 
to state that this experiment is conclusive proof of the glucose-concentration dependant 
effect.  However, considering the data in at least a semi-quantitative manner, the assay 
does consistently associate higher glucose concentrations with higher absorbances. 
Further work would be required to quantify the extent that different glucose 
concentrations affect the assay.  Ideally, a glucose-only control solution would have been 
tested, combined with solutions containing significantly lower concentrations of glucose 
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(so that the signal is within the linear quantifiable zone) to enable quantification of the 
effect of glucose concentration on the assay. 
TT stock concerns 
The tetanus toxoid stock solution was of unverified purity and concentration.  In order to 
address this, SDS-PAGE was performed in an attempt to purify and quantify the stock 
solution.  The experiment was performed with 4 sample columns, of which one was the 
TT stock solution, with the others containing solutions of TT and glucose of the three 
concentrations used to load the devices, and a BSA positive control column.  SDS-PAGE 
was performed, but was unsuccessful in detecting any protein in the samples of interest 
(columns 1-4), as shown in Figure A4 by the lack of identifiable protein bands.  Mature 
BSA protein has a molecular weight of approximately 66 kDa [248].  The BSA positive 
control displayed a clear protein band between 50 and 75 kDa, which validates that the 
assay was functioning and performed correctly.  We would expect to detect protein bands 
in the other experimental columns at 150 kDa, or 100 and 50 kDa representing the 
separate heavy B-chains and light A-chains of the tetanus toxin, respectively.  
Additionally, further analysis by A280 and BCA (non-micro) assays were also 
unsuccessful in detecting protein. 
Methodology oversight and limitations  
While the microBCA assay was able to get positive absorbance signals from sample 
solutions, as shown in Figure A2, it was discovered that the maximum compatible 
concentration of glucose with the kit was 1 mM [249].  Glucose was listed as a known 
interfering agent at the back of the assay manual, which section was overlooked at the 
time of purchasing and conducting the microBCA assay.  Beyond 1 mM, the error in 
protein concentration determination may exceed 10 %.  With our minimum initial 
osmogent concentration being 3 M, it would be reasonable to anticipate that it would 
exceed the 1 mM limit rapidly after device burst.  This expectation is likely to be 
especially relevant for the xPCL tubes that release a greater extent of inner contents at 
burst and therefore as part of that, glucose.  Unfortunately, this ultimately means that this 
method of protein quantification is not suitable for the sample material in its current state.    
Future work improvements 
For future protein-release experiments, if utilising the same TT material, further in-depth 
confirmation/characterisation of the stock would be important to ensure that the protein 
is in its expected state, and not denatured/degraded.  Otherwise, use of a different already 
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characterised protein material of a known initial concentration would be recommended.  
The issues regarding the potential glucose concentrations surpassing the microBCA kit 
limitations would remain regardless of protein stock used.  A method of eliminating 
interfering substances, which would include glucose, from samples for BCA protein 
assays are suggested in the tech tip series from Thermo Scientific [250].  The procedure 
involves precipitation of the protein material in -20 oC acetone, centrifugation, removal 
of supernatant, and resuspension of the protein pellet in a known volume of ultrapure 
water.  The microBCA reagents are then added, and the assay performed as normal.  
Another method suggested involves a highly similar procedure with trichloroacetic acid 
and sodium deoxycholate instead of acetone.  Lastly, dialysis of the sample would 
separate the 150 kDa protein from the 0.18 kDa glucose, but would require determination 
of the extent of dilution of the TT in the glucose-free solution, and is likely to also be 
more time intensive. 
Another aspect to consider regarding true quantification is that the protein colour response 
from the microBCA assay will show differences depending on the protein it is being used 
to detect and quantify.  The microBCA assay is centred on bovine serum albumin (BSA), 
and has known adjustment ratios for 13 commonly tested proteins (which does not include 
tetanus toxoid material).  For protein material that is not already standardised for this kit, 
it is encouraged to generate a calibration curve from purified target protein of a known 
starting concentration.  As mentioned previously, the TT stock used was of unverified 
purity and concentration.  The stock protein concentration was estimated (15,105 µg/mL) 
by preparing a dilution series and performing the microBCA assay on those samples as 
mentioned in section “protein release calibration” and shown in Figure A1 (b), assuming 
a 1:1 protein colour response of the TT with the BSA standards included in the kit.  It is 
quite likely that in reality a 1:1 colour response is not the case for TT, and that this 
estimation contains a substantial degree of error.  If a stock of known concentration was 
used, it would have been possible to determine a correction factor (correction ratio), as 
noted within the assay kit manual. 
Conclusions 
Osmotically triggered delayed release of tetanus toxoid was demonstrated from the 
delivery devices, with a mean delay to burst of 20 ± 9 days.  Due to glucose interference 
with the colourimetric aspect of the microBCA assay, it was not possible to quantify the 
protein released from the devices with any degree of confidence.  However, a future 
attempt at releasing protein from such devices may benefit from methodology 
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adjustments, such as use of a protein stock of known concentration and purity, and 
utilising one of the strategies to eliminate or minimise the interfering effects of high (> 1 




APPENDIX B: mark I dip coater g-code and ImageJ wall thickness 
calculation script 
Dip coating g-code 
The dip coating g-code for production of PCL and xPCL tubes via the mark I dip coating 
apparatus is shown below. The code should be copied into a notepad file and saved with 
an appropriate g-code file extension suffix, such as .gcode. 
 
The non-crosslinked PCL dip cycle g-code is shown below: 
G17 G21 G40 G49 G54 G80 G91 G94 F1200  %G91 is relative coordinates! 
 
F100 G1 y10   % slow rotation to check things are aligned             
F1200 G1 x-115 y10      % speed is 1200 for both x and y and move the tube up 115 mm 
whilst rotating y for 6 seconds (or 1 rotation) 
F100 G1 Y10           % F = rotate y at a speed of 100 ; Y = for 6 seconds (or 1 rotation) 
F1200 G1 x115 y10       % F = speed is 1200 for both x and y and move the tube down 
115 mm whilst rotating y for 6 seconds (or 1 rotation) 
F100 G1 Y300            % F = rotate y at a speed of 100; Y = for 3 mins (or 30 rotations) 
 
F1200 G1 x-115 y10      % speed is 1200 for both x and y and move the tube up 115 mm 
whilst rotating y for 6 seconds (or 1 rotation) 
F100 G1 Y6              % F = rotate y at a speed of 100 ; Y = for 3.5 seconds (or 2/3 rotation) 
F1200 G1 x115 y10       % F = speed is 1200 for both x and y and move the tube down 
115 mm whilst rotating y for 6 seconds (or 1 rotation) 
F100 G1 Y300            % F = rotate y at a speed of 100; Y = for 3 mins (or 30 rotations) 
 
F1200 G1 x-115 y10      % speed is 1200 for both x and y and move the tube up 115 mm 
whilst rotating y for 6 seconds (or 1 rotation) 
F100 G1 Y4             % F = rotate y at a speed of 100 ; Y = for 2.5 seconds (or 2/5 rotation) 
F1200 G1 x115 y10       % F = speed is 1200 for both x and y and move the tube down 
115 mm whilst rotating y for 6 seconds (or 1 rotation) 




F1200 G1 x-115 y10      % speed is 1200 for both x and y and move the tube up 115 mm 
whilst rotating y for 6 seconds (or 1 rotation) 
F100 G1 Y3             % F = rotate y at a speed of 100 ; Y = for 2 seconds (or 1/3 rotation) 
F1200 G1 x115 y10       % F = speed is 1200 for both x and y and move the tube down 
115 mm whilst rotating y for 6 seconds (or 1 rotation) 
F100 G1 Y300            % F = rotate y at a speed of 100; Y = for 3 mins (or 30 rotations) 
F100 G1 y10   % slow rotation to check things are aligned at the end   
 
The photo-curable xPCL dip cycle g-code is shown below: 
G17 G21 G40 G49 G54 G80 G91 G94 F1200  %G91 is relative coordinates! 
%initial dip 
F100 G1 Y10  %Initial turns to check for collisions 6 seconds of rotation 
F1000 G1 X-120 Y6 %Moves tube upwards for dip with slow y rotation of rod 
F40 G1 Y10  %rotates at 4rpm for 15 seconds 
F1000 G1 X120 Y6 %moves tube back down 
F60 G1 Y420  %rotates at 6 rpm for 7 mins - cure stage 
 
%2nd dip 
F1000 G1 X-120 Y6 %Moves tube upwards for dip with slow y rotation of rod 
F40 G1 Y10  %rotates at 2rpm for 1 mins 
F1000 G1 X120 Y6 %moves tube back down 
F60 G1 Y420  %rotates at 6 rpm for 7 mins - cure stage 
 
%3rd dip 
F1000 G1 X-120 Y6 %Moves tube upwards for dip with slow y rotation of rod 
F40 G1 Y10  %rotates at 2rpm for 1 mins 
F1000 G1 X120 Y6 %moves tube back down 
F60 G1 Y420  %rotates at 6 rpm for 7 mins - cure stage 
F60 G1 Y420  %rotates at 6 rpm for 7 mins - post cure stage  
ImageJ script code 
Below is the ImageJ script code for batch-processed calculation of wall thicknesses of 
tubular parts. Note that this script requires ImageJ version of 1.52k or newer to run 
correctly. The text below should be arranged as a .txt file and selected through the 
“process>batch>macro…” processing window. Input folder of images to be measured 
167 
 
must be selected as the input. The script assumes all images will have the sample holder 
and the sample itself present. After processing, the measurements will be listed within a 
table in ImageJ, and can be saved in multiple file formats (.csv was chosen here). Note 
that the variable “pel” that determines the ‘pixels per mm’ of the image can be set to 
whatever known scale for the images. In this instance pel was kept at 1, and the 
measurements were converted afterwards. 
// imagej-macro "batch pipe wall thickness (CoC)"  
requires( "1.52k" ); 
nme = "Polar_Transformer.class"; 
if ( !File.exists( getDirectory( "plugins" ) + nme ) ) exit( "Macro requires PlugIn \"" + 
nme + "\" !" ); 
setBackgroundColor(0, 0, 0); 
setOption("BlackBackground", true); 
pel = 1; // pixels per millimeter 
inc = 1; // angular increment in degrees 
dir=getDirectory(""); 
list=getFileList(dir); 
setBatchMode( true ); 
for ( i=0; i<list.length; i++ ) {  
   open(dir+list[i]); 
   wallThickness( inc, pel, File.nameWithoutExtension  ); 
   close(); 
} 
setBatchMode( false ); 
exit(); 
function wallThickness( deg, scale, fileName ) { 
   run("Set Scale...", "distance=0 known=0 pixel=1 unit=pixel"); 
   run( "8-bit" ); 
   setAutoThreshold( "Default dark" ); 
   run( "Convert to Mask" ); 
   doWand( 90, getHeight() * 0.48 ); 
   run("Clear Outside"); 
   List.setMeasurements; 
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   x = List.getValue( "XM" ); 
   y = List.getValue( "YM" ); 
   nMax = round( List.getValue( "Perim." ) ); 
   run( "Select None" ); 
   outer = newArray( 0, y ); 
   inner = newArray( x, y ); 
   fitCircle( outer ); 
   fitCircle( inner ); 
   run( "Select None" ); 
   x = ( outer[0] + inner[0] ) * 0.5; 
   y = ( outer[1] + inner[1] ) * 0.5; 
   n = round( 360 / deg ); 
   if ( n > nMax ) { n = nMax; deg = 360 / nMax; } 
   run( "Polar Transformer", "method=Polar degrees=360 number=[n] center_x=[x] 
center_y=[y]" ); 
   run( "Make Binary" ); 
   wMax = 0; 
   wMin = getWidth(); 
   wMean = 0; 
   for ( i=0; i<n; i++ ) { 
      w = calcWidth( i ); 
      wMean += w; 
      if ( w > wMax ) wMax = w; 
      if ( w < wMin ) wMin = w; 
   } 
   wMean /= n; 
   setResult( "Label", nResults, fileName ); 
   setResult( "#Angles", nResults-1, n ); 
   setResult( "Mean/mm", nResults-1, wMean/scale ); 
   setResult( "Min/mm", nResults-1, wMin/scale ); 
   setResult( "Max/mm", nResults-1, wMax/scale ); 
   close(); 
} 
function fitCircle( a ) { 
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   doWand( a[0], a[1] ); 
   run( "Fit Circle" ); 
   getSelectionBounds( x, y, w, h ); 
   a[0] = x + w * 0.5; 
   a[1] = y + h * 0.5; 
} 
function calcWidth( idx ) { 
   makeRectangle( 0, idx, getWidth(), 1 ); 
   p = getProfile(); 
   s = 0; 
   for ( i=0; i<p.length; i++ ) { if ( p[i] > 0 ) s++; } 
   return s; 
} 
// imagej-macro "batch pipe wall thickness (CoC)"  
Originally from Herbie G., 04./06. Feb. 2019 
With edits from Kerr S 
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